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END-OF-LIFE CARE
Death comes to us all. Nowadays, acute deaths due to infectious diseases have largely been replaced 
by non-sudden deaths, caused by e.g. cancer or cardiovascular diseases 1-2. Advances in health care 
technologies have improved life expectancy and have also expanded the range of interventions 
which potentially prolong the life of severe ill patients. These changes involved more prolonged death 
trajectories, which are likely to involve some form of end-of-life care 2. 
Palliative care has been defined by the World Health Organization (WHO) as “an approach that improves 
the quality of life of patients and their families facing the problem associated with life-threatening 
illness, through the prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and spiritual”. Palliative care 
is promoted as the preferred approach to care for people with life-threatening illnesses, and has defined 
it as a major public health priority for all countries 3. Palliative care has been divided into three stages 4:
•	 advancing	disease	with	the	goals	to	decrease	disease;
•	 increasing	decline,	with	the	goal	to	prevent	and	treat	symptoms;
•	 end-of-life	care,	with	the	goal	to	have	a	dignified	death.	
End-of-life care is a special part of palliative care, which refers to the management of patients and 
relatives during the final stages of life (see figure 1). In the last decades, many advances have been made 
to alleviate patients’ suffering at the end of life, such as better management of pain through thoughtful 
use of common analgesics, including opioids, and improved management of other symptoms than pain 5. 
 
Figure 1. The scope of palliative care
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END-OF-LIFE DECISIONS
End-of-life decision-making is a sensitive but important aspect of end-of-life care that can have a 
significant impact on the process of dying and dying patients’ comfort in the last days of life. Moreover, 
death is often preceded by medical end-of-life decisions with a certain or potential life-shortening effect: 
the frequency of such decisions has been found to be 44% of all deaths in the Netherlands and to range 
from 23-51% of all deaths in Europe 6. 
The Dutch tradition
The Netherlands have a long tradition, since 1990, in conducting research on end-of-life decisions 7-11. 
Within this research tradition, medical end-of-life decisions are classified into five categories:
•	 Euthanasia;	the	administration	of	drugs	with	the	explicit	intention	of	hastening	death	at	the	patient’s	
explicit request
•	 Physician-assisted	suicide;	the	prescription	or	supply	of	drugs	with	the	explicit	intention	to	enable	
the patient to end his or her own life
•	 Ending	of	life	without	an	explicit	patient	request;	the	administration	of	drugs	with	the	explicit	
intention of hastening death without an explicit patient request
•	 Alleviation	of	pain	and	symptoms;	in	dosages	which	are	large	enough	to	include	the	hastening	of	
death as a likely or certain side-effect
•	 Withholding	or	withdrawing	potentially	life-prolonging	treatment
Internationally, the practice of these five end-of-life decisions varies 6. Furthermore, also which decisions 
are defined as being an end-of-life decision differs. Our international survey among palliative care experts 
that aimed at getting insight into important end-of-life decisions showed a broad scope of different 
end-of-life decisions, going beyond the five medical end-of-life decisions mentioned above. These 
international palliative care experts mentioned decision-making regarding withdrawing or withholding 
treatment, symptom management and place of dying often as important end-of-life decisions. Euthanasia 
was mentioned less often, although it was also mentioned also by some countries without legislation 
regarding assistance in dying 12. 
Dutch legalization regarding end-of-life decisions
End-of-life decision-making is regulated by legislation, guidelines, and professional codes. Two important 
legislations in the Netherlands are the Dutch Euthanasia Act and the Dutch Act on Medical Treatment (in 
Dutch: WGBO).
Dutch Euthanasia Act
In the Netherlands, the discussion about euthanasia and physician-assisted suicide has started in the 
previous century, which has led to the Dutch Euthanasia Act (formally referred to as the Termination of 
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Life on Request and Assisted Suicide Act). Since 2002, this Act regulates the practice of euthanasia and 
physician-assisted suicide in the Netherlands and formulates criteria of due care. The physician has to 
perform	euthanasia	or	physician-assisted	suicide	according	to	these	criteria;	otherwise	his	actions	still	will	
be punishable. The criteria of due care require the physician be convinced that: 
•	 there	is	a	voluntary	and	well-considered	request	from	the	patient;
•	 the	patient	is	suffering	unbearably	without	prospect	of	improvement;
•	 the	patient	is	informed	about	his	situation	and	prospects;
•	 there	are	no	reasonable	alternatives	to	relieve	suffering;
•	 an	independent	physician	must	be	consulted;
•	 euthanasia	or	physician-assisted	suicide	is	performed	with	due	medical	care	and	attention.	
Furthermore, physicians have to report euthanasia or physician-assisted suicide to one of the five regional 
multidisciplinary review committees. These review committees assess whether or not the physician has 
acted in accordance with the criteria of due care. The judgments of the review committees and case law, 
as being jurisprudence, provide a definite interpretation of the act.
Although the Dutch Euthanasia Act is for more than ten years in place, public and professional debates 
remain, especially about the boundaries and interpretation of the Dutch Euthanasia Act. Nowadays, the 
debate mainly focuses on euthanasia or physician assisted suicide in older people who are tired of living, 
without having a serious medical condition and in patients with late-stage dementia and the role of 
an advance directive. For the former, a citizens’ initiative was launched in 2010, aiming to achieve legal 
assistance of dying in older people who are tired of living. The House of Representatives has rejected the 
proposal of this citizens’ initiative, but the debate continues.
Dutch Act on Medical Treatment
In the Netherlands, the Dutch Act on Medical Treatment regulates the relation between the patient and 
healthcare professionals 13. This act states that patients have to consent with a medical treatment and 
that the patient has the right to refuse medical treatment at any moment. Moreover, patients can also 
record their preferences for end-of-life care in an advance directive. A physician has to respect a negative 
advance directive, in which the patient refuses treatment, whereas a positive advance directive only 
guides a physician to better understand the patient’s values and preferences. In the Netherlands, such 
a positive advance directive may also include a request for euthanasia. With such a request, patients ask 
their physician for assistance in dying in specific situations, which is a relatively common type of advance 
directive in the Netherlands 14. As stated by the Dutch Royal Medical Association, such advance directives 
for euthanasia are mere supportive, and do not replace the need for personal communication.
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NUTRITION AND HYDRATION AT THE END OF LIFE
End-of-life care often involves decisions about withholding or withdrawing potentially life-prolonging 
treatment, such as artificial nutrition and hydration. Decisions about artificial nutrition and hydration are 
important decisions at the end of life, as demonstrated by our international survey among palliative care 
experts 12. Although most terminally ill patients have a decreased oral intake and loss of appetite at the 
end of life (39-82%) 15-17, providing artificial nutrition and hydration to all terminally ill patients at the end 
of life does not seem to be widely accepted among physicians in Europe. Moreover, decision-making 
regarding forgoing nutrition and hydration at the end of life occurs quite frequently, varying from 2.6% in 
Italy and 10.9% in the Netherlands 2. 
Despite the fact that decision-making regarding artificial nutrition and hydration occurs frequently and 
is perceived to be important, little is known about the burden and benefits of the provision of artificial 
nutrition and hydration at the end of life. Currently, no consensus exists about the most appropriate 
management for terminally ill patients at the end of life with limited oral intake 18-19. This lack of consensus 
is also reflected in the variety of provision of artificial nutrition and hydration in clinical practice within 
Europe 6. Moreover, end-of-life decision-making regarding artificial nutrition and hydration might also be 
influence by social, cultural and religious factors 20-22. 
PUBLIC OPINION ON END-OF-LIFE DECISIONS
Societal debate about end-of-life decisions might be strengthened by better understanding of the public 
opinion. Also for healthcare professionals it is important to be aware of the public opinion, expectations, 
and preferences regarding end-of-life care. Members of the general public are future patients or relatives 
who might be involved in end-of-life decision-making. Furthermore, from a democratic viewpoint the 
public	opinion	is	also	important;	it	informs	the	political	agenda	and	give	insight	into	the	level	of	societal	
support for current legislation. 
Several studies on the opinions on end-of-life care and decision-making of the general public have 
been performed, most often focusing on euthanasia or physician-assisted suicide. Several Dutch studies 
concerning the public opinion on euthanasia have been conducted. These studies showed that 83-
88% of the general public supports euthanasia 23-24. Internationally, opinions on euthanasia has been 
studied by the European Value Study that showed large cross-national differences in the acceptance rate 
of euthanasia in Europe, and it ranged from 2.2-6.7 on a 10-point scale 25. Furthermore, the European 
Value Study showed an increasing support for legalization of euthanasia and physician-assisted suicide 
throughout Europe 26, although different trends in euthanasia acceptance across Europe were present 27. 
Beyond Europe, in Canada 66-71% of the general public supports legalizing of euthanasia 28-29 and a US-
study showed that one-third of the general public supports euthanasia, one-third supports assistance in 
dying in certain circumstances and one-third opposes euthanasia 30.
Public opinions on withholding or withdrawing treatment at the end of life have been studied less 
frequently. In Canada, 85% of the general public approved forgoing life-sustaining treatment in a 
competent patient who was unlikely to recover. A key factor influencing public opinion regarding forgoing 
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life-sustaining treatment was the patient’s prognosis 29. A recent Korean survey showed that 89-89% of 
the general public approves the withdrawing or withholding of life-sustaining treatment at the end of life 
in terminally ill patients 31, and in Japan 57-69% would not want life-sustaining treatments at the end of 
life when having cancer or being frail 32. In Sweden, 78% of the general public was willing to withdraw 
treatment in a terminally ill patient, while only 40% would withhold treatment 33.
Advance care planning
Nowadays, people in Europe are less familiar with death and dying than a century ago. They generally 
experience death and dying in their near surrounding later in life, because of the increased life expectancy. 
Death and dying is also increasingly a private occasion. That said, end-of-life care has become more 
complex and medicalized, and end-of-life decision-making often occurs. Therefore, the need for end-of-
life communication is more acute. Advance care planning is a process of communication among patients, 
healthcare professionals, and relatives regarding end-of-life care. It aims to ensure that patients’ values 
remain central in decision-making and that the care provided is consistent with patients’ preferences 34, 
and is encouraged extensively 35. 
To effectively promote communication about end-of-life care, insight into the values and perceptions 
of the target population is important. Members of the general public have already been identified as 
a potential target population 36-37. Moreover, in the UK a national program called ‘Dying Matters’ has 
recently been launched to encourage people to talk about their wishes and preferences regarding the 
end of life and to raise public awareness. STEM 38 is the Dutch equivalent. Insight into opinions on advance 
care planning and end-of-life discussions of the general public is needed to inform such initiatives. A 
recent Japanese survey showed that the majority of the general public have an interest in advance 
directives  39, and almost half of the general public had discussed life-sustaining treatments with their 
relatives 32. Important themes within the public opinions on advance directives are trust in the family and 
the medical system, need for control, and knowledge about the legal status of advance directives 40. Little 
information about the Dutch public opinions on advance care planning is available.
THIS THESIS
In the Netherlands, the Euthanasia Act came into effect in 2002, and after eight years of legislation societal 
debate remains, especially regarding the boundaries and interpretation of the Euthanasia Act. Nowadays, 
one main topic for debate concerns euthanasia or physician-assisted suicide in older people who are 
tired of living and want to die. Better understanding of the current public opinions on euthanasia and its 
boundaries can strengthen the societal debate. Therefore, this thesis aims to study the public opinions on 
end-of-life decision-making in the Netherlands.
End-of-life decision-making encompasses more than euthanasia and physician-assisted suicide. Another 
internationally shared important end-of-life decision concerns withholding or withdrawing potentially 
life-prolonging treatment, in particular artificial nutrition and hydration at the end of life. To contribute to 
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better end-of-life decision-making regarding nutrition and hydration at the end of life, this thesis further 
aims to study nutrition and hydration at the end of life.
To achieve these aims, the following research questions will be addressed:
Part 1:  The public opinion on end-of-life decision-making
1. What is the opinion of the Dutch general public on the legal requirements of euthanasia and PAS? 
(chapter 2)
2. What is the opinion of the Dutch general public regarding euthanasia and PAS in older persons who 
have a wish to die, without the presence of a serious medical condition? (chapter 3).
3. To what extent is the Dutch general public currently involved or inclined to be engaged in advance 
care planning? (chapter 4)
Part 2:  Nutrition and hydration at the end of life
4. What key issues do healthcare professionals encounter when making decisions regarding artificial 
nutrition and hydration at the end of life? (chapter 5)
5. What are the practices, effects of, and attitudes towards artificial nutrition and hydration at the end 
of life in terminally ill patients? (chapter 6 and 7) 
6. How do relatives perceive nutrition and hydration at the end of life of the patient? (chapter 8)
METHODS
This thesis is based upon three studies:
KOPPEL study
The KOPPEL study is a national study to determine the Knowledge and Opinions of the general Public 
and Professionals regarding End-of-Life care and decisions, supported by a national grant of ZonMw. The 
KOPPEL consortium existed of the Erasmus MC Rotterdam, University Medical Center Utrecht (UMCU), 
University Medical Center Groningen (UMCG), University of Utrecht and University of Groningen. The 
KOPPEL study has used a mixed method approach and involved a national questionnaire survey among 
physicians, nurses and members of the general public, qualitative interviews, case studies, and a media 
analysis. 
National survey among the general public
For the national survey among the general public, we have used the CentERpanel of the University of 
Tilburg, a representative sample of the general Dutch public. This panel comprised a random sample of 
postal codes in the Netherlands. Multiple measures are in place to avoid selection bias of this internet 
panel, such as guaranteeing accessibility for all selected households without Internet access at time of 
study recruitment. The panel is a dynamic panel, and during the survey period 2503 were active member of 
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the panel and received the questionnaire. Items in the questionnaire referred to knowledge and opinions 
regarding end-of-life care and decision-making, using statements, closed questions, and vignettes. The 
questionnaire has been sent between December 2009 and February 2010. In total, 1960 completed the 
questionnaire (response rate: 78%).
OPCARE9 collaborative
OPCARE9 is a European collaborative project to optimize research for the care of cancer patients in the 
last day of life, supported by a 3 year EU FP7 Coordination & Support Action grant. In total, nine countries 
were involved: Argentina, Germany, Italy, Sweden, Switzerland, the Netherlands, New Zealand, and 
the UK. Through systematically investigating current end-of-life practices across a range of healthcare 
environments and diverse cultures, it shared the existing knowledge base and identified knowledge gaps 
to reach consensus positions on optimum care and develop innovative research protocols to address 
identified needs. Methods used within OPCARE9 were Delphi studies, expert meetings and systematic 
literature reviews. 
Erasmus MC Rotterdam was the lead of work package 2: end-of-life decision-making. The first step for 
our work package on end-of-life decision-making was to establish a shared base by finding a common 
definition of what constitutes an end-of-life decision. End-of-life decision was defined as a decision 
involving a person who is in the last days of life that has (or may have) a significant impact on the quality, 
place and/or time of dying. An international inventory was conducted to get insight into which end-of-life 
decisions palliative care experts considered most important in care at the end of life. In total, 114 experts 
mentioned more than 800 end-of-life decisions. Regardless of country or profession, most frequently 
mentioned decisions involved withdrawing and/or withholding medical treatment and symptom 
management. Decisions about withdrawing and/or withholding of medical treatment frequently 
concerned artificial nutrition and hydration, or anti-cancer treatment. Decisions about symptom 
management often concerned the use of sedatives.
Systematic literature reviews 
Based on the results of this international inventory, we conducted two systematic literature reviews 
regarding artificial nutrition and hydration at the end of life. The first review addressed the practice and 
effects of artificial nutrition and hydration in the last week of life of cancer patients, the second review 
focused on attitudes towards artificial hydration. We conducted an electronic search of several databases 
for papers that were published in English. In addition, we hand searched the most recent issues of relevant 
peer-reviewed journals.
Delphi study
We also conducted an international Delphi survey among 90 international palliative care experts. We 
aimed to include four physicians, three nurses, two other professional caregivers and one volunteer per 
country, resulting in 90 experts in total. These experts received two structured questionnaires, the first 
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to identify important issues they encounter when making end-of-life decisions, by using open questions 
(round 1). The second round was informed by the results of round 1 and explored the extent to which 
experts thought that research on the important issues would be useful. The questionnaires were written 
in English and distributed electronically. The first questionnaires were sent between October 2009 and 
November 2009, and the second between May 2010 and June 2010. The response rate of the first round 
was 76% and of the second round 60%.
COMMEND study
The COMMEND study is a collaboration between the Arohanui Hospice, Palmerston North, New Zealand 
and Erasmus MC Rotterdam to improve insight into communication at the end of life regarding nutrition 
and hydration. This study was supported by the Dutch Cancer Society, Genesis Cancer Society NZ and 
the Erasmus Trust Fund. The COMMEND study involved qualitative interviews with bereaved relatives 
and healthcare professionals and participatory observations of patients who had been referred to the 
palliative care service in Palmerston North, New Zealand.
Interviews with bereaved relatives
We performed a qualitative interview study among bereaved relatives of patients who had been referred 
to a New Zealand palliative care service to study the bereaved relatives’ experiences and perspectives 
on the patient’s oral intake of nutrition and hydration at the end of life. We used a semi-structured 
questionnaire,	 addressing	 the	 following	 topics;	 experiences	 in	 last	month	 of	 life,	 awareness	 of	 dying	
(patient and relative), satisfaction with care, experiences with food and fluids intake, perception of food 
and fluid intake, communication at the end of life. At the end of the interview, the respondents completed 
the Quality of Death and Dying Questionnaire (QODD) 41. All respondents gave written consent prior to 
the	 interview;	all	 interviews	were	audio-taped	and	transcribed	verbatim	by	a	confidential	 transcribing	
service. The interviews were held between January 2012 and March 2012. In total, 23 bereaved relatives 
participated in an interview. 
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ABSTRACT
Background
The practice of euthanasia and physician-assisted suicide (PAS) in the Netherlands has been regulated 
since 2002 by the Euthanasia Act. In the on-going debate about the interpretation of this Act, comparative 
information about the opinions of the different stakeholders is needed.
Aim
To evaluate the opinions of Dutch physicians, nurses and the general public on the legal requirements for 
euthanasia and PAS.
Design
A cross-sectional survey among Dutch physicians and nurses in primary and secondary care and members 
of the Dutch general public, followed by qualitative interviews among selected respondents. The 
participants were: 793 physicians, 1243 nurses and 1960 members of the general public who completed 
the	questionnaire;	83	were	interviewed.
Results
Most respondents agreed with the requirement of a patient request (64–88%) and the absence of a 
requirement concerning life expectancy (48–71%). PAS was thought acceptable by 24–39% of respondents 
for patients requesting it because of mental suffering due to loss of control, chronic depression or early 
dementia. In the case of severe dementia, one third of physicians, 58% of nurses and 77% of the general 
public agreed with performing euthanasia based on an advance directive. Interviewees illustrated these 
findings and supported the Act. 
Conclusions
Health care professionals and the general public mostly support the legal requirements for euthanasia and 
PAS. The law permits euthanasia or PAS for mental suffering but this possibility is not widely endorsed. The 
general public is more liberal towards euthanasia for advanced dementia than health care professionals. 
We conclude that there is ample support for the law after eight years of legal euthanasia.
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INTRODUCTION
Legalizing euthanasia and physician-assisted suicide (PAS) is an issue for debate in many countries. 
The practice of euthanasia and PAS in the Netherlands has been regulated since 2002 in the Dutch 
Euthanasia Act (Termination of Life on Request and Assisted Suicide Act). The Act formulates criteria of 
due care. Only if a physician performs euthanasia or PAS according to these criteria, will his actions not be 
punishable. The criteria of due care require that the physician be convinced that (1) there is a voluntary 
and well-considered request from the patient, (2) the patient is suffering unbearably without prospect of 
improvement, (3) the patient is informed about his situation and prospects, (4) there are no reasonable 
alternatives to relieve suffering, (5) an independent physician must be consulted and (6) euthanasia or 
PAS is performed with due medical care and attention. The act does not entail a legal right to euthanasia 
or PAS nor does it contain a limit on a patient’s life expectancy. Physicians have to report euthanasia or 
PAS to one of five regional multidisciplinary review committees. These review committees assess whether 
or not the physician has acted in accordance with the criteria of due care. The judgments of the review 
committees and case law thus provide a definite fulfilment of these criteria. Dutch opinions have been 
studied before 1. In previous research as well as in the on-going societal debate about the interpretation of 
this Act, growing divergence is claimed between the knowledge and opinions of health care professionals 
and the general public 2. Comprehensive current comparative information about the opinions of the 
different stakeholders is lacking and is needed. The aim of this study was to evaluate opinions about the 
law among Dutch health care professionals and the general public after eight years of official euthanasia 
legislation. The following research question was addressed: What are the opinions of physicians, nurses 
and the general public in the Netherlands on legal requirements for euthanasia and PAS?
METHODS
Design and population
We conducted a cross-sectional survey among physicians, nurses and members of the Dutch general 
public, followed by a qualitative interview study among a selection of the respondents. Regarding ethical 
approval, according to Dutch law, this kind of observational study is exempt from ethical review.
Survey 
A questionnaire was sent to a random sample of 1250 medical specialists of internal medicine, cardiology, 
pulmonology, neurology and surgery, 500 general practitioners and 250 elderly care physicians. Addresses 
were taken from the Royal Dutch Medical Association (KNMG), the Dutch Institute for Research of Health 
Care (NIVEL) and the Dutch Association of Elderly Care Physicians (Verenso), respectively. Respondents had 
to: (1) be working in the Netherlands, (2) have at least two years of experience in their current specialty, 
and (3) if retired, have been retired no longer than two years prior to participation or be under 67 years of 
age. The questionnaire could be completed by mail or electronically over a four-month period (January 
through May 2010). Two reminders were sent. During the same period, a similar questionnaire was 
offered to nurses by various professional nursing organizations in the Netherlands, through websites and 
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journals. This questionnaire was freely accessible on the internet. To be eligible for the study, respondents 
had to: (1) be a registered nurse, (2) be working as such for at least two years, and (3) be working in 
the Netherlands. The questionnaire started with three selective questions. If respondents did not meet 
the criteria, they were automatically excluded from completing the questionnaire. A comparable online 
questionnaire was offered to an established panel of members of the Dutch general public (CentERdata, 
University of Tilburg, The Netherlands). This panel comprises a random sample of postal codes in the 
Netherlands. Multiple measures are in place to avoid selection bias of this panel, such as guaranteeing 
accessibility for all selected households by providing all selected members of the panel with a free tool 
that enables response by internet or television. During the survey period (December 2009–February 2010), 
2503 persons were active members of the total panel. We only included respondents aged 18 or over.
Interview study
At the end of the questionnaire, we invited respondents to participate in an interview and if they consented, 
to provide us with their personal contact details. Anonymity was indicated to the respondents to be lost 
in this case. For all groups, based on their responses to the questionnaires, we selected candidates who 
were willing to participate in in-depth interviews. We used the method of purposive sampling 3 in order 
to guarantee a wide range of different opinions. We selected respondents with and without experience 
with euthanasia and with different attitudes towards euthanasia (liberal, conservative or neutral). Besides 
this, we strived for a balanced distribution of age, education and gender. We selected 25 respondents per 
subgroup, 125 respondents in total. We continued enrolling subjects for interviews in each group until we 
had achieved conceptual saturation for each group.
Data collection
The questionnaires involved questions on respondent characteristics as well as on experiences and 
opinions regarding euthanasia and PAS. Statements on euthanasia were rated using a five-point Likert 
scale, ranging from ‘totally agree’ to ‘totally disagree’. Respondents were also asked about their opinions 
regarding unbearable suffering as a reason for euthanasia and PAS, presented in different vignettes 
(Box  1).The questionnaire was pretested for length, comprehensibility and feasibility for online use 
among 10 physicians, 8 nurses and 14 members of the general public. These pilots resulted in small 
adjustments in the questionnaire. Interviews were conducted by five researchers (PK, NR, DvT, BvdV and 
HW) and two medical students. There was no relationship between the interviewees and the interviewers 
prior to the study and no personal characteristics of the interviewers were known to the interviewees. 
Most interviews with professionals were conducted at their working place and with the public in the 
privacy of their homes. Before the start of the interview, the voluntary character and confidentiality of 
participation were emphasized. The one-hour interviews were semi-structured with use of an interview 
guideline with open questions and topics. First, we asked about the respondents’ association with the 
term ‘euthanasia’. To explore opinions about euthanasia further, we asked what the participant would 
say to a foreign colleague (for professionals) or a foreign tourist (for members of the general public) about 
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Dutch euthanasia practice and how it is regulated. The interviewees were asked to reflect on some of the 
vignettes that were used in the questionnaires. Finally, personal experiences (if any) with (requests for) 
euthanasia were addressed. The interview guideline was tested for length and comprehensibility. This 
led to some minor adjustments. Because several researchers performed the interviews, the use of the 
interview guideline was discussed and practised in detail during training for all interviewers.
Box 1.  Vignettes of patients requesting euthanasia or physician-assisted suicide: different ways of suffering*
1(a) Mrs de Jong (60 years old) has breast cancer with metastases. Despite undergoing several treatments, her disease 
is no longer curable. She is in severe pain that cannot be sufficiently relieved. In addition, she dislikes the feeling 
of loss of control that she experiences. In her working days, she always felt in control. She indicates that she 
cannot take it anymore. She asks her general practitioner for physician-assisted suicide. The general practitioner 
decides to honour her request and performs physician-assisted suicide.
1(b) Mrs de Jong (60 years old) has breast cancer with metastases. Despite undergoing several treatments, her disease 
is no longer curable. She has no physical symptoms at the moment. She dislikes the feeling of loss of control that 
she experiences. In her working days, she always felt in control. She indicates that she cannot take it anymore. 
She repeatedly asks her general practitioner for physician-assisted suicide. The general practitioner decides to 
honour her request and performs physician-assisted suicide.
1(c) Mr de Bruyn is 86 years old. He used to be a professor at the university. He enjoyed his life at that time. He never 
married and has no children. Now he has grown old, many of his friends have died. He often feels lonely. He is in 
good physical and mental condition. Though Mr de Bruyn is aware that he could live for many years he fears this. 
He would rather be dead and has told his general practitioner this several times. Mr de Bruyn repeatedly asks his 
general practitioner for physician-assisted suicide. The general practitioner decides to honour his request and 
performs physician-assisted suicide.†
1(d) Mrs Langezaal is middle-aged. She is physically well, but mentally ill. She has been suffering from severe 
depression for years and her psychiatrist’s treatment has not worked. She regularly tells her physicians that she 
wants to die. She already has had one unsuccessful suicide attempt. Mrs Langezaal visits her psychiatrist and 
repeatedly asks for physician-assisted suicide. The psychiatrist decides to honour her request and performs 
physician-assisted suicide.
1(e) Mrs de Koning is 65 years old. She suffers from early dementia and sometimes she is forgetful. She fears what is 
to come, the progressive loss of memory and the moment she will not recognise her surroundings anymore. Her 
own mother suffered from severe dementia and she absolutely doesn’t want to experience this process herself. 
Mrs de Koning repeatedly asks her general practitioner for physician-assisted suicide. The general practitioner 
decides to honour her request and performs physician-assisted suicide.
1(f) Mr Smit is 62 years old and suffering from dementia. He doesn’t recognise his wife and children anymore, refuses 
to eat and withdraws into himself more and more. It is no longer possible to communicate with him about his 
treatment. Shortly before he became demented, he drafted an advance directive with a euthanasia request 
in case of dementia. His family agrees. The physician decides to honour his patient’s advanced directive and 
performs euthanasia.
* For the general public, these vignettes were the same in contents, but slightly adapted in language in order to be understandable for this 
group of respondents
† 1(c): Not in accordance with the Dutch Euthanasia Act (2002)
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Statistical analysis
The quantitative data were analysed with descriptive statistics using SPSS 17.0. Valid percentages are 
presented	in	the	tables;	missing	values	did	not	exceed	10%.	Opinions	on	euthanasia	and	PAS	were	recoded	
and reported in three categories: ‘agree’, ‘neutral’ and ‘not agree’. For each group of physicians a weight 
factor was calculated in order to make the results representative for all physicians in the Netherlands. All 
interviews have been transcribed verbatim and were analysed with content analysis using Atlas.ti version 
6.1.1. Two researchers per group coded all interviews, using a uniform code tree that was developed and 
agreed on by all interviewers on the basis of the results. Transcripts were not returned to the interviewees.
RESULTS
Characteristics of respondents
The numbers of respondents were 793 for physicians (response rate 41%), 1243 for nurses and 1960 for the 
general public (response rate 78%). The mean age was 51 years for physicians, 53 years for the general public 
and 44 years for nurses. Two-thirds of the physicians, 10% of nurses and 54% of the general public were 
male;	81%	of	nurses	and	39%	of	the	general	public	respondents	were	highly	educated.	Most	physicians	and	
nurses had experience with a request for euthanasia or PAS in the last five years. Most respondents of the 
general public had no such experience (Table 2.1). In total 83 interviews were conducted until saturation 
was	reached;	49	with	physicians,	18	with	nurses,	and	16	with	members	of	the	general	public.
Opinions on the Dutch Euthanasia Act
Broad support for the Dutch Euthanasia Act was displayed among interviewees, irrespective of their 
personal attitude. Interviewees based their approval mainly on two arguments. First, euthanasia can be 
morally right because it is the last resort to end unbearable suffering without prospect of improvement. 
Second, autonomy is highly valued (Box 2 (1a)). Even principal opponents among the interviewees often 
defended the Act against allegedly misinformed (foreign) critics (Box 2 (1b)). Also interviewees considered 
its function as a safeguard to both careful and transparent practice to be an important benefit of the Act 
(Box 2 (1c)). Furthermore, some physicians experienced the Act as a helping hand in making decisions that 
they experience as highly demanding. Some felt that it could be used as a shield against patients who 
claim euthanasia as their right (Box 2 (1d)).
Opinions of health care professionals on legal requirements
In our survey, almost two-thirds of physicians (56%) and more than one-third of nurses (36%) agreed with 
the current absence of a right to euthanasia and PAS (Table 2.2). A majority of physicians (71%) and nurses 
(64%) agreed that euthanasia and PAS should not be limited to patients who have a life expectancy of only 
several weeks. A vast majority of physicians (88%) and nurses (77%) agreed with the need for a patient 
request.
Reviewing a vignette of a cancer patient suffering from loss of control and severe pain, 77% of physicians 
and 49% of nurses personally agreed with the performance of PAS (Box 1, Table 2.3). If in the same vignette 
CHAPTER 2  OPINIONS ON EUTHANASIA AND PHYSICIAN-ASSISTED SUICIDE
31
physical symptoms were absent, fewer professionals agreed (36–37%). A minority of professionals agreed 
with providing PAS in vignettes of a patient with chronic depression (35–36%) or early dementia (28–31%). 
One-third of physicians (33%) and almost two-thirds of nurses (58%) agreed with performing euthanasia 
 Table 2.1  Background characteristics of respondents
Physicians*
(n=793)
%
Nurses
(n=1243)
%
General 
public 
(n=1960)
%
Age
Mean ± SD 51 ± 8 44 ± 11 53 ± 15
Gender
Male 65 10 54
Female 35 90 46
Education†,‡
Low n.a. n.a. 32
Middle n.a. 19 29
High 100 81 39
Experience with euthanasia request§
Yes 71 64 14
No 29 36 86
Care setting
Hospital care 39 41 n.a.
Home care 51 23 n.a.
Nursing home care 10 28 n.a.
Years of working experience||
2-5 years 6 15 n.a.
5-10 years 16 13 n.a.
>10 years 78 72 n.a.
Attitude towards euthanasia and physician-assisted suicide
Liberal 45 59 -
Reserved 48 27 -
Against 7 14 5
n.a.:		 not	applicable;	SE:	standard	deviation
*  Weighted percentages 
†  Low = level 1-3 according to International Standard Classification of Education (ISCED) guidance (primary school, lower secondary 
general education, lower vocational education), middle= level 4 according to ISCED (intermediate vocational or higher secondary general 
education), high= level 5-7 according to ISCED (higher vocational education or university)
‡  Nurses: middle=assistant-nurse, high=registered nurse
§  Experience with a patient’s (for physicians and nurses) or relative’s (for the general public) actual request in the last five years
|| Physicians: mean ± SD= 19 ± 9
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Box 2.  Example quotations of responses
1a: 
Arguments for 
the possibility of 
euthanasia: ‘end 
suffering’ and 
‘autonomy’
 ‘Anyhow, I think it is very good we have a euthanasia law in the Netherlands. Because I think 
every person that really suffers unbearably should have the right to end his life.’ (member of 
the general public )
‘I think we have a very correct legal system in the Netherlands, which clearly prescribes 
what is allowed and what is not. So we have said, we highly esteem the autonomy of the 
patient. If someone wishes to end his life, and there is unbearable suffering, there is careful 
deliberation and there is freedom, then I think that we, as doctors, can cooperate with that.’ 
(physician with experience with euthanasia)
1b: 
Defence against 
misinformed 
critics
‘People from outside the Netherlands seem to think that it is just a phone call to the doctor 
who prescribes a recipe for a lethal drug in order to put you out of this world. Well, that is 
not how it is. There are many conversations and checks before a wish is granted. So before 
something like that is done, there have been a lot of control moments, in order to make sure 
it is all done in a careful manner. So it is not easily done.’ (member of the general public)
‘I would say it happens in the most careful way, and always in a situation of endless suffering. 
But doctors are really not eager to perform euthanasia. It is not part of everyday practice, but 
it may be an ultimate act in a situation of necessity, which is never decided alone but always 
in consultation of another doctor. The Netherlands is not a country in which you can just say 
‘I don’t want to go on anymore, and I step out’.’ (nurse) 
1c: 
Euthanasia Act 
as a safeguard 
for careful and 
transparent 
practice
‘It is not as easy as one may think. There have to be very good reasons. There have to be two 
doctors. Only if they are both convinced that this euthanasia is really what the person wants 
and if they think the suffering becomes unbearable. Only then you can perform euthanasia.’ 
(nurse)
‘I have some difficulties with it (euthanasia). Yet it is good such a law exists and that one 
should follow strict criteria. But actually I would want that things like euthanasia and 
abortion did not happen.’ (nurse)
‘You still perform a criminal act and you can go to jail for it. I think there is a strong urge for 
doctors to act in a careful manner. There is a procedure that has to be followed. And it has to 
be reported. I think it is an honest procedure, I don’t have problems with that.’ (physician who 
refuses to perform euthanasia himself )
1d: 
Legal rules as a 
‘helping hand’ 
and as a ‘shield’
‘I think the law is good. It is a helping hand, because listen, you do end some one’s life. The 
law is not without a purpose, it was constructed very carefully. In such a way that you always 
have to act very carefully and I think that is good. It is a highly demanding process. For the 
patient, but also for the doctor.’ (physician with experience with euthanasia)
‘Sometimes you come in the ward and then, all of a sudden, you get a request to perform 
euthanasia. Then I say ‘that is not how it works’. Unless it is a very exceptional situation. But 
then you may use that argument and tell the patient ‘I have to protect myself as well. I have 
to fulfil the due care requirements, it is not so easily done’. So in that way I am happy with 
the rules. It may help to keep off patients who think too easy about it. Personally I may not 
have huge difficulties with it, but I do not think it should ever become a routine. I won’t go 
that far. So I agree with those criteria of due care, they are very logical to me.’ (physician with 
experience with euthanasia)
CHAPTER 2  OPINIONS ON EUTHANASIA AND PHYSICIAN-ASSISTED SUICIDE
33
in a vignette of a patient with advanced dementia based on a written advance directive. Almost two-
thirds of professionals disagreed (64–66%) with PAS in the case of being tired of living.
In reviewing some of the same vignettes during the interviews, professionals often considered physical 
symptoms without prospect of improvement as a necessary part of unbearable suffering. Some 
professionals felt it to be difficult to empathize with patients requesting euthanasia due to mental 
suffering. Also the absence of the terminal phase was sometimes seen as problematic.
Opinions of the general public on legal requirements
Almost a quarter of the general public (23%) agreed with the current absence of a right to euthanasia and 
PAS (Table 2.2). Two-thirds of the general public (64%) agreed with the need for a request of the patient. 
Almost half of respondents (48%) agreed with the absence of a limitation of euthanasia to patients who 
have a life expectancy of only several weeks. The majority of the general public (65%) personally agreed 
with PAS in the vignette of a cancer patient suffering from loss of control and severe pain (Box 1, Table 2.3). 
Seventy-seven percent did so in a patient with advanced dementia who had completed a written advance 
euthanasia directive. Reviewing other vignettes of mental suffering, a minority of the general public 
agreed with PAS. In the cases of mental suffering from loss of control due to cancer (without severe pain), 
chronic depression or early dementia, respectively 39%, 28% and 24% agreed with PAS. Furthermore, 
Table 2.2  Opinions on euthanasia and physician-assisted suicide
Physicians*
(n=793)
%
Nurses
(n=1243)
%
General 
public 
(n=1960)
%
In my opinion everybody should have a right to get euthanasia 
or physician-assisted suicide when he or she wants
(Totally) agree 28 45 57
(Totally) disagree† 56 36 23
Neutral 14 19 20
In my opinion a physician is only allowed to perform 
euthanasia or physician-assisted suicide in persons with a life 
expectancy of a few weeks
(Totally) agree 16 18 27
(Totally) disagree† 71 64 48
Neutral 12 19 25
In my opinion euthanasia and physician-assisted suicide 
should only be allowed to be performed at explicit patient 
request
(Totally) agree† 88 77 64
(Totally) disagree 7 14 16
Neutral 5 9 21
* Weighted percentages
† In accordance with the Dutch Euthanasia Act (2002)
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a minority agreed in case of suffering due to being tired of living (26%). In the interviews respondents 
related unbearable suffering primarily to physical suffering. In case of mental suffering interviewees found 
it difficult to assess the request for PAS and would like to explore other solutions, such as counselling for 
the patient.
Table 2.3  Opinions on euthanasia and physician-assisted suicide: agreement with the physician’s act in different 
cases of suffering. See box 1 for vignettes
Yes
(%)
No
(%)
I don’t know
(%)
(a) Cancer with loss of control and severe pain
Physicians* n=156 77 17 7
Nurses n=254 49 38 13
General public n=421 65 15 19
(b) Cancer with loss of control, without physical symptoms
Physicians* n=161 37 45 19
Nurses n=245 36 48 15
General public n=393 39 44 17
(c) Old age and tired of living†
Physicians* n=143 18 66 16
Nurses n=245 19 64 18
General public n=378 26 58 16
(d) Severe depression
Physicians* n=173 35 39 26
Nurses n=253 36 46 19
General public n=380 28 52 20
(e) Early dementia
Physicians* n=156 28 53 17
Nurses n=246 31 49 20
General public n=388 24 60 16
(f) Advanced dementia and written advance directive for 
euthanasia
 Physicians* n=197 33 56 11
Nurses n=316 58 29 13
General public n=472 77 14 9
* Weighted percentages
† Not in accordance with the Dutch Euthanasia Act (2002)
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INTERPRETATION
Our study shows support for the Dutch Euthanasia Act both among health care professionals and in 
wider society. Major arguments for this support are the possibility of relief of unbearable suffering and 
respect for the patient’s autonomy. Moreover, the Act safeguards careful and transparent practice. The 
majority of the general public is in favour of a (currently non-existing) right to euthanasia. However, most 
professionals and members of the general public seem to be more conservative regarding the boundaries 
for euthanasia or PAS than the Act. Both professionals and members of the general public tend to consider 
suffering as unbearable and qualifying for assistance in dying particularly in the presence of physical 
symptoms. They are more reticent about early dementia, depression and being tired of living. This is in 
line with previous studies in which more variation in the acceptance of euthanasia and PAS was found 
among health care professionals for non-physical as compared to physical suffering 4-5. An exception is 
advanced dementia. In a case of a patient with advanced dementia who had a written advance request 
for euthanasia, a majority of the general public and nurses agreed with granting this request, but only 
a minority of physicians did. Another study among elderly care physicians and relatives of people with 
dementia who had an advance directive for euthanasia also found them to be reticent in adhering to 
advance directives for euthanasia 6. Physicians have become more accepting over time 2, but variance 
in views on the admissibility of euthanasia in a case of advanced-stage dementia between physicians, 
nurses and the general public has been demonstrated elsewhere too 7-8. Although all parties seem to 
be guided by the best interest of the patient, different responsibilities in end-of-life decision-making 
may play a role here. The fact that performing euthanasia is solely allowed for physicians and has a clear 
emotional impact on them 9 may explain their reticence. Euthanasia for a patient in an advanced stage of 
dementia may involve an even greater emotional burden due to the fact that the person receiving it is not 
capable of confirming his wish anymore.
The general support for the Dutch Euthanasia Act is in line with an international trend towards public 
acceptance of euthanasia 10-11. Also, earlier studies have shown a small number of opponents among the 
Dutch general public 12. However, international professional acceptance of euthanasia varies widely 13-20.
The strengths of our study include the large and high quality nationwide samples of physicians and the 
general public. Our mixed-methods approach gives more in-depth understanding of the underlying 
reasoning of our quantitative data and makes a more accurate interpretation of quantitative results 
possible. Moreover, the questionnaires were highly comparable between all groups of respondents 
and consisted of a combination of different types of questions and presentations including statements 
and vignettes. Vignettes are widely used in decision-making research 21 and have shown their value 22. 
However, it should be taken into account that respondents could have based their judgments on different 
aspects of the vignettes. Our study has some other limitations as well. No random sample was available 
for nurses, due to the absence of a national registry for nurses in the Netherlands. Therefore we aimed 
at reaching as many nurses as possible by open invitation. For all groups, possible selection bias should 
be taken into account. For physicians, the response rate was rather low (41%). However, the results were 
made representative for all physicians from the studied groups by applying a weight factor. It is possible 
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that especially physicians and nurses with experience and affinity with the discussion about euthanasia 
have participated in this study. This should be taken into account when interpreting the results, but is not 
likely to alter the direction of our findings. Since the interview study showed even physicians who have 
principled objections against euthanasia to be content with the Act, it can be concluded that there is ample 
support for the law in this group. Moreover, the number of opponents of euthanasia and physician-assisted 
suicide is comparable to earlier studies in the Netherlands. Therefore we think that bias is not very likely.
Additionally, despite a good response rate among the general public, respondents were not fully 
representative	of	the	Dutch	population;	they	were	slightly	older,	more	often	male,	higher	educated	and	
more often sharing a household. Also migrants were underrepresented. This latter issue is known to be 
the case in nationwide surveys on other topics too. To assess their opinions purposive sampling should 
be considered. Furthermore, the questionnaires were rather extensive, which resulted in a substantial 
number of missing answers at the end of the questionnaires. 
In conclusion, health care professionals, as well as the general public, mostly support the legal 
requirements for euthanasia and PAS. The law permits euthanasia or PAS for mental suffering, but this 
principle is not widely endorsed. There is one exception. The majority of the general public and nurses 
agree with the possibility of euthanasia in advanced dementia. Physicians are more reticent. We conclude 
that the Dutch Euthanasia Act can count on ample support both among health care professionals and 
within general society.
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ABSTRACT
Background
The Dutch Euthanasia Act regulates physicians’ assistance in dying for patients who are suffering un-
bearably from a medical condition. We studied the attitudes of the Dutch population regarding assistance 
in dying for older persons who have a wish to die, without the presence of a serious medical condition. 
Methods
A national cross-sectional survey was conducted among a representative sample of 1960 adults (response 
rate 78%), using an online questionnaire. Statements and vignettes regarding attitudes towards assistance 
in dying in older persons who are tired of living were used.
Results
A minority of 26% agreed with a vignette in which a physician warrants the request for physician-assisted 
suicide of an older person with a wish to die, who is tired of living without having a serious medical 
condition. Furthermore, 21% agreed with the statement “In my opinion euthanasia should be allowed for 
persons who are tired of living without having a serious disease”. A majority of 65% agreed with a vignette 
of a physician providing assistance in suicide to a terminally ill cancer patient.
People supporting the possibility of assistance in dying for older persons who are tired of living, were 
more	likely	to	be	highly	educated	(OR	1.6;	CI:1.1-2.3),	to	be	non-religious	(OR	1.7;	CI:1.3-2.3),	to	have	little	
trust	in	physicians	to	comply	with	their	wishes	(OR	1.6;	CI:	1.2-2.2)	and	to	consider	it	important	to	be	able	
to	make	one’s	own	health	care	decisions	(OR	1.7;	CI:1.3-2.3)	than	opponents.	Age	and	health	status	were	
unrelated to people’s attitudes. 
Conclusions
A substantial minority of the Dutch population supports allowing assistance in dying for older people who 
are tired of living without having a serious medical condition. Those who support assistance in dying in such 
cases are more likely to be highly educated and to prefer a sense of control in medical decision making. 
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BACKGROUND
Populations around the world are ageing, and high quality medical care for older people has become 
more important than ever. However, excellent care cannot always prevent that for some older people 
aging coincides with such a declined sense of purpose in life that they develop a wish to die. Previous 
studies reported this to be the case in 5-25% of older persons 1-7. Often, such wishes are associated with 
suffering from physical and mental health problems, such as progressive diseases and increasing disability. 
However, sometimes older persons have this wish without having serious health problems. In these cases, 
these wishes have been found to be associated with loneliness, a small social network, a perceived lack 
of control, visual/hearing impairment, speech impediment, involuntary urine loss and residential care 1, 
3-4, 8-9. Older persons without a serious medical condition who have a wish to die are often referred to as 
being “tired of living” 9.
Studies on people with death wishes have shown that having a wish to die does not necessarily mean 
they want to pursue this wish. A distinction has been made between passive and active ideators. Passive 
ideators report a wish to die but do not pursue their wish, while active ideators seriously consider taking 
their own life. The estimated prevalence of active ideators among older persons is 1-9% 3, 6-7. Furthermore, 
it is known that suicide attempts at older age have a higher case fatality compared to attempts at a 
younger age 10.
In the Netherlands, since 2002, assistance in dying, both as euthanasia and as physician-assisted suicide, 
is legally regulated. Core conditions are an explicit request of the competent person and unbearable and 
hopeless suffering as a result of a medical condition. Assistance in dying for persons who are tired of living 
without having serious medical problems is not subject to this legislation and is therefore criminalised. 
Nevertheless, there is currently a sparking debate in the Dutch society about whether it could be justified 
to allow euthanasia and physician-assisted suicide for older persons who are tired of living, since a group 
of prominent older citizens is seeking societal, medical and legal support for the allowance of euthanasia 
and physician-assisted suicide in such instances. This claim echoes earlier debates, starting in the early 
nineties when professor Drion suggested that older persons should be allowed to use a suicide pill, 
when they are tired of living. In 2002, the Supreme Court stated that unbearable suffering, resulting in a 
request for physician-assisted suicide, should arise from a medical cause to be subject to the Dutch Act. 
The reasoning behind it was that in non-medical suffering physicians are not able to judge the extent 
of suffering and whether or not other treatment options are available. More recently, the Royal Dutch 
Medical Association followed this reasoning by stating that they consider the presence of a medical 
condition to be a strict prerequisite for euthanasia and physician-assisted suicide. 
The level of public support for assistance in dying in older persons who are tired of living remains unclear, 
and more insight would enrich this often emotional debate with empirical evidence. Therefore the aim of 
this study is to gain insight into the attitudes of the Dutch general public regarding assistance in dying for 
older persons who have a wish to die, without the presence of a serious medical condition and to describe 
the characteristics of supporters and opponents. 
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METHODS
Study design and population
This cross sectional survey was conducted in the Netherlands. An online questionnaire was administered 
to a representative sample of the general Dutch population, using an established panel (CentERdata, 
University of Tilburg, the Netherlands). This panel comprised a random sample of postal codes in the 
Netherlands, and during the survey period 2503 persons were included in the panel. Multiple measures 
were in place to avoid selection bias of this digital panel, such as guaranteeing accessibility for all selected 
households by providing them with a free tool that enabled response by internet or television. If needed 
additional devices were provided. 
Questionnaire
The structured questionnaire assessed attitudes towards euthanasia and physician assisted suicide for 
older persons without a serious medical condition. The questionnaire included statements, vignettes and 
closed questions. The respondents were asked to indicate to which extent they agreed with five statements 
regarding their attitude towards euthanasia, using a 5-point Likert scale. Further, respondents’ attitudes 
towards the acceptability of physician assisted suicide were assessed using two vignettes (Box  1), i.e. 
hypothetical case descriptions, representing an older person being tired of living and asking for physician 
assisted suicide versus a reference case of a patient with incurable cancer who asks for physician assisted 
suicide. Respondents were asked whether they thought that the person described in the vignette suffered 
unbearably, whether they agreed with the physician’s act, and whether they would request physician 
assisted suicide if they imagined themselves in this situation. Answer categories were: ‘yes’, ‘no’ and ‘I don’t 
know’. Additionally, respondents were asked whether they trusted physicians to comply with their wishes 
about medical care and treatments at the end of life. Preferences for end of life decision-making styles 
were measured by providing three options: ‘physicians should make decisions, based on what is best for 
me’, ‘physicians and I should make decisions together’ and ‘I should make decisions, based on what is best 
Box 1.  Vignettes of persons requesting physician-assisted suicide
I  Old age and 
tired of living *
 Mr de Bruyn is 86 years old. He used to be a professor at the university. He enjoyed his life 
at that time. He never got married and has no children. Now he has grown old, many of 
his friends have died. He often feels lonely. He is in good physical and mental condition. 
Though Mr de Bruyn is aware that he could live for many years, he fears that. He would 
rather be dead and has told his family doctor this several times. Mr de Bruyn repeatedly asks 
his general practitioner for physician-assisted suicide. The general practitioner decides to 
honour his request and performs physician-assisted suicide. 
II  Cancer: loss 
of control and 
severe pain
Mrs de Jong (60 years old) has breast cancer with metastases. Despite undergoing several 
treatments, her disease is no longer curable. She is in severe pain that cannot be sufficiently 
relieved. In addition, she dislikes the feeling of loss of control that she experiences. In her 
working days, she always felt in control. She indicates that she cannot take it anymore. She 
asks her general practitioner for physician-assisted suicide. The general practitioner decides 
to honour her request and performs physician-assisted suicide.
* Not in accordance with the Dutch Euthanasia Act
CHAPTER 3  ASSISTANCE IN DYING FOR OLDER PEOPLE
43
for me’. All questions were based on previous research11-12, literature and expert opinion. 
A pilot study was conducted to examine the length, comprehensibility and feasibility for online use 
among 14 members of the Dutch general public. They varied in educational level, age and gender. This 
pilot resulted in small adjustments of the questionnaire. The digital questionnaire and two follow-up 
reminders were sent between December 2009 and February 2010.
Socio demographic data for the panel were obtained through CenERdata (age, gender, education level, 
composition of the household, religious beliefs, urbanization of living area and health status), based on 
self-reported data. For comparison, background characteristics of the whole Dutch population were 
obtained from Statistics Netherlands (CBS)13.
Statistical analyses
Summary data are presented as frequencies and proportions for categorical variables. Univariate analyses, 
followed by logistic regression analyses were used to calculate odds ratios with 95% confidence intervals 
for the relationships between positive attitudes towards assistance in dying in case of being tired of 
living and personal characteristics. The personal characteristics education, religious belief, health status, 
trusting a physician to comply with wishes, and the importance to make one’s own health decisions were 
dichotomized. Age was imputed as numeric into the model. All statistical analyses were carried out using 
SPSS for Windows software, version 17.0.
Ethical considerations
The Dutch Medical Research Involving Human Subjects Act (also known by its Dutch abbreviation WMO) 
does not apply to this study. Therefore, no ethical approval of the Medical Ethical Committee was needed.
RESULTS
Sample characteristics
In total, 2004 of 2503 questionnaires were returned, and 1960 were complete and eligible for analyses 
(response 78%). The reasons for exclusion of 44 questionnaires were incompleteness (n=17) and age of 
the respondent < 18 (n=27). The respondents were aged between 18 and 95 years. Compared to the Dutch 
general public, respondents in the sample were somewhat more often older, male, highly educated, living 
with a partner, and native Dutch (Table 3.1).  
Attitudes towards assistance in dying
Of the respondents, 21% agreed with the statement “In my opinion euthanasia should be allowed for 
people who are tired of living without having a serious disease”. Furthermore, 36% was in favour of 
enabling the oldest old to get medication to end their life if they would want so (suicide pill). Somewhat 
over half of the respondents thought that everybody should have the right to receive euthanasia when 
they want (57%) and was in favour of the right for everybody to determine their own life and death (53%) 
(Table 3.2). Table 3.3 shows the opinions of the respondents regarding the vignettes, describing physician-
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Table 3.1  Background characteristics of the respondents of the online survey, as compared to  
the Dutch population
Respondents 2010
(n=1960)
Dutch population * 
Age (mean ± SD) 53.4 ± 15.1 48
% (95% CI) % (95% CI)
Gender
Male 54 (52-56) 50
Female 46 (44-48) 50
Education †
Low 32 (30-34) 32
Middle 29 (27-31) 40
High 39 (37-41) 29
Composition household
Living with partner 76 (74 -78) 64
Living without partner 22 (20-24) 36
Religious beliefs
Yes 58 (56-60) 59
No 42 (40-44) 41
Urbanisation living area
Low/middle 61 (59-63) 57
High 39 (37-41) 43
*	Data	based	on	statistics	from	2009	of	Statistics	Netherlands	(CBS);	http://statline.cbs.nl/statweb
† Low = level 1-3 according to ISCED guidance, (primary school, lower secondary general education, lower vocational education), middle = level 
4 according to ISCED guidance (intermediate vocational or higher secondary general education), high = level 5-7 according to ISCED guidance 
(higher vocational education or university).
Table 3.2  Opinions of the respondents regarding assistance in dying 
In my opinion
%
agree
%
neutral
%
disagree
…euthanasia should be allowed for people who are tired of living, without 
having a serious disease. 21 27 52
…the oldest old should be able to get medications that enable them, if they 
want so, to end their life 36 30 35
…a physician is only allowed to perform euthanasia in persons with a life 
expectancy of a few weeks 27 25 48
… everybody should have a right to euthanasia 57 20 23
… every human being has the right to determine their own life and death 53 25 23
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assisted suicide in two cases with different types of suffering (Box 1). Respondents less often judged the 
suffering of an old person who is tired of living as unbearable suffering (20%), compared to the suffering 
of a patient with terminal cancer (69%) (p<0.001). Respondents also less often agreed with the physician to 
perform physician-assisted suicide in case of a person being tired of living (26%) than in case of a patient with 
cancer (65%) (p<0.001). 19% would ask for euthanasia themselves if they would be in a situation as described 
in a vignette of an old person who was tired of living, versus 48% if they would have cancer as described in a 
vignette (p<0,001). Respondents who judged the suffering described in the vignettes as unbearable, more 
often than others agreed with the physician performing physician-assisted suicide (p<0,001) and more often 
would ask for euthanasia for themselves when being in a similar situation (p<0,001).
Characteristics of supporters and opponents
Euthanasia for a person who is tired of living without having a serious medical condition was significantly 
more	 likely	 to	be	accepted	by	people	with	a	higher	education	 (OR	1.6;	CI:	1.1-2.3),	having	no	religious	
belief	(OR	1.7;	CI:	1.3-2.3),	having	little	trust	in	the	physician	to	comply	with	their	wishes	(OR	1.6;	CI:	1.2-2.2)	
and	considering	it	important	to	be	able	to	make	one’s	own	end-of-life	decisions	(OR	1.7;	CI:1.3-2.3),	than	
by	others.	The	acceptance	rate	was	not	associated	with	respondents’	age	(OR	1.0;	CI:	0.99-1.0)	or	by	their	
health	status	(OR	1.2;	CI:	0.8-1.7).	Agreeing	with	the	vignette	describing	physician-assisted	suicide	in	case	
Table 3.3  Opinions on physician-assisted suicide in different cases of suffering
Vignette I
Old age 
and tired of 
living
%
Vignette II
Cancer: loss 
of control 
with severe 
pain
%
P-value
In your opinion, does this situation concern unbearable 
suffering?
Yes 20 69 <0.001
No 65 13
Don’t know 15 18
Do you personally agree with the physician’s act? 
Yes 26 65 <0.001
No 58 15
Don’t know 16 19
Imagine yourself as the person in this situation. Would you ask 
your physician for euthanasia?
Yes 19 48 <0.001
No 53 16
Don’t know 28 36
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of a person who is tired of living was associated with the same personal characteristics, except for higher 
education	(OR	0.9;	CI	0.4-2.1).
Respondents who were in favour of enabling the oldest old to get medication to end their life if they want 
so were more likely to be higher educated (OR 1.5, CI:1.1-2.1) and not religious (OR 2.2 CI:1.7-2.8)  than 
those who opposed that option. They also were more likely to have little trust in the physician to comply 
with	 their	wishes	 (OR	2.4;	CI:	1.8-3.2)	and	 to	consider	 it	 important	 to	be	able	 to	make	own	end-of-life	
decisions	(OR	1.8;	CI:	1.4-2.3).	Age	and	health	status	were	not	related	to	respondents’	opinions.	
DISCUSSION
Our study shows that a substantial minority of the Dutch general public supports euthanasia and physician 
assisted suicide for older people who have a wish to die because they are tired of living without having 
a serious medical condition, which is significantly less compared to the 65% acceptance of physician-
assisted suicide for patients who are terminally ill. Furthermore, 36% supports the idea of enabling the 
oldest old to get medication to end their life if they would want so. 
Recently, a trend analysis of Dutch older people’s attitudes towards euthanasia showed that in 2008 one 
third agreed with making a suicide-pill available for older people who have a wish to die because they 
are tired of living, in the absence of a severe disease 14. Little is known about the true prevalence of older 
people who have a wish to die because they are tired of living. Recently, it has been estimated that Dutch 
physicians annually receive 400 requests for assistance in dying from older people because they are tired 
of living 15. Thus, the medical practice of euthanasia and physician-assisted suicide for older people who 
are tired of living appears to be relatively small, given our aging society with 2.5 million individuals aged 
65 or older, and 19% of the general public indicating that they would ask for physician-assisted suicide in 
case they would be tired of living.
A second finding of our study is that age and health are not associated with acceptance of assistance 
in dying for older people who are tired of living. This might suggest that experiencing declining health 
as well as old age does not instigate favouring or opposing of assistance in dying for persons who are 
tired of living. Furthermore, those in favour of assistance in dying for older people were more likely to be 
higher educated, have less trust in their physician to comply with their wishes and more often prefer to 
make their own health decisions rather than physicians making these for them. The bottom line seems 
to be that those who accept assistance in dying for older people who are tired of living value control 
over their health care decisions. A feeling of loss of control is known to play a role in suicide among older 
people, especially in those who had been predominately ‘action-oriented’ persons all their lives 16-17. In 
the Netherlands, the debate on assistance in dying for older persons who are tired of living is sparked 
with arguments related to the need to maintain control 18. The fact that older people are often negatively 
portrayed in the media 19, such as being a burden on society and frail non-contributors as a result of 
declining health, might play a role in the shaping of these notions of control. Furthermore, a recent 
interview study aiming to understand why older people want to die also found that the need to control is 
an important issue. Traumatic events, early or late in life, a life of adversity and agony, poor quality of life or 
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a recurring depression, resulted in people experiencing a lack of control to change their life 15. 
For this study, some methodological considerations should be taken into account. First, despite a good 
response	rate,	the	respondents	were	not	fully	representative	for	the	Dutch	population;	the	respondents	
were slightly older, more often male, higher educated and more often sharing a household. Furthermore, 
migrants were underrepresented. This has possibly led to an overestimation of the support for assistance 
in dying for older people who are tired of living. Secondly, an internet panel for surveys may involve some 
degree of selection bias. To minimize such bias, the CentERpanel was used that consist of a randomised 
sample of people (not self-selected) and that enables all selected members to participate (no restriction 
to internet users only). Thirdly, another limitation to a quantitative survey is that statements and vignettes, 
in order to be standardized, are inevitably simplifying the complex reality, stripping it of its emotional and 
personal context. To ensure the veracity and quality of the vignettes, the vignette of tired of living has 
been based on a true court case. Our study shows less support for the statement regarding assistance 
in dying in case of being tired of living, compared to the vignette addressing the same topic. Whether 
these results reflect the use of different measures (vignette vs. statement) or the use of different ways of 
assistance in dying (euthanasia vs. physician assisted suicide) is unclear.
In conclusion, a substantial minority of the Dutch public considers euthanasia and physician-assisted 
suicide acceptable for older people who have a wish to die because they are tired of living, while a majority 
of the Dutch public considers assistance in dying acceptable for patients whose suffering is rooted in a 
serious medical condition. Those who support assistance in dying for older people who are tired of living 
are more likely to be higher educated and to prefer a sense of control than others.
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ABSTRACT 
Background
Advance care planning (ACP) is a process of communication among patients, healthcare providers and 
relatives regarding end-of-life care and decision making, to ensure patients’ preferences remain central in 
end-of-life care when the patient is no longer capable of decision-making. Health policies state that ACP 
promotes high quality end-of-life care and should, therefore, be promoted. However, little is known about 
the actual and preferred involvement of people in ACP as a process.
Objective 
To describe the actual and preferred involvement in ACP of the Dutch general population.
Design
A national cross-sectional survey.
Setting/subjects
Random sample of Dutch adults (1,960 respondents: response rate 78%).
Measurements
Questionnaire on the actual and preferred involvement in ACP.
Results
Of all respondents, 70% had thought about ACP and 64% had discussed ACP with their relatives. 
Furthermore, 13% had actively discussed ACP with their physician and 7% had an advance directive. 
About 20% need more information about ACP. Factors positively associated with actual involvement in 
ACP were: age ≥ 55 years, having had an experience with a relative who requested euthanasia, acceptance 
of euthanasia, a preference for making one’s own health decisions rather than physicians doing this, and 
having some knowledge about end-of-life issues.
Conclusions 
The majority of the Dutch general public has thought about their ideas and preferences regarding end-
of-life care and decision-making or has actively discussed these ideas with relatives, whereas a substantial 
subgroup indicated a need for more information about ACP. However, ACP is rarely discussed with 
physicians. In clinical practice, it is important to be aware of this potential interest among older people 
in ACP.
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INTRODUCTION
Advance care planning (ACP) is a process of communication among patients, healthcare providers, and 
relatives regarding the end-of-life care. ACP aims to ensure that patients’ values remain central in decision-
making when patients can no longer make decisions and that this care remains consistent with patients’ 
preferences 1. ACP encompasses various components, including the consideration of treatment goals, 
and communication with relatives and physicians 2.  ACP may also involve the designation of a surrogate 
decision-maker, or an advance directive (AD) in which treatment preferences are recorded. ADs can 
contain a refusal of treatments (negative directive) or preferences for care and treatments to be applied 
(positive directive) under specified conditions. 
In the Netherlands, the Dutch Medical Treatment Act states that patients have the right to refuse medical 
treatment and can do this in writing through an AD. In principle, a physician has to follow such a negative 
AD when it is clear and sufficiently detailed. In contrast, a positive AD only serves to support a physician in 
understanding the preferences of the patient 3-4. In the Netherlands, a positive AD might include a specific 
request for euthanasia, which is a relatively common type of AD in the Netherlands 5.
Although ACP comprises more than drafting an AD, most research has focused on ADs that have been 
subject to increasing criticism 6. Important limitations of ADs are related to its drafting (e.g. it is difficult 
to foresee future wishes, people may change their preferences) and its interpretation (e.g. it is difficult to 
interpret	the	content;	ADs	may	involve	incomplete	or	conflicting	information).	Furthermore,	research	on	
the impact of ADs has shown disappointing results. Over the last decades, the prevalence of having an 
AD ranged from 3-36% among the general public 5, 7-12 and from 5-19% among (deceased) patients 10, 13-14. 
Various efforts to improve patients’ completion rate of an AD have not been very successful 15, 16 and 
minimal effects of ADs on directing end-of-life care and its quality have been reported 13, 17-18. 
Currently, the focus of research on ACP has shifted towards ACP as a process of communication, and aims 
to approach ACP as a concept that is wider than solely drafting an AD19-20. One study showed that ACP, as 
a process, improves end-of-life care for elderly patients, as well as patients’ and families’ satisfaction with 
care;	also	among	surviving	relatives,	ACP	 leads	to	stress	 reduction,	 less	anxiety	and	 less	depression	21. 
Because of these potential benefits of ACP, it might be seen as a healthy and useful behavior to promote 
among the general public 22. Although qualitative studies have assessed the patient’s perspective on 
ACP 2, 19, 23-24 and the barriers they define for ACP 25-27, little information is available on the involvement of 
the general public in ACP. Therefore, the aim of the present study is to determine if people are currently 
involved or are inclined to be engaged in ACP, and to delineate the factors associated with greater 
engagement. 
METHODS
Design and population
This cross-sectional survey was conducted in the Netherlands. An online questionnaire was completed 
by a representative sample of the Dutch general public, derived from an established internet panel 
(CentERdata, University of Tilburg, the Netherlands). This panel comprised a random sample of national 
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postal codes. Multiple measures were in place to avoid selection bias of this internet panel, such as 
guaranteeing accessibility for all selected households without internet access at time of study recruitment 
by providing them with a free tool, the so-called Net.Box. This tool enabled those without internet access 
to respond via a telephone line and a television set. During the survey period 2,503 persons were active 
members of the total panel. 
Questionnaire
The structured questionnaire addressed actual and preferred involvement in ACP, as well as factors 
associated with engagement. The questionnaire was developed by the KOPPEL research group, 
comprising physicians, ethicists, researchers and a methodologist. Questions were based on literature 28, 
previous research 29-30 and expert opinion. The questionnaire was pretested for length, comprehensibility 
and feasibility for online use by 14 members of the Dutch general public. The pretest population varied in 
educational level, age and gender. The questionnaire and two reminders were sent between December 
2009 and February 2010.
Additional background characteristics were provided by CentERdata, based on self-reported data. For 
comparison purposes, background characteristics of the whole Dutch population were obtained from 
Statistics Netherlands (CBS) 31.
Statistical analyses
Descriptive statistics were computed on background characteristics, involvement in ACP, need for 
information, health, experiences, attitudes and knowledge. Univariate analyses, followed by multivariate 
logistic regression analyses, were used to calculate odds ratios with 95% confidence intervals for the 
relationships between involvement in ACP and demographic characteristics, health, experiences, 
attitudes and knowledge. Involvement in ACP was analyzed based on three items: ‘having thought about 
end-of-life decisions’, ‘having discussed end-of-life decision-making with relatives or physicians’ and 
‘having a written AD’. Having discussed end-of-life decision-making was scored on a 4-point Likert scale 
and dichotomized (seldom, sometimes and often were recoded to ‘yes’ and never as ‘no’). The variables of 
trust, attitudes toward decision-making, knowledge of palliative care and need for more information were 
also dichotomized. Respondents were defined as having ‘substantial knowledge of the Euthanasia Act’ if 
they answered all of four related questions correctly. 
Four indicators concerning attitude towards euthanasia were used to compose an index measuring 
acceptance of euthanasia of the respondent, based on the outcome of factor analysis (1 factor with 
eigenvalue > 1.0, 78% explained variance) and reliability analysis (Cronbach’s alpha = 0.79). Using the 
median score of the sum scores, we distinguished respondents who generally accept or reject euthanasia.
Ethical considerations
The Dutch Medical Research Involving Human Subjects Act does not apply to this research proposal. 
Therefore, no ethical approval of the Medical Ethical Committee was needed.
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RESULTS
Sample characteristics
Of the 2,503 questionnaires, 2,004 were returned, and 1,960 were complete and eligible for analyses 
(response 78%). The age of the respondents ranged from 18-95 years. Reasons for exclusion of 44 
questionnaires were incompleteness (n=17) and age of the respondent <18 years (n=27). Compared to 
the Dutch general public, respondents in the sample were older, more often male, more highly educated, 
more often living with a partner, and more often native Dutch (Table 4.1). Furthermore, non-respondents 
were younger, more often female, more often living without a partner, and more often had a lower 
education level.  
Table 4.1  Background characteristics of the respondents of the online survey compared with the Dutch general 
population
Respondents
(n=1.960)
Dutch adults *
Age (mean ± SD) 53.4 ± 15.1 48
(%) (%)
Gender
Male 54 50
Education †
Low 32 32
Middle 29 40
High 39 29
Composition of household
Living with partner 76 64
Religious beliefs
Yes 58 59
Urbanisation living area
Low/middle 61 57
High 39 43
Nationality  
Native Dutch 96 80
Immigrants ‡ 4 20
*	 Based	on	2009	data	of	Statistics	Netherlands	(CBS);	http://statline.cbs.nl/statweb	
† Low=level 1-3 according to the ISCED guidance, (primary school, lower secondary general education, lower vocational education), 
middle=level 4 according to the ISCED guidance (intermediate vocational or higher secondary general education), high=level 5-7 
according to the ISCED guidance (higher vocational education or university)
‡ Immigrants are defined as being born in a country other than the Netherlands, or having a mother or father who was born in a country 
other than the Netherlands. 
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Of the 1960 respondents, 85% reported good general health, and 11% reported to have (had) a life-
threatening disease, 14% have had experience with a relative requesting euthanasia and 16% with a 
relative receiving palliative sedation (Table 4.2). In addition, 77% expressed trust that physicians would 
comply with their wishes about medical care/treatment in the last days of life. Most respondents favored 
shared decision-making (67%), 31% preferred making their own decisions and 2% preferred the physician 
to make the decisions. Respondents expressing little trust that physicians would comply with their wishes 
about medical care/treatment in the last days of life more often preferred to make their own decisions 
(p<0.001). Of all respondents, 18% believed that a physician’s current judgment about a patient’s situation/
treatment is better than the patient’s judgment in an earlier stage. Almost all respondents were aware of 
the existence of the Dutch Euthanasia Act (95%), 37% correctly answered all four questions regarding this 
Act and 53% were familiar with the term ‘palliative care’.
Involvement and preferences to be involved in ACP
Of all 1,960 respondents, 70% indicated to have thought about issues related to medical decision-making 
at the end of their life (Table 4.3). Of all eligible respondents, 64% had discussed at least one of these 
issues with their relatives (6% often, 35% sometimes, and 24% seldom), and 13% had discussed these 
issues with a physician (0.3% often, 3% sometimes, and 9% seldom). In total, 33% had thought about end-
Table 4.2  Other characteristics of the respondents of the online survey: experiences, attitudes and knowledge 
related to end of life issues
Respondents
(n=1.960)
(%)
Good self-reported general health * 85
Having (had) a life-threatening disease 11
Experience with euthanasia request of a relative 14
Experience with palliative sedation for a relative 16
Trusting physicians to comply with patient’s wishes at the end of life † 77
Believing that physician’s current judgment is better than the patient’s in an earlier stage ‡ 18
Preference for end-of-life decision-making style:
Physicians should make decisions, based on what is best for me 2
Physician and I should make decisions together 67
I should make decisions, based on what is best for me 31
Substantial knowledge of the Dutch Euthanasia Act § 37
Familiar with the term ‘palliative care’ 53
* Missing values on self-reported health were >10%. Valid percentage was based on 1403 respondents
†  Trusting=a lot of trust and quite a lot of trust.
‡		 Agree=agree;	completely	agree.	Not	agree=	neither	agree	nor	disagree;	don’t	know,	disagree;	completely	disagree
§  Substantial knowledge includes those who gave a correct answer to all four questions about the Act
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of-life decision-making and had discussed it with their relatives, but had not discussed it with a physician 
and had not written an AD. Of all respondents, 7% had documented their wishes in a written AD. Of all 
respondents with an AD (n=139), 24% had discussed the AD with their physician, and 81% had discussed 
it with their relatives. Overall, 21% of the respondents wanted more information on end-of-life decision-
making, e.g. medical care and treatments at the end of life, ADs or euthanasia. These respondents would 
look for information on the internet (54%) or ask their general practitioner (GP) (69%). Older persons, 
people who had thought about or discussed end-of-life issues with a relative or a physician, or who had 
an AD, more often wanted information than others.
Factors associated with involvement in ACP
The probability of having thought about end-of-life decision-making was higher for persons aged ≥ 55 
years, as well as for females, for persons without religious beliefs, persons with a poor health status, persons 
who had experienced a euthanasia request of a relative, persons who generally accept euthanasia, persons 
Table 4.3  Involvement in advance care planning (ACP) among Dutch adults
Respondents
(n=1.960)
(%)
Has thought about one of the following topics regarding end-of-life decision-making 70
Medical treatments that I would (not) want at the end of life 57
Whether and in which circumstances I would want resuscitation 48
Whether and in which circumstances I would want euthanasia 55
Who decides about medical treatments when I am no longer able to 53
Has discussed one of these topics with relatives * 64
Has discussed one of these topics with a physician * 13
Has a need for more information about these topics † 21
Possible sources for information on these topics:
General practitioners 69
Internet 54
Relatives 44
Has a written advance directive, describing: 7
The circumstances in which I would not want certain medical treatments 4
The circumstances in which I would not want resuscitation 4
The circumstances in which I would want euthanasia 3
Who decides about my medical treatments when I am no longer able to 4
Other 1
*  Responses measured on a 4-point Likert scale. ‘Yes’ includes seldom, sometimes, and often.
†  Responses measured on a 4-point Likert scale. ‘Yes’ includes sometimes and often.
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who expressed little trust that physicians would comply their wishes, persons not preferring physicians to 
make decisions for them, and persons who knew the term ‘palliative care’ and were familiar with the Dutch 
Euthanasia Act (Table 4.4). Similar patterns were found for discussing and having a written AD. Persons 
living with a partner less often had a written AD than persons living without a partner.
 
Table 4.4  Factors associated with involvement in advance care planning in the respondents of 
the online survey *
Thought about 
end-of-life decision-
making
OR (95% CI)
Discussed preferences 
with relatives or 
physicians
OR (95% CI)
Has a written advance 
directive
OR (95% CI)
Demographic characteristics
Age≥55 years 1.83 (1.37 – 2.45) 1.91 (1.45 – 2.51) 2.96 (1.76 – 5.00)
Male 0.59 (0.45 – 0.79) 0.60 (0.46 – 0.78) 1.37 (0.84 – 2.23)
High education 0.87 (0.65 – 1.17) 0.79 (0.59 – 1.04) 0.78 (0.47 – 1.27)
Living with partner 0.82 (0.58 – 1.16) 1.02 (0.74 – 1.41) 0.54 (0.33 – 0.90)
Having religious beliefs 0.64 (0.48 – 0.86) 0.71 (0.54 – 0.94) 0.98 (0.61 – 1.59)
Health
Good health status 0.64 (0.42 – 0.98) 0.66 (0.45 – 0.98) 0.47 (0.28 – 0.80)
Having (had) a life-threatening 
disease 1.17 (0.72 – 1.90) 1.33 (0.84 – 2.10) 1.30 (0.71 – 2.35)
Experience with end-of-life 
decision-making 
Experience with euthanasia 
request of a relative 2.65 (1.50 – 4.70) 2.61 (1.55 – 4.38) 1.99 (1.08 – 3.67)
Experiences with palliative 
sedation for a relative 1.39 (0.88 – 2.20) 1.46 (0.95 – 2.25) 0.80 (0.42 – 1.53)
Attitudes
Acceptance of euthanasia 1.58 (1.09 – 2.29) 1.67 (1.19 – 2.36) 2.71 (1.65 – 4.44)
Trusting physicians to comply 
with patient’s wishes at the end 
of life 0.40 (0.28 – 0.59) 0.51 (0.37 – 0.72) 1.00 (0.59 – 1.70)
Preference for physician to make 
end-of-life decisions for me 0.19 (0.07 – 0.49) 0.24 (0.10 – 0.62) -
Knowledge
Familiar with the term ‘palliative 
care’ 2.76 (2.05 – 3.70) 2.35 (1.78 – 3.09) 0.98 (0.59 – 1.63)
Knowledge of the Dutch 
Euthanasia Act 2.06 (1.51 – 2.82) 2.13 (1.59 – 2.85) 1.63 (1.02 – 2.63)
* Adjusted odds ratios (ORs) were estimated with multivariate logistic regression analyses. These analyses included 1.231 respondents with 
complete information of all variables.
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DISCUSSION
This study shows that the majority of the Dutch population has thought about end-of-life care and 
decision-making, and a substantial part of the population has actively discussed their preferences with 
relatives. Furthermore, it shows that one fifth of the general public indicated a need for information on 
end-of-life care, and would use the GP as the major source of information. However, discussions with 
physicians about end-of-life care are rare among the general public, even among people who have an AD. 
Several findings deserve particular attention. First, although many people think about end-of-life care 
and decision-making, only 13% had discussed these issues with their physician. This is less compared to 
a recent study that found that Dutch and Belgian GPs had discussed medical treatment in the last phase 
of life in advance with 34% of their patients who had died non-suddenly 32. The higher percentage in 
this study might be explained by differences in the population studied, i.e. the general population vs. 
deceased patients, and by the respondents’ perspective, i.e. physicians’ vs. patients’ perspective.
Second, in the present study, 7% of the members of the general public reported to have an AD. This 
finding supports previous research on the prevalence of ADs in the general population with percentages 
ranging from 3-36% 5, 7, 9, 11, 33-34. Compared to the United States where the estimated prevalence of ADs in 
the general population varies from 18-36% 7, 12, 34, the prevalence of ADs in the Netherlands seems lower. 
It has to be noted that the US Patient Self-Determination Act (PSDA), requiring healthcare institutions to 
provide information about ADs to adult patients upon their admission 35, came into effect earlier than the 
Dutch Medical Treatment Act. However, the SUPPORT study showed no effect of the PSDA on completion 
rates of ADs 36. As said, the effects of ADs have been subject to major criticism, such as that they are not 
able to direct end-of-life care 13 and that they even involve a false promise, i.e. that the advance directive 
concept itself is fundamentally flawed 6. The limited effects of ADs have been suggested to be partly 
due to little involvement of physicians in the completion of ADs, to physicians often being unaware of 
the availability of ADs, and to nonspecific wording of preferences in ADs 13, 18, 37. Our study confirms 
that physicians are rarely involved in completing an AD as only 24% of all respondents with an AD had 
discussed it with their physician.
Third, most demographic factors associated with engagement in ACP are consistent with earlier studies 
on the drafting of ADs. Patients who have completed an AD were found to be older, more highly educated, 
more often female, and have increased dependency 5, 7, 11, 33, 38, and older age has also been reported to 
be positively associated with ACP as a process 25. Furthermore, a predictor of being interested in AD is the 
wish of having control 39. Our results support this idea of control. Those respondents in favor of physicians 
making decisions and expressing trust that physicians would comply with their wishes were significantly 
less inclined to be involved in ACP. Persons who accept euthanasia, also associated with wish for control 29, 
were also more inclined to be involved in ACP. 
Besides individual factors, societal and legal factors can influence the level of involvement in ACP. In the 
Netherlands, an accessible health system is present with compulsory social health insurance and a special 
role for GPs as gatekeepers. Dutch people often have a long-lasting relationship with their GP, which 
might contribute to the high level of trust in physicians in the Netherlands. This trust might diminish 
PART I  PUBLIC OPINION ON END-OF-LIFE DECISIONS
58
the perceived need for ADs. Furthermore, the Dutch societal and public debate on euthanasia (which 
resulted in the Euthanasia Act in 2002) might influence the prevalence of ACP in the Netherlands and 
limit international comparability of the Netherlands. The Dutch general public is highly familiar with the 
advanced euthanasia directive 5, indicating the dominance of the issue of euthanasia in the Netherlands 
regarding end-of-life decision-making 8. This context hampers the generalisability of our results to other 
settings. Also some other methodological considerations of the study need to be addressed. First, despite 
a	good	response	rate,	the	respondents	were	not	fully	representative	of	the	Dutch	general	population;	the	
respondents were older, more often male, more highly educated and more often sharing a household. 
This may have led to an overestimation of the involvement in ACP of the Dutch general public. Moreover, 
non-native Dutch people were underrepresented and cultural factors are known to impact health care 
use 40 and health communication 41, thus influencing end-of-life care and decision-making 42. In studies 
from the United States, ADs are more common among the white population 7, 11, 43. Additionally, an 
internet panel used for surveys may involve selection bias. To minimize this bias, we made use of an 
existing panel consisting of a randomized sample of people (thus not self-selected) and this enabled all 
selected members to participate (no restriction to internet users only). Finally, because this study only 
examines the respondents’ report of their involvement, without triangulation, the results may be subject 
to recall bias. 
Although until now only one study has shown positive effects of ACP as a process 21 and more research is 
needed to confirm these results, ACP may be a potential contributor to better end-of-life care. Our study 
shows that most people are open to discussions about end-of-life care, that a need for more information 
is present. Since only a very small percentage of our study population has discussed end-of-life issues 
with their physician, our findings suggest that a more active role of physicians in initiating end-of-life 
discussions would be useful. In line, it has been suggested earlier, that physicians have a responsibility to 
start end-of-life discussions in a timely way 44-47, by informing and educating their patients. Therefore, to 
facilitate ACP, we suggest a dual approach to inform both the public and health care professionals. Firstly, 
to increase the awareness of the general public regarding the need to take the next step in ACP, i.e. to have 
timely discussions with physicians about their preferences at the end-of-life, such as the ‘Dying Matters’ 
initiative in UK 48. This will contribute to overcome known barriers related to end-of-life discussions at the 
patient level, such as patients’ ambivalent attitudes towards their prognosis, and a general reluctance to 
(spontaneously) talk about their problems and needs 46. Secondly, physicians need to be educated and 
supported in how to initiate and have end-of-life discussions, because physicians are reluctant to discuss 
end-of-life issues and wait until the patient raises the topic 49. This training and support should reach 
beyond technical aspects of communication and involve reflection of the physicians’ own emotions and 
values 50. 
In conclusion, the majority of the Dutch population has thought about their ideas and preferences 
regarding end-of-life decision-making or has actively discussed these ideas with relatives, and a need 
for information on end-of-life care is present. Despite the fact that the majority of Dutch population 
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seems open to discussions about end-of-life care, our study reveals that discussions with physicians 
are exceedingly rare. To improve ACP as a joint process between patients, relatives and physicians, the 
general public’s awareness of the importance of end-of-life discussions with their physicians needs to 
be increased and physicians need to play a more active role by initiating conversations and dialogue 
regarding end-of-life care. 
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ABSTRACT
Background
End-of-life decision making is an important aspect of end-of-life care that can have a significant impact on 
the process of dying and patients’ comfort in the last days of life. 
Aim
The aim of our study was to identify issues and considerations in end-of-life decision making, and needs 
for more evidence among palliative care experts, across countries and professions. 
Participants
90 palliative care experts from nine countries participated in a modified Delphi study. Participants were 
asked to identify important issues and considerations in end-of-life decision making and to rate the need 
for more evidence. 
Results
Experts mentioned 219 issues in end-of-life decision making related to the medical domain, 122 issues related 
to the patient wishes and 92 related to relatives’ wishes, regardless of profession or country (p > 0.05). In 
accordance, more than 90% of the experts rated the comfort and wishes of the patient and the potential 
futility of treatment as important considerations in end-of-life decision making, although some variation 
was present. When asked about issues that are in need of more evidence, 87% mentioned appropriate 
indications for using sedatives and effects of artificial hydration at the end of life. A total of 83% mentioned 
adequate communication approaches. 
Conclusions
Palliative care experts from different professions in different countries encounter similar issues in end-
of-life decision making. Adequate communication about these issues is universally experienced as 
a challenge, which might benefit from increased knowledge. This shared experience enables and 
emphasizes the need for more international research.  
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INTRODUCTION
End-of-life decision making is a sensitive but important aspect of end-of-life care that can have a significant 
impact on the process of dying and dying patients’ comfort in the last days of life. Such decision making 
may involve withdrawing or withholding treatment, such as artificial nutrition (AN) and hydration (AH), 
or providing intensive treatment to alleviate suffering, for example by using opioids or sedatives. Some 
countries, such as the Netherlands and Belgium, allow the provision of life-ending drugs upon the explicit 
request of the patient.
To date evidence on the effects, either beneficial or harmful, of providing or not providing different 
types of treatment in the last days of life is limited 1-2. Current research focuses mostly on practices and 
experiences or attitudes of physicians, nurses, patients, relatives or the general public and is often locally 
based. However, some international research has been conducted 3. Hence, we know that the frequency 
of foregoing treatments, such as AH and AN 4, and the manner of alleviation of severe suffering at the 
end of life 5-6 vary between countries. Many factors can contribute to this variation, such as cultural, 
legal and practice differences, for example in the organization of health care. Research has shown that 
European intensive care unit (ICU) physicians’ primary consideration in decision making on withdrawing 
or withholding life support or actively shortening the dying process was the patient’s medical condition, 
while quality of life, patient age and patient or family request were less important 7. In the Netherlands, 
important considerations in decision making about anti-cancer treatment for end-stage cancer patients 
were found to be the chance of improvement, patient wishes, the degree of suffering and the chance of 
therapy being successful 8.
Besides variation in end-of-life decision-making practices between countries, previous research has also 
shown differences between professions in attitudes regarding end-of-life decision making 9, which are 
probably related to different responsibilities, roles and levels of involvement.
More insight into the international and interdisciplinary variety in end-of-life decision-making practices 
can contribute to international understanding and debate and to the identification of international 
research themes 10. The aim of this study was therefore to get more insight into the most important 
issues and considerations in end-of-life decision-making processes. We asked palliative care experts from 
different countries and professions to identify the key issues they encounter when making end-of-life 
decisions, their considerations when making end-of-life decisions, and the extent to which they feel that 
more evidence on these issues is needed.
METHODS
Design and population
A modified two-round digital Delphi survey was conducted. This study was framed within the European 
research collaborative OPCARE9, in which palliative care practitioners and researchers from nine countries 
are identifying areas for optimizing care for the dying. These countries are Argentina, Italy, Germany, the 
Netherlands, New Zealand, Slovenia, Sweden, Switzerland and the UK. Within OPCARE9, every country 
constructed a national reference group, a multidisciplinary group comprised of palliative care experts, 
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known leaders in the field and volunteers. Convenience sampling was used to construct these reference 
groups. Using these national reference groups, a purposive strategy was applied to identify experts with 
an interest and involvement in end-of-life decision making. We aimed at including four physicians, three 
nurses, two other professional caregivers and one volunteer per country.
Data collection
Two structured questionnaires were developed. In these questionnaires, decisions on AH, AN, and the 
use of sedatives were used as examples of topics for end-of-life decision making. A pre-Delphi survey 
among 114 experts in nine countries showed that they considered these topics as very important at the 
end of life. In the first questionnaire, we asked the experts which important issues they encounter when 
making end-of-life decisions on AH, AN and using sedatives, by using open questions. We also presented 
them with 43 statements on eight considerations when making such decisions. The eight considerations 
assessed were comfort of patient, relative and professional caregiver, the wish of patient and relative, the 
effect on length of survival, futility of the treatment and ability to die at home. Participants were asked 
to rate the importance of these considerations on a seven-point Likert scale, ranging from unimportant 
(1) to highly important (7). The second questionnaire explored the extent to which experts thought that 
research on the issues that were frequently mentioned in round 1 would be useful. They were asked to 
which extent they agreed with statements that decision making would significantly improve if there would 
be more knowledge and/or evidence-based guidance on these issues. They rated their agreement on a 
five-point Likert scale, ranging from 1 ‘totally disagree’ to 5 ‘totally agree’. The background characteristics 
of the experts (country, profession, work setting, age and experience) were asked in both questionnaires. 
The questionnaires were written in English and distributed electronically. The first questionnaire was sent 
between October 2009 and November 2009, and the second between May 2010 and June 2010. For both 
questionnaires reminders were sent in the case of non-response within three weeks.
Statistical analysis
All issues mentioned in response to the open question were labelled, categorized and counted. We 
used the analysis of variance (ANOVA) to compare the number of issues mentioned in different domains 
between countries and professions, for those domains which met the requirements. Likert scores on 
the importance of considerations were dichotomized (1–4 ‘not important’ and 5–7 ‘important’) and the 
percentage of scores in either consideration was calculated. Likert scores on the potential of research to 
contribute to the quality of end-of-life decision making were also dichotomized (1–3 ‘not important, 4–5 
‘important’). Differences between countries and professions in percentage of respondents who thought 
that specific considerations and research needs were important were tested using the non-parametric 
Fisher’s Exact Test. For statistical analyses, we used SPSS software (SPSS PASW 17 17.0.2 ENG, WinWrap 
Basic, Polar Engineering and Consulting).
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Ethical considerations
This study was evaluated by nine ethics committees in all beneficiary countries, as part of the whole 
project OPCARE9. No ethical objections were raised.
 
RESULTS
Response
In the first round the response rate was 76% (n = 68) and in the second round 60% (n = 54). The mean age 
of the experts was 45.8 years in the first round and 47.9 years in the second round. All professions were 
represented as planned (Table 5.1). All countries were represented and the distribution of professions per 
country did not differ in either round. Almost all experts were working in institutions and they had an 
average experience in palliative care of 12 years.
Table 5.1  Profile of respondents in the first and second round of the Delphi study
Round 1 Round 2
Response rate % (n) 76% (n = 68) 60% (n = 54)
Age (mean, SD) 45.8 (8.5) 47.9 (7.9)
Profession
Physician 46% (31) 52% (28)
Nurse 25% (17) 33% (18)
Other caregiver * 29% (19) 15% (8)
Setting
Hospital 27% (18) 26% (14)
Hospice 31% (21) 32% (17)
PCU 34% (23) 33% (18)
Other 8% (5) 9% (5)
Country
Argentina 16% (11) 18% (10)
Italy 15% (10) 9% (5)
Germany 12% (8) 6% (3)
New Zealand 12% (8) 13% (7)
Slovenia 3% (2) 4% (2)
Sweden 15% (10) 16% (9)
Switzerland 7% (5) 9% (5)
The Netherlands 9% (6) 15% (8)
United Kingdom 12% (8) 11% (6)
Expertise Mean (SD) Mean (SD)
Years working in palliative care 11.1 (7.1) 12.4 (6.8)
Attending deaths per year 159 (146) 120 (111)
* Other caregivers were social workers, psychologists, spiritual caregivers, occupational therapists, volunteers and a dietician.
PCU: palliative care unit 
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Issues in end-of-life decision making
The experts mentioned 552 issues that they encounter when making end-of-life decisions: 189 related 
to AN, 182 related to AH and 181 related to the use of sedatives at the end of life. The issues mentioned 
could be categorized into nine domains. Most issues were related to the medical domain, followed by 
issues related to addressing patients’ wishes, addressing relatives’ wishes and to multidisciplinary team 
decision making. Issues in the cultural and legal domains were least often mentioned. The number of 
issues mentioned per domain did not differ between professions or countries.
Considerations in end-of-life decision making
According to the experts, the most important consideration in end-of-life decision making is the comfort 
of the patient, for all three types of decisions, followed by the potential futility of treatment and the wishes 
of the patient (Table 5.2). The least important considerations were the comfort of professional caregivers 
and the (expected) effect of treatment on postponing death or foreshortening life. The importance of 
these considerations was rated similarly by all professions. There were significant differences between 
countries: futility of treatment was least often rated as an important consideration in the UK (overall 
p<0.05) and enabling people to die at home was most often rated as important in Argentina and least 
often in Sweden (overall p<0.01).
Need for more guidance in end-of-life decision making
Table 5.3 shows the percentage of experts who thought that end-of-life decision making could 
significantly improve if there were more evidence-based guidance. Of the experts, 87% (totally) agreed 
with the statement that more evidence-based guidance on ‘optimal strategies for communication with 
the patient’ could improve end-of-life decision making, and 83% agreed with a comparable statement on 
communication with relatives. Other important research themes were indications for using sedatives at 
the end of life (87% of the experts), the effects of (de)hydration at the end of life (83% of the experts) and 
the dosage of sedatives to use at the end of life (80% of the experts). No differences between countries 
were found in the rating of the importance of more evidence for the different themes. There were some 
differences between professions: the effect of dehydration on quality of life was more often considered 
important by physicians and nurses than by other caregivers (overall p < 0.05) and multidisciplinary team 
decision making was more often considered important by nurses (overall p = 0.01).
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Table 5.2  Percentage of respondents rating considerations in end-of-life decision making as important
Considerations in end-of-life  
decision making
Physicians
%  
important
Nurses
% 
important
Other 
caregivers
% 
important
Total
% 
important
Difference 
professio-
nals
p-value
Difference 
countries
p-value
Comfort of patient 100 100 100 100 n.a. n.a.
Futility of treatment 90 81 100 90 0.30 <0.05
Wishes of patient 83 100 93 90 0.17 0.13
Enable patients to die at home 79 75 57 73 0.33 <0.01
Comfort of relatives 30 41 50 38 0.45 0.43
Wishes of relatives 28 32 36 31 0.93 0.21
Possible effect on length of 
survival 11 0 15 9 0.42 <0.05*
Comfort of professional caregivers 7 18 0 9 0.23 0.39
Dichotomized scores on a seven-point Likert scale (1–4 = not important, 5–7 = important). 
* Little relevant differences between countries, although statistically significant, due to very low % of experts who rated this consideration as 
important. 
Table 5.3  Percentage of respondents agreeing that more evidence on end-of-life decision making issues could 
improve end-of-life decision making
End-of-life decision making on AN/
AH/sedatives could substantially 
improve if there would be more general 
knowledge and/or evidence-based 
guidance on…    
Physicians
% agree
Nurses
% agree
Other 
caregivers
% agree
Total
% agree
Difference 
profes sio-
nals
p-value*
Difference 
countries
p-value*
… optimal strategies for communication 
with patients 86 94 71 87 0.32 0.82
… for what indication to use sedatives 93 78 88 87 0.28 0.47
… optimal strategies for communication 
with relatives 85 89 63 83 0.32 0.67
… the effect on quality of life of 
dehydration † 89 89 50 83 <0.05 0.33
… what dose to use for sedation ‡ 79 83 75 80 0.90 0.45
… diagnosing dying 82 67 88 78 0.44 0.93
… what medications to use for sedation‡ 82 72 75 78 0.67 0.38
… the side effects 75 83 50 74 0.25 0.91
… the effects on quality of life 75 72 63 72 0.77 0.52
… how to improve multidisciplinary 
team decision making 56 94 63 70 0.01 0.59
… the impact of cultural perception 67 72 63 68 0.85 0.99
… relatives’ perceptions 71 53 75 66 0.42 0.43
…	ethical	considerations;	respecting	
autonomy of patients 54 72 83 64 0.33 0.27
… legal aspects of making decisions 56 67 75 62 0.59 0.91
… patients’ wishes 61 56 63 59 0.93 0.55
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DISCUSSION
This study shows that palliative care experts from different professions in nine countries encounter similar 
issues in end-of-life decision making. Important issues were often related to the medical domain, such 
as uncertainty about the effects of (de)hydration and appropriate indications for the use of sedatives, 
and to communication, such as how to address patients’ and relatives’ wishes and how to inform those 
involved. The most important considerations for all professions, when making end-of-life decisions, were 
the comfort and the wishes of the patient and the potential futility of treatment. Improved knowledge 
regarding appropriate indications for using sedatives, the effects of AH at the end of life and adequate 
communication approaches was identified as contributing to better end-of-life decision making.
It is important to emphasize that the term ‘end-of-life decision’ is surrounded by some confusion. In the 
early 1990s this term was predominantly used for decisions in the patient domain, involving advance 
care planning and gaining insight into the values of the patient. A significant amount of research on 
medical end-of-life decision-making practices focused on decisions in which the physician aims at or 
takes into account a life-shortening effect 3, 11-16. In this international collaborative, the term ‘end-of-life 
decisions’ was defined as a broad concept that included all decisions that may have a significant impact 
on how, where and when patients die. A preparatory survey, utilizing this definition over 100 experts in all 
participating countries, identified decisions on medical issues such as AH, AN and use of sedatives as the 
important end-of-life decisions.
Our study has both strengths and limitations. To assess issues, considerations and needs related to end-of-life 
decisions, a large international expert panel was used. The experts were selected within the nine beneficiary 
countries of the OPCARE9 consortium. It is not possible to determine if the panel is representative of the 
population of palliative experts. Nevertheless, the presence of different professions and the average length 
of palliative care experience (12 years) suggest that our panel represents a broad and experienced group. 
The response was satisfactory, namely 76% in the first Delphi round and 60% in the second. It is important 
to note that almost all experts worked in an institutional setting, which makes it difficult to generalize our 
results to home care settings. In addition, the participants were predominantly physicians and nurses, 
because they were more inclined to respond. This partly explains the emphasis on medical issues.
Table 5.3  Percentage of respondents agreeing that more evidence on end-of-life decision making issues could 
improve end-of-life decision making
…	ethical	considerations;	possible	
shortening life of patients 44 67 75 57 0.23 0.47
… reasoning behind patients’ wishes 57 47 63 55 0.75 0.83
… the effects on patients’ length of life 57 44 63 54 0.70 0.45
… relatives’ wishes 29 38 50 35 0.52 0.95
Dichotomized scores on a five-point Likert scale (1–2 = agree, 3–5 = disagree). AN: artificial nutrition, AH: artificial hydration
*  p-values are based on Fisher’s Exact Test.
†  statement only on use of artificial hydration at the end of life
‡  statement only on using sedatives at the end of life.
Continued
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This study shows that palliative care experts from different countries share experiences regarding issues 
and considerations in end-of-life decision making. The fact that these shared opinions regarding the 
importance of patient comfort, futility of the treatment and patients’ wishes in end-of-life decisions 
making do not seem to involve similar practices 3 may be related to the fact that evidence-based end-of-
life care is still evolving. Therefore practices can only result from the limited objective data informed by 
experience and humanistic considerations.
We also identified some variation between countries and professionals. ‘Enabling the patient to die at 
home’ was least often rated as an important consideration in end-of-life decision making in Sweden. 
This finding coincides with a relatively low rate of about 21% home deaths (of all non-sudden deaths) 
in Sweden 17. This consideration may also be of less importance in Sweden, due to the high availability 
of technical devices in palliative home care in Sweden. Hence, decision making about AH or AN is not 
a determinate of place of care and dying. In Argentina, where approximately 59% of all people die at 
home 18, it was most often mentioned as an important consideration.
This Delphi study also assessed the extent to which experts believed evidence-based guidance in end-
of-life decision making would be helpful. This practice-based identification of research themes is not only 
useful and feasible, but it also may increase ownership of the future research results and the likelihood 
of these results influencing clinical practice19. Stakeholders in many fields are already involved in 
identification and prioritization of research themes, and increasingly so in palliative care 10, 20-22. However, 
this mostly national involvement of stakeholders in end-of-life research is still insufficient. Recently an 
international study identified ‘lack of culture for research in palliative care services’ and the ’disconnection 
in understanding between clinician and researcher’ as important barriers in end-of-life research 23. Using 
an international, multidisciplinary expert panel, our study may contribute to improving involvement in 
end-of-life research. In addition, our findings regarding the need for evidence-based guidance in end-of-
life decision making are in line with previous research: communication has been shown to be considered 
as an important theme for end-of-life research by patients and their relatives too10.
In conclusion, we found a large degree of international and interdisciplinary consensus on important 
issues and considerations in end-of-life decision making. Communication with terminally ill patients and 
their relatives is a challenge that could benefit from more evidence, together with appropriate indications 
for and effects of end-of-life therapies. This international and interdisciplinary consensus underlines the 
possibility of and need for more international research.
Acknowledgements 
The authors would like to thank the international experts who participated in this study and also the additional 
OPCARE9 members: Simon Allan, Branka Cerv, Simon Chapman, Franzisca Domeisen, Steffen Eychmüller, Carl Johan 
Fürst, Margarita Jorge, Maren Galushko, Olav Lindqvist, Urska Lunder, Carina Lundh Hagelin, Ovidiu Popa Velea, 
Vanessa Romotzky, Stefanie Schuler and Ruthmarijke Smeding.
PART II  NUTRITION AND HYDRATION AT THE END OF LIFE
76
REFERENCES
1. Raijmakers NJ, van Zuylen L, Costantini M, et al. Artificial nutrition and hydration in the last week of life in cancer patients. 
A	systematic	literature	review	of	practices	and	effects.	Ann	Oncol	2011;22:1478-86.
2. Claessens P, Menten J, Schotsmans P, Broeckaert B. Palliative sedation: a review of the research literature. J Pain Symptom 
Manage	2008;36:310-33.
3. van der Heide A, Deliens L, Faisst K, et al. End-of-life decision-making in six European countries: descriptive study. Lancet 
2003;362:345-50.
4. Buiting HM, van Delden JJ, Rietjens JA, et al. Forgoing artificial nutrition or hydration in patients nearing death in six 
European	countries.	J	Pain	Symptom	Manage	2007;34:305-14.
5. Bilsen J, Norup M, Deliens L, et al. Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-
life	care	in	six	European	countries.	J	Pain	Symptom	Manage	2006;31:111-21.
6. Miccinesi G, Rietjens JA, Deliens L, et al. Continuous deep sedation: physicians’ experiences in six European countries. J 
Pain	Symptom	Manage	2006;31:122-9.
7. Sprung CL, Woodcock T, Sjokvist P, et al. Reasons, considerations, difficulties and documentation of end-of-life decisions in 
European	intensive	care	units:	the	ETHICUS	Study.	Intensive	Care	Med	2008;34:271-7.
8. van Leeuwen AF, Voogt E, Visser A, van der Rijt CC, van der Heide A. Considerations of healthcare professionals in medical 
decision-making	about	treatment	for	clinical	end-stage	cancer	patients.	J	Pain	Symptom	Manage	2004;28:351-5.
9. Sprung CL, Carmel S, Sjokvist P, et al. Attitudes of European physicians, nurses, patients, and families regarding end-of-life 
decisions:	the	ETHICATT	study.	Intensive	Care	Med	2007;33:104-10.
10.	 Heyland	DK,	Cook	DJ,	Rocker	GM,	et	al.	Defining	priorities	for	improving	end-of-life	care	in	Canada.	CMAJ	2010;182:E747-
52.
11. van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, et al. End-of-life practices in the Netherlands under the Euthanasia 
Act.	N	Engl	J	Med	2007;356:1957-65.
12. Deliens L, Mortier F, Bilsen J, et al. End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. 
Lancet	2000;356:1806-11.
13. Kuhse H, Singer P, Baume P, Clark M, Rickard M. End-of-life decisions in Australian medical practice. Med J Aust 
1997;166:191-6.
14. Meier DE, Emmons CA, Wallenstein S, Quill T, Morrison RS, Cassel CK. A national survey of physician-assisted suicide and 
euthanasia	in	the	United	States.	N	Engl	J	Med	1998;338:1193-201.
15.	 Seale	C.	National	survey	of	end-of-life	decisions	made	by	UK	medical	practitioners.	Palliat	Med	2006;20:3-10.
16. Van den Block L, Deschepper R, Bilsen J, Bossuyt N, Van Casteren V, Deliens L. Euthanasia and other end of life decisions 
and	care	provided	in	final	three	months	of	life:	nationwide	retrospective	study	in	Belgium.	BMJ	2009;339:b2772.
17. Cohen J, Bilsen J, Fischer S, et al. End-of-life decision-making in Belgium, Denmark, Sweden and Switzerland: does place of 
death	make	a	difference?	J	Epidemiol	Community	Health	2007;61:1062-8.
18. National Institute for Statistics and Surveys Argentina. (Accessed 01-12-2010, at http://www.indec.gov.ar/.)
19. Vella K, Goldfrad C, Rowan K, Bion J, Black N. Use of consensus development to establish national research priorities in 
critical	care.	BMJ	2000;320:976-80.
20. Shipman C, Gysels M, White P, et al. Improving generalist end of life care: national consultation with practitioners, 
commissioners,	academics,	and	service	user	groups.	BMJ	2008;337:a1720.
21. Harding R, Gomes B, Foley KM, Higginson IJ. Research priorities in health economics and funding for palliative care: views 
of	an	international	think	tank.	J	Pain	Symptom	Manage	2009;38:11-4.
CHAPTER 5  ISSUES AND NEEDS IN END-OF-LIFE DECISION-MAKING
77
22. Steele R, Bosma H, Johnston MF, et al. Research priorities in pediatric palliative care: a Delphi study. J Palliat Care 
2008;24:229-39.
23. Sigurdardottir KR, Haugen DF, Bausewein C, et al. A pan-European survey of research in end-of-life cancer care. Support 
Care	Cancer	2012;20:39-48.
Annals of Oncology, 2011, July; 22(7):1478-86
N.J.H Raijmakers, L. van Zuylen, M. Costantini, A. Caraceni, . J. Clark, G. Lundquist, R. Voltz, J.E. Ellershaw, 
A. van der Heide
Artificial nutrition and hydration in the last week of 
life in cancer patients. A systematic literature review 
of practices and effects
CHAPTER 6
PART II  NUTRITION AND HYDRATION AT THE END OF LIFE
80
ABSTRACT
Background
The benefits and burdens of artificial nutrition (AN) and artificial hydration (AH) in end-of-life care are 
unclear. We carried out a literature review on the use of AN and AH in the last days of life of cancer patients.
Materials and methods
We systematically searched for papers in PubMed, CINAHL, PsycInfo and EMBASE. All English papers 
published between January 1998 and July 2009 that contained data on frequencies or effects of AN or AH 
in cancer patients in the last days of life were included.
Results
Reported percentages of patients receiving AN or AH in the last week of life varied from 3% to 53% and 
from 12% to 88%, respectively. Five studies reported on the effects of AH: two found positive effects (less 
chronic nausea, less physical dehydration signs), two found negative effects (more ascites, more intestinal 
drainage) and four found also no effects on terminal delirium, thirst, chronic nausea and fluid overload. 
No study reported on the sole effect of AN.
Conclusions
Providing AN or AH to cancer patients who are in the last week of life is a frequent practice. The effects 
on comfort, symptoms and length of survival seem limited. Further research will contribute to better 
understanding of this important topic in end-of-life care. 
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INTRODUCTION
Most terminally ill cancer patients have a reduced oral intake in the last days of life. This can be due 
to different causes, related to either cancer or its treatment, such as dysphagia 1, anorexia, nausea 
or vomiting  2-6, or mechanic problems, such as a physical obstruction in the digestive tract due to 
gastrointestinal or gynaecologic malignancies 7,8. Reduced oral intake may be seen as part of the 
natural dying process, or it may result in clinically relevant dehydration or malnutrition. Terminal cancer 
patients 9,10 often have symptoms that compromise their quality of life, but an association with reduced 
oral intake has not been proven for the last days of life 9,11,12.
Patients in whom medical treatment for dehydration or malnutrition seems indicated can be treated 
with artificial nutrition (AN), artificial hydration (AH), or artificial nutrition and hydration (ANH). Different 
routes of administration are possible, such as enteral (tube into any part of the gastrointestinal system) 
or parenteral access (i.v. or s.c.). Such treatments are used in different settings for several populations of 
severely ill patients, such as patients with dementia, nursing home residents, pre-, peri- and postoperative 
patients and patients undergoing chemotherapy or other anticancer treatment 7,13-21.
Recently, two Cochrane reviews have been published on the effects of medically assisted hydration and 
nutrition in adult patients receiving palliative care, including the terminal and dying phase. These reviews 
only included level A evidence studies, i.e. randomised controlled trials and high-quality prospective 
controlled studies. It was concluded that the currently available evidence is insufficient to make any 
recommendations for practice with regard to the use of medically assisted nutrition and hydration in 
patients receiving palliative care 22,23.
Patients have different symptoms 24 and different needs 25 in different phases of their disease. When 
investigating practices and effects of ANH in advanced cancer patients, it is therefore important to 
distinguish different phases, such as the review dying phase where life expectancy is hours or a few days at 
most. Randomised controlled trials in the dying phase are complex and rare because of ethical and practical 
considerations related to randomisation, informed consent and follow-up. Observational studies can also 
provide useful information. The objective of this review was to give a comprehensive overview of currently 
available evidence on practices and effects concerning AN and AH in the last week of life of cancer patients. 
METHODS
Research questions
We aimed at addressing the following research questions: (i) how and how often are AN and AH provided 
in	the	last	week	of	life	of	cancer	patients;	(ii)	what	is	the	effect	of	AN	and	AH	during	the	last	week	of	life	on	
symptoms, comfort and quality of life of cancer patients and (iii) does providing or not providing AN and 
AH hasten death or prolong life?
Literature search
We conducted an electronic search of the databases such as PubMed, CINAHL, PsychInfo and EMBASE 
for papers that were published in English between January 1998 and May 2009. We used MeSH headings 
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(palliative care, terminally ill, terminal care, fatal outcome, nutrition support, feeding methods, fluid 
therapy) and a broad range of search keywords for end of life and AN and AH. The complete search 
strategy is presented in Table 6.1.
In addition, we hand searched the most recent issues (January 2008–February 2009) of 10 relevant 
peer-reviewed journals: Journal of Pain and Symptom Management, Journal of Palliative Care, Palliative 
Medicine, Journal of Clinical Oncology, New England Journal of Medicine, Lancet, British Medical Journal, 
JAMA, Annals of Internal Medicine and Archives of Internal Medicine. 
  
Table 6.1  Electronic search strategies
Databases Keywords MESH headings
End of Life
Medline;
PsychInfo;
CINAHL;
EMBASE
#1 “End of Life” in All Text
Terminally	Ill	[Mesh];
Terminal	Care	[Mesh];
Palliative Care [Mesh] 
#2 (“End” in All Text near/1 “Life” in All Text)
#3 “Ending life” in All Text
#4 “Terminally Ill” in All Text
#5 (“Terminal” in All Text near/1 “Care” in All Text)
#6 (“Terminal” in All Text near/1 “Ill” in All Text)
#7 “Palliat*” in All Text
#8 “Die” in All Text
#9 “Dying” in All Text
#10 “Dying process” in All Text
#11 “Approaching death” in All Text
#12 “Dying Phase” in All Text
#13 “Care for dying” in All Text
#14 “Final days of life” in All Text
#15 “Last days of life” in All Text
#16 “Last 24 hours” in All Text
#17 “Last 48 hours” in All Text
#18 “Last 72 hours” in All Text
#19 “Advanced Cancer” in All Text
#20 “Life-sustaining” in All Text
#21 “Life-shortening” in All Text
#22 “Hastened Death” in All Text
#23 “Delaying Death” in All Text OR “Delayed Death”
#24 “Proximity to Death” in All Text
#25 “imminently dying” in All Text 
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Study selection
Two reviewers (NR and AvdH) used a stepwise procedure to identify relevant studies. First, all papers’ titles 
were assessed as probably relevant, possibly relevant and not relevant. Not relevant titles were excluded. 
In the second step, abstracts of the remaining papers were screened on potential relevance. In step 3, 
abstracts of all potentially relevant papers were formally screened on the following inclusion criteria: 
studies had to (i) include cancer patients and (ii) describe original empirical research, thus excluding case 
reports, reviews, discussion papers and ethical papers. If the abstracts met these two inclusion criteria, 
papers were assessed full text. 
Full text papers were assessed on the following criteria: (i) they had to include data on the last week of life, 
(ii) they had to describe frequencies of practices or effects of AN or AH and (iii) at least 25% of included 
patients had to be cancer patients. 
Data extraction and synthesis
We collected information on general aspects of the studies and results related to our research questions. 
Extracted data included number of patients, study setting, study design (prospective or retrospective) 
and general patient characteristics. We also assessed frequencies, administration routes, measurement of 
effects and direction of effects. Data were extracted using a standardised data extraction form. Reviewers 
were not blinded for authors, institutions or journal of publication. We compared results across papers 
Table 6.1  Electronic search strategies
Artificial Nutrition and hydration
Medline;
PsychInfo;
CINAHL;
EMBASE
#1 “Nutrition” in All Text
Nutrition	Support	[Mesh];	
Feeding	methods[Mesh];
Fluid Therapy[Mesh] 
#2 “Hydration” in All Text
#3 “Fluid” in All Text
#4 “Food” in All Text
#5 “Artificial feeding” in All Text
#6 “Artificial nutrition” in All Text
#7 “Artificial hydration” in All Text 
#8 “Artificial” in All Text near/3 ”Feeding”
#9 “Artificial” in All Text near/3 ”Nutrition”
#10 “Artificial” in All Text near/3 ”Hydration” 
#11 “Tube feeding” in All Text
#12 “Infusion” in All Text 
#13 “Parenteral fluid” in All Text 
#14 “Parenteral hydration” in All Text 
#15 “Parenteral nutrition” in All Text 
#16 “Nasogastric tube” in All Text 
#17 “Gastrotomy tube” in All Text
#18 NOT (“Cell Death” or “Apoptosis” or “Cell”) 
Continued
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that addressed similar research questions. We used SPSS 15.0 for Windows (LEAD Technologies, USA) for 
data management and descriptive statistics. 
RESULTS
Selection of papers
We identified 2198 articles from the different electronic databases, excluding 780 duplicates. In the first 
step, 1682 papers were excluded on assessment of relevance of title. In the second step, 134 papers were 
excluded because their abstracts proved their non-relevance. Reading abstracts of possibly relevant papers 
resulted in the exclusion of another 124 papers. This resulted in a total of 258 potentially relevant papers. Of 
these,	102	were	excluded	because	the	abstracts	proved	that	they	did	not	include	cancer	patients;	32	were	
excluded because they did not include original patient data. Finally, a total of 124 papers were assessed full 
text: this resulted in the exclusion of another 110 papers, 51 because they did not report about the last week 
of life but on earlier phases, 25 because they only described knowledge of and attitudes towards AN or AH 
instead of practices and effects, 7 because they did not include at least 25% cancer patients and 27 because 
they included no relevant data on AN or AH. After screening the references of the remaining 14 papers, 
1 paper was added. So, finally 15 papers were included in this review (Figure 1). 
Practices of ANH
Frequencies of AN in the last week of life
Four papers reported on frequencies of AN during the last week of life: two involved retrospective 26,27 
and two prospective studies 3,28. All studies reported on hospital practices and described several ways of 
administering AN, such as tube feeding and total parenteral nutrition. Reported frequencies of providing AN 
varied from 3% to 50%. Overall, there was a higher frequency of AN in prospective studies (range 3%–50%) 
compared with retrospective studies (range 2%–15%) and on non-palliative hospital wards (range 8%–53%) 
compared with palliative wards (range 3%–10%). All studies were conducted in Asian countries (Table 6.2).
Frequencies of AH in the last week of life
Seven papers have reported on frequencies of AH during the last week of life: four retrospective 26-28,30 and 
three prospective 3,29,31 studies. Six studies reported on practices in hospital settings, including one that 
also studied patients in a palliative home care setting and one that was carried out in a hospice setting. 
The studies described several ways of administering AH, such as i.v. and s.c. administration. Reported 
frequencies of providing AH in the last week of life ranged from 10% to 88%. Overall, there was a tendency 
towards a higher frequency of AH in retrospective studies (range 10%–88%) compared with prospective 
studies (range 12%–43%). In hospital settings, the frequency of AH was higher (range 10%–88%) than 
in the hospice (range 33%–44%) (Table 6.2). The frequencies of AH on a palliative care unit (PCU) and 
an acute ward in the same hospital were similar, but these wards differed on the amount of AH given: 
patients in the acute ward received significantly larger volumes of AH, with or without palliative care 
consultation, compared with patients in the PCU 30. 
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Figure 1. Flowchart inclusion and selection papers
Electronic search: 2957 hits
Hand searching: 17 hits
Electronic alerts: 4 hits
TOTAL: 2978 titles
Titles excluded (n=2462)
Doublets (n=780)
Irrelevant titles (n=1682)
Abstracts excluded (n=258)
Irrelevant abstracts (n=258)
Abstracts excluded (n=134)
Did not describe cancer patients (dementia, 
stroke, ICU) (n=102)
No empirical data (discussion paper, case 
report, review) (n=32)
Reference on ANH in last week of life 
(n=1)
Full text excluded (n=110)
Did not describe last 7 days of life (n=51)
On attitudes and knowledge of ANH (n=25)
No relevant data (n=16)
Low proportion of cancer patients (n=7)
Voluntary refusal of food/fluids, no ANH (n=4)
Papers on surgical techniques (n=6)
Potentially relevant titles
(n=516)
Potentially relevant abstracts
(n=258)
Potentially relevant papers for 
full text assessment (n=124)
Included papers on practices  
& effects (n=15)
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Withholding and withdrawing of ANH in the last week of life 
Four papers reported on frequencies of withholding and withdrawing of ANH while taking into account 
or	intending	hastening	of	death	as	a	possible	result;	AN	and	AH	were	not	separated.	In	a	nationwide	study	
in the Netherlands, ANH was found to be withheld or withdrawn in 8% of all deaths 33. A subsequent 
international study found nationwide percentages in several European countries of withholding and 
withdrawing ANH ranging from 2.6% to 10.9% of all deaths 16,34. A retrospective medical chart study in a 
large urban teaching hospital in the United States found a comparable frequency of withdrawing ANH, 
namely in 5.5% of all deceased patients in a large urban teaching hospital. When only looking at deceased 
patients who were actually receiving AN or AH before death, such treatment was withdrawn in 19% 35. 
Effects of ANH
Effect of AN in the last week of life on quality of life
No studies of the effect of AN in the last week of life on quality of life were found. However, a prospective 
observational study reported the combined effect of ANH. In this study, medical staff assessed the comfort 
level of 196 terminal cancer patients who received ANH. Two days before death, 145 patients still received 
ANH: 75% of them did not perceive any changes in comfort compared with an earlier assessment, 6% 
perceived more discomfort and 18% perceived more comfort 3. 
Effect of AH in the last week of life on quality of life
None of the studies used quality-of-life assessments to measure effects of AH compared with no AH. Five 
papers reported on the effects of AH on symptoms during the last week of life. Details of these studies are 
described in Table 6.3. The number of patients included in these studies ranged from 78 to 284 patients. 
Four	studies	had	a	prospective	design,	one	of	which	used	randomisation	for	the	allocation	of	AH;	one	
study had a retrospective design. All studies included cancer patients who were admitted to a hospital 
ward;	 one	 study	 also	 included	 cancer	 patients	 who	were	 participating	 in	 home-based	 palliative	 care	
programme.
The prospective randomised trial found no significant effects in controlling several symptoms, except 
for chronic nausea that had improved significantly more after 48 h in the AH group 37. When comparing 
patients receiving or not receiving AH, two prospective studies found respectively significantly more 
ascites 38 and more intestinal drainage in the AH group 29. The latter study found no differences in ascites 
and pleural drainage. It is not clear was the authors meant by intestinal drainage. Secondary analyses 
of data from a large, prospective observational study revealed a significant association between AH 
24 h before death and the absence of physical signs of dehydration (dry mouth, axillary moisture and 
sunkenness of eyes) 38. Another prospective study only reported the feasibility and side-effects of rectal 
AH 36 and a retrospective study compared two different protocols for preventing delirium by opioids and 
AH;	no	difference	in	delirium	was	found	32.
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Effect of ANH on survival
Only one study reported on the effect of ANH in the last week of life on survival of terminal cancer 
patients admitted to the hospice or PCU of the university hospital in Taiwan (Table 6.4). The study did not 
distinguish AN and AH. Providing ANH in advanced cancer patients at either the time of admission or 2 
days before death was found not to be a significant determinant of survival 3. 
DISCUSSION
Although research with patients who are in the last week of life is challenging, we could include 15 
papers in our review. AN and AH appear to be a substantial part of medical care in the last week of life 
of cancer patients, especially in hospital, with frequencies up to 50% and 88%. Explicit withholding or 
withdrawing AN or AH was rarely studied. Several studies reported on the benefits and burdens of AN 
or AH. No studies that assessed the effect of AN on symptoms and quality of life during last week of life 
were found, except one that studied the combined effect of ANH and found no change in comfort, as 
perceived by the patients. AH was found to have a limited impact on patients’ symptoms: one study found 
less chronic nausea after receiving AH and another study found some association between AH and signs 
of dehydration. No significant relationships between AH and general comfort or quality-of-life measures 
were found. One study assessed the effect of ANH on survival and found no association. 
The frequent practice of providing AN or AH during the last days of life is thus not based on evidence of its 
effectiveness. However, dying cannot be predicted in all cases. The studies that are included in our review 
probably often involve the provision of AN or AH to patients who were not expected to die within a few 
days. This hypothesis is supported by our finding that the frequencies were generally lower in specialized 
palliative or hospice care settings. Dying was probably less often diagnosed in general hospital settings. In 
specialised palliative or hospice care settings, diagnosing dying is an integral aspect of care. Several care 
pathways for the dying have been developed, such as the Liverpool Care Pathway for the dying 39,40 and 
the Gold Standard Framework in Care Homes 41. These instruments contribute to the care for the dying 
patient, as shown in recent studies 42,43, although more research is needed 44.
Table 6.4  Studies on effects artificial nutrition and hydration (ANH) in last week of life on length of life in cancer 
patients
Author, 
country Setting
Patient 
characteristics Design
Sample 
size
Date 
collection 
methods
Inter-
vention Outcome Effects
Diagnosis Age*
Chiu 
et al. 3, 
Taiwan
Hospital Cancer 
patients
62 Prospective 344 By profes-
sionals
ANH Survival Using ANH 48h 
before death did 
not influence sur-
vival	significant;	
hazard ratio 1.03 
(95% con fidence 
interval 0.76-1.38)
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Professional caregivers working in palliative care have been shown to be more reserved about the benefits 
of AN and AH than other professionals: most of them do not believe that they contribute to the alleviation 
of symptoms and many are concerned about the burdens of ANH in the last week of life 28,45,46.
On the other hand, terminal patients and relatives often have a positive attitude towards hydration in 
the last week of life and often perceive AH and AN as clinically useful standard care at the end of life 47-50. 
Whereas shared decision making is considered standard practice in modern end-of-life care, such positive 
attitudes of patients and relatives most likely influence the practice of providing AN or AH, despite limited 
evidence of their effectiveness. Professionals therefore should communicate clearly with patients and 
relatives about the limited evidence of beneficial effects of AN and AH. Evidently, this communication 
involves ethical challenges. These ethical issues in decision making on AN and AH at the end of life have 
been widely debated in the last decades 51,52.
The overrepresentation of Asian studies in our review was notable: 75% of studies on frequencies were 
Asian studies and all data on AN in the last week of life originated from Asia. Cultural differences in end-
of-life decision making 53-57 and legal issues may have influenced both the number of studies on these 
topics and the frequencies of using AN or AH. For example, Taiwan was the first Asian country to pass the 
Natural Death Act in 2000. This act gives dying patients and their families the right to refuse unnecessary 
medical management that only prolongs a state of agony 58. Such legal developments and public debate 
may have given rise to an interest in and relatively large number of Asian studies on medical treatment 
at the end of life.
The studies in our review mainly had narrowly defined patient populations, which obviously limits the 
generalizability of the results too. Almost all studies only included patients who were admitted to a 
hospital;	only	one	study	also	included	patients	receiving	home	palliative	care.	In	this	review,	we	focused	
on the last week of life of cancer patients because their needs concerning AN or AH may be different 
from those of cancer patients with a longer prognosis. However, our findings were in line with studies on 
medically assisted hydration and nutrition in palliative care in general 22,23. Two systematic reviews found 
insufficient studies on the effects of AN and AH to draw firm conclusions. They describe two studies that 
found less sedation, myoclonus and dehydration after AH, but AH also led to fluid retention symptoms, 
such as pleural effusion, peripheral oedema and ascites. Other studies in these reviews did not show 
significant effects of AH. One of the studies involved a randomised trial on AH in dehydrated advanced 
cancer patients with no further treatment planned. It found improvement of myoclonus, sedation and 
an overall benefit of AH as assessed by the physician. It found no significant differences in the perceived 
benefit by patients and in symptoms such as fatigue and hallucinations 59. None of the studies in our 
review	used	quality	of	life	as	an	outcome	measure	for	comparing	AH	with	no	AH;	all	assessed	only	physical	
signs and symptoms. The association of these physical findings with quality of life is unknown. Several 
quality-of-life instruments 60-63 have already been used in palliative care research, although, according to 
a recent review on the feasibility and clinimetric quality of these instruments, more work has to be done 64.
Overall, current literature suggests that the benefits of providing AH are limited and do not clearly 
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outweigh the burdens for cancer patients. But, as known, cancer patients in the last days of life can be 
heterogeneous in (de)hydration, (mal)nutrition and related symptoms. Patients receiving AH already have 
been shown to differ from not receiving patients, on diagnoses, average days of admission and mode of 
death 65. This heterogeneity of background, onset and process of dehydration needs more attention in 
future research to identify patients who can profit of AH or AN, as suggested earlier 66. The need for more 
research on the benefits and burdens of AN and AH in the last days of life is clear. Research in the dying 
phase is a challenge, ethically and methodologically. Researchers have to be creative and innovative in 
developing new research methods, e.g. by obtaining the advance consent of patients 67. The need to 
develop alternative methods is not solely a challenge in palliative care but also in other fields of medicine 
such as critical care 68,69, paediatrics 70 and surgery 71. Much can be learned from initiatives in these fields, 
such as obtaining consent from a substitute decision maker (proxy consent) and clinical equipoise (a state 
in which clinicians are uncertain about the outcome of different treatments, no treatment prevails) as an 
inclusion criterion for yielding two comparable groups. 
CONCLUSION
When a patient is recognised as having entered the dying phase, medical treatment should primarily 
contribute to the patient’s comfort. Issues concerning nutrition and hydration are an important and 
significant aspect of cancer patient care in the last days of life. Current literature suggests that the benefits 
of providing AH are limited and do not clearly outweigh the burdens, although some effects on specific 
symptoms may be present in some patients. Evidence concerning the effects of continuing or withdrawing 
AN in the last days of life is lacking and little is known concerning the life-shortening or prolonging effect 
of either AN or AH. Innovative and creative methodologies for research are needed to further improve the 
evidence base for care for the dying. 
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ABSTRACT
Purpose of review
Artificial hydration in end-of-life care is an important and emotive topic that frequently raises concerns 
from patients, relatives and healthcare professionals (HCPs). The aim of this review was to give an overview 
of currently available evidence around opinions and attitudes towards artificial hydration at the end of life.
Recent finding
In total 11 studies reported on opinions towards providing artificial hydration, nine studies reported on 
attitudes towards the effect of artificial hydration on quality-of-life and four studies towards its effect on 
survival. Reported percentages of respondents in favour of providing artificial hydration at the end of life 
varied from 22 to 100% and for nonprovision from 0 to 75%. One-third of the general public has been 
found to think that artificial hydration improves comfort, while among patients a majority feels it can have 
a physical or psychological benefit. HCPs were found to be less optimistic: 1–43% thought patients benefit 
from artificial hydration at the end of life. HCPs mostly agree artificial hydration does not prolong survival, 
although up to 89% of patients expect it does.
Summary
Opinions and attitudes towards the use of artificial hydration at the end of life vary. Communication of this 
imperative topic in end-of-life care is important for better care and should be research-based.
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INTRODUCTION
Most terminally ill cancer patients have a reduced oral intake in the last phase of life. This can be due 
to different causes, such as dysphagia 1, anorexia, nausea or vomiting 2-6 or mechanical problems  7,8. 
Reduced oral intake may be seen as part of the natural dying process, or it may result in clinically 
relevant dehydration or malnutrition. Currently no consensus exists about what is the most appropriate 
management for terminally ill patients with limited oral intake 9,10, although artificial hydration seems a 
frequent practice 10.
Due to this lack of consensus, it is likely that not only the physical needs of the patient, but also social, 
cultural and religious factors influence physicians’, patients’ and relatives’ views upon artificial hydration at 
the end of life. These factors have been discussed previously 11 highlighting the symbolic nature of fluids 
in the Jewish Culture, and discussing the social and cultural aspects of fluids 12. There may also be variation 
in views among healthcare professionals (HCPs) depending on their speciality and clinical experience.
Understanding more about current opinions on artificial hydration at the end of life could help to highlight 
misconceptions surrounding the practice, to illuminate differences of opinions between different groups, 
and to inform clinical practice. The aim of this review was to give an overview of currently available 
evidence around opinions on the use of artificial hydration at the end of life. The following research 
questions were addressed: What are the opinions towards providing and not providing artificial hydration 
at the end of life? What are the expected effects of artificial hydration at the end of life on its quality? What 
are the expected effects of artificial hydration at the end of life on survival?
METHODS
We performed two extensive searches for studies that were published in English between January 1998 and 
December 2010 in different electronic databases. Search 1 was aimed at studies on artificial nutrition and 
hydration (ANH) at the end of life, using Medical Subject Headings (Mesh) and a broad range of keywords. 
In a stepwise procedure two reviewers (NR and AvdH) selected 124 studies for full text assessment 10. For 
the current review, only those studies reporting on attitudes towards artificial hydration were included 
(n=25). An additional search (search 2) was performed focusing primarily on attitudes towards artificial 
hydration, which resulted in 17 studies. Both searches were merged and doublets (n=12) were excluded. 
This total resulted in 30 studies which were assessed full text by two reviewers (NR and SF). The selected 
studies had to include quantitative data about opinions regarding usage of artificial hydration or opinions 
about the effects of artificial hydration in the last month of life. These criteria resulted in the inclusion of 
13 studies (Figure 1).
Data extraction
We collected information on general aspects of the studies and results related to our research questions. 
Extracted data included number of respondents, study setting, study design, response rate, selection bias 
and validation of the questionnaire used. Data were extracted using a standardized data extraction form.
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Figure 1. Flowchart showing results search strategies and selection process
2978 hits
(780 doublets excluded)
TOTAL: 2198 titles
Excluded (n=2074)*
No relevant title (n=1682)
No relevant abstract (n=392)
Excluded (n=99)
No relevant data on attitudes (n=63)
Only data on artificial nutrition (n=36)
Additional search on attitudes (n=17)
Including 12 doublets
Full text excluded (n=17)
No relevant data on attitudes and AH (n=12)
Only information on advance directives 
(n=2)
Only qualitative data (n=1)
Life expectancy > 1 months (n=2)
Papers for first full text 
assessment (n=124)
Included papers
(n=25)
Included papers for second  
full text assessment (n=30)
Included papers on attitudes 
towards AH (n=13)
*Raijmakers et al, 2011
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RESULTS
Providing or not providing AH at the end of life 
Twelve studies reported on opinions of different populations towards artificial hydration at the end of life 
(Table 7.1).
General public 
Two studies, both from Japan, reported on the opinions of the general public towards providing or not 
providing artificial hydration at the end of life. The first study used a random sample of the general public in 
four different areas in Japan (n=2548). Additionally they included a purposive sample of bereaved families 
from patients who had passed away in palliative care units (PCUs) in these areas (n=513). Thirty-eight 
percent of the general public without bereavement experience believed ‘artificial nutrition and hydration 
should be continued as the minimum standard until death’ compared with 43% of those who had 
experienced a recent bereavement 13. The second study reported on a voluntary 1 h educational lecture 
on end-of-life care for cancer patients, open for the community. In total 595 respondents were included 
and 52–62% of the participants wanted to receive ‘artificial hydration as life-prolonging treatment’14.
Patients and relatives
Two studies have looked at the opinions of patients and their relatives regarding receiving artificial 
hydration at the end of life. The percentage that preferred receiving artificial hydration varied from 48 
to 86% and 14 to 29% preferred not to receive artificial hydration. An Italian study included admitted 
patients to a PCU with an expected survival of more than 2 weeks. These patients required hydration, 
indicated by signs of dehydration, nausea/vomiting, opioid toxicity and diarrhoea. Seventy-one percent 
of these patients and 86% of their relatives stated they would want to continue hydration for a prolonged 
period of time 15. In a Taiwanese study of 197 admitted patients with terminal cancer 48% of patients 
wished to use artificial hydration at the end of life and 24% did not wish to do so 16.
Healthcare professionals
Seven studies reported on the opinions of HCPs. Almost all HCPs were recruited via institutional care 
facilities,	mostly	hospitals;	one	study	included	nurses	attending	a	nurse	leaders’	seminar.	Overall,	22–100%	
of HCPs preferred providing artificial hydration at the end of life, whereas 1–75% preferred not providing 
artificial hydration.
In a nationwide Japanese survey among physicians (n=584) working in hospitals or PCUs, 74% 
recommended artificial hydration (1–2L/d) in a vignette of a gastric cancer patient, who was terminally ill 
and almost incapable of oral intake. Sixty-six percent recommended artificial hydration in a similar patient 
with	terminal	lung	cancer;	15%	and	26%	recommended	no	artificial	hydration,	respectively,	and	the	rest	
were undecided. Those specialized in palliative medicine had a less positive attitude towards providing 
artificial hydration 17. This previous nationwide study was expanded with nurses (n=3328) also working in 
hospitals or PCUs. Forty percent of the physicians and 22% of the nurses believed artificial hydration to be 
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a component of ‘minimum standard of care’ for terminally ill cancer patients 18. Another study including 
160 Japanese nurses attending a nurse leaders’ conference showed that 75% of nurses thought it was 
ethical to withdraw ANH from a dying patient, if requested by the patient. Nurses thought withdrawing 
ANH was also ethical when it is causing pain (70%), when the patient is very near death (42%), when it 
would shorten the patient’s life (41%), when the patient is unconscious (40%), when the patient is very 
old (39%), when ordered by the physician (28%) and when requested by the family (25%) 19. A Taiwanese 
study 20 showed that 98% of 197 nurses, working in a Taiwanese hospital, were likely to provide artificial 
hydration in a terminal stomach cancer patient who cannot be fed orally because of intestinal obstruction. 
Thirty percent of these nurses agreed that it is ethically acceptable to withhold ANH in terminal cancer 
patients with multiple-organ failure and an expected survival of less than one month, 23% disagreed 
and 47% were undecided on this dilemma. A second Taiwanese study 21 included nurses as part of an 
educational intervention. It showed that 98–100% of 88 nurses were likely (59%) or very likely (41%) to 
give artificial hydration to terminal cancer patients. Another hospital-based survey among 36 nurse key 
workers and 77 clinicians (consultants and specialist registrars), both with a special interest in palliative 
care, was conducted in the UK. It showed that 61% of consultants agreed with the statement ‘hydration 
by the parenteral route should be continued’ applying to the clinical scenario of a patient in the last days 
of	life;	21%	disagreed	and	18%	was	undecided.	The	nurses’	responses	were	reversed:	25%	agreed	with	the	
statement, 42% disagreed and 33% was undecided 22. In a prospective study of 145 admitted inpatients of 
a Taiwanese hospice and PCU using ANH, 85% of the medical staff thought it was appropriate to use ANH 
2 days before death in these patients, compared with 1% who thought it was inappropriate 23.
Effect of artificial hydration on quality of life at the end of life 
Nine studies reported on attitudes or opinions regarding the effect on quality of life of artificial hydration 
at the end of life (Table 7.2).
General public
Two Japanese studies have looked at the general publics’ opinions. In a population-based survey 13, 
29% of the general public without bereavement experience and 15–31% of those with bereavement 
experience felt ANH relieves patients’ symptoms. In a study 14 looking at knowledge on end-of-life care of 
people attending a voluntary 1 h educational lecture on end-of-life care for cancer patients, 24–35% of 
the respondents believed ANH relieves symptoms (n=595). 
Patients and relatives
Three studies reported on patients’ and relatives’ opinions. These opinions were collected via a 
questionnaire in all studies 15,16,23. In one study from Taiwan 23 on 145 admitted inpatients with terminal 
cancer using ANH, 19% perceived more comfort and 6% perceived discomfort. In 197 admitted inpatients 
with terminal cancer, 70% felt ANH increased physical strength and 61% felt it symbolised care of 
families 16. An Italian study 15 asked 54 admitted inpatients and relatives about their knowledge and views 
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regarding intravenous and subcutaneous hydration. Ninety percent of patients and 96% of relatives 
considered artificial hydration useful while 93% of patients and 94% of relatives felt it would improve the 
patient’s clinical condition. Ninety-three percent of patients and 91% of relatives also felt it was useful 
psychologically. 
Healthcare professionals
Four Japanese studies 17,18,24,25 have looked at HCPs opinions. In a nationwide survey among physicians 
performed in 2007 18, 43, 34 and 20% of physicians felt artificial hydration alleviates thirst, fatigue or 
delirium, respectively, compared with 20, 19 and 11% of nurses. Sixty-five percent of the physicians and 
71% of the nurses agreed that maintaining a venous route is a burden for the patient, which is similar 
to findings in another survey of physicians 17 where 65% agreed that maintaining a venous route was a 
burden. However, 77% of physicians in this survey believed symptom alleviation is an important factor in 
indicating intravenous hydration.
In another nationwide survey of physicians and nurses 24 from different settings (palliative care, 
oncology, general hospital), less than 25% of all respondents felt artificial hydration could improve thirst, 
consciousness or malaise. Less than 7% of the palliative care nurses felt artificial hydration improves any 
of the above symptoms. Up to 82% of respondents felt artificial hydration could worsen fluid retention 
symptoms such as oedema (82%), ascites (68%) and pleural effusions (65%) with palliative care physicians 
and nurses reporting harmful effects more often than oncologists. This result is in agreement with findings 
of another study 25 conducted among nurses attending a voluntary workshop on the Japanese clinical 
guideline for artificial hydration for terminally ill cancer patients. Seventy-one to eighty-six percent of 
the	nurses	agreed	that	artificial	hydration	may	worsen	ascites	or	pleural	effusion;	64–88%	of	participants	
agreed that artificial hydration does not improve general wellbeing. 
Effect of artificial hydration on survival
Four studies, all from Asia, reported on attitudes or opinions regarding the effect of artificial hydration on 
survival (Table 7.3).
Patients and relatives
A Taiwanese study of 197 admitted patients with terminal cancer showed that 66% of the patients thought 
ANH would prolong life and 89% thought it could prevent starving to death 16. 
Healthcare professionals
HCPs’ opinions were assessed in a study among Japanese nurses attending a voluntary workshop on 
palliative care. The majority agreed that no improvement of survival can be obtained by fluid infusion 
in patients expected to die within several days (64–88%) 25. Another Japanese study included both 
physicians and nurses working at cancer centres, general hospitals and PCUs. This study showed that 
29% of the physicians and 23% of the nurses thought withholding artificial hydration would shorten 
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the patient’s survival 17,18. Fifteen percent of the physicians thought withdrawing artificial hydration is 
indistinguishable from an act of intentional acceleration of death 17. 
Quality assessment of studies
All studies used self-developed questionnaires, which were not shown in the published studies. One 
study on the attitudes of non-HCPs reported the response rate of the study (range 54–75%) and four of 
the studies including HCPs did (range 53–83%). Four studies including HCPs and one study with non-HCPs 
reported on the validation of the questionnaires used.
DISCUSSION
Opinions on providing and not providing artificial hydration at the end of life vary: 38–62% of the general 
public have been found to be in favour of providing artificial hydration, compared with 48–86% of patients 
and relatives, and 22–100% of HCPs. Attitudes towards the effects of artificial hydration on quality of life 
and survival also differ. Overall the majority of professionals feel that artificial hydration at the end of life 
can have significant negative effects mainly related to fluid retention. The majority of patients and relatives 
and one third of the general public believe artificial hydration to have a positive effect on quality of life, 
including improvement in symptoms and overall clinical condition. Professionals appear to vary in their 
opinions regarding positive effects of artificial hydration: those with specialisation in palliative medicine 
seem less optimistic regarding positive effects of artificial hydration on quality of life and more wary 
of the burdens. Regarding the effect of artificial hydration on survival patients and their relatives often 
believe artificial hydration to prolong life, while only the minority of professionals believe so. Differences 
between professionals may be due to different levels of experience in caring for people with reduced oral 
intake at the end of life. Palliative medicine professionals are likely to have more experience than general 
physicians and oncologists. The amount of education and training received by HCPs regarding end-of-life 
care may also impact on attitudes that have been highlighted in the intervention study in this review 25. 
A previous study has suggested that palliative medicine specialists are more reluctant to start artificial 
hydration in patients at the end of life and highlighted the possible implications of this for the relatives 
and also ethically and legally 26. The over-representation of Asian studies in our review was notable: 80% 
of studies on attitudes were Asian studies. Cultural differences in end-of-life decision making 27-31 and 
legal issues may have influenced both the number of studies on this topic and the attitude towards 
artificial hydration. For example, Taiwan was the first Asian country to pass the Natural Death Act in 2002. 
This act gives dying patients and relatives the right to refuse unnecessary medical management that only 
prolongs a state of agony 32. Such legal developments and public debate may have given rise to an interest 
in medical treatments at the end of life. Subsequently, the quality of the studies available for review was 
difficult to assess, due to limited information. All authors used self-developed questionnaires which were 
not shown in the studies. Hence, the results were difficult to compare. Additionally, the definition of 
artificial hydration was unclear in many studies and may therefore be interpreted differently, regarding 
administration route or dose. It is known that the practice of artificial hydration at the end of life varies and 
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currently no clear consensus is present about the most appropriate management for terminally ill patients 
with limited oral intake 9,10. This lack of consensus means that end-of-life decision making on this topic 
is influenced by personal opinions rather than objective and rational considerations. Obviously, cultural 
and social values should be taken into account in each individual case. However, there is a definite need 
for more validated research into the effects of artificial hydration on patients at the end of life, including 
effects on symptoms, quality-of-life, psychological aspects and survival.
CONCLUSION
Opinions on providing and not providing artificial hydration at the end of life vary, as well as attitudes 
towards its effects on quality of life and survival. The discrepancy in attitudes of physicians and patients 
underlines the importance of adequate communication on artificial hydration at the end of life. The more 
reluctant attitude of specialists in palliative medicine suggests that education for HCPs on this important 
topic in end-of-life care could be useful. For effective communication and education on artificial hydration 
at the end of life, more evidence of its effects is needed. 
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ABSTRACT
Background
Patients approaching death often have a decreasing oral intake, which can be distressing for relatives. 
Little is known about the relatives’ experiences with and perceptions of oral intake at the end of life. 
Aim
This study aims to contribute to a more thorough understanding of relatives’ concerns regarding 
decreased oral intake of the patient at the end of life. 
Design
Qualitative interview study: semi-structured interviews were transcribed verbatim and analysed using 
qualitative content analysis. 
Setting/participants
Twenty-three bereaved relatives of patients who had been referred to a New Zealand palliative care 
service were interviewed. 
Results
All relatives experienced significant changes in patients’ oral intake at the end of life. Oral intake towards 
the end of life was considered important and is perceived as meaningful by relatives in different ways, 
such as nutritional value, enjoyment, social time, daily routine and a way of caring. Relatives responded 
differently	to	decreasing	oral	intake;	some	accepted	it	as	inherent	to	the	dying	process,	others	continued	
efforts to support the patient’s oral intake. Some relatives perceived decreasing oral intake as the patient’s 
choice, and some viewed maintaining oral intake as part of the battle against the disease. Relatives 
recalled limited communication with health-care professionals concerning oral intake at the end of life. 
Conclusions
This study revealed the complexity of meaning relatives’ experiences with dying patients’ decreasing oral 
intake. Their perceptions and concerns were related to their awareness of the imminent death. These 
findings can guide staff involved in care delivery to better support relatives.
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INTRODUCTION
Patients receiving palliative care often have a decreased oral intake of food and fluids and anorexia 
is a frequent problem at the end of life, occurring in 39-82% of patients receiving palliative care 1-3. 
Furthermore, loss of appetite is one of the most common symptoms in patients when referred to palliative 
care 2. It is known that decreased oral intake of the patient at the end of life causes considerable emotional 
distress for relatives 3-4. Most scientific literature on oral intake at the end of life has focused on artificial 
(medically assisted) nutrition and hydration (ANH), including descriptions of practices 5-6, clinical effects 5, 
7-8, ethical aspects 9, and attitudes of patients, relatives, or healthcare professionals  10-12. The impact of 
decreasing oral intake at the end of life on patients and relatives has been scarcely researched, and there 
is little insight into underlying mechanisms of related distress. One study on the impact of decreasing 
oral intake among bereaved relatives has recommended that care aimed at reducing relatives’ emotional 
distress related to a patient’s inability to take nourishment orally, should include “relieving the relatives’ 
sense of helplessness and guilt”, “providing up-to-date information about hydration and nutrition at the 
end of life” and “understanding relatives’ concerns and providing emotional support” 3. Additionally, a 
qualitative study among relatives has demonstrated that ‘doing what’s best’ is an overarching theme in 
beliefs and behaviour related to nutritional care for terminally ill patients 13. 
Due to limited in-depth knowledge of the underlying mechanisms of relatives’ distress related to the 
patient’s decreased oral intake, there are few clues for health care providers to support relatives when 
caring for a terminally ill patient. The main purpose of this study is to contribute to a more thorough 
understanding of relatives’ concerns regarding decreased oral intake of the patient at the end of life. 
METHODS
Study design and setting
This qualitative study was conducted in a specialist palliative care service in New Zealand. The service 
included an in-patient unit, with a 10-bed capacity, a 24/7 community service and a consultation team 
in the allied hospital. We performed semi-structured interviews with bereaved relatives of patients who 
died under the care of this specialist palliative care service. Semi structured interviews as a method of data 
collection was appropriate to meet the study objectives.
Recruitment of respondents
Forty-five bereaved relatives of patients who died in November-December 2011 under the service 
received an information letter about the study. The bereaved relatives, as registered in the patient files as 
first contact person, were approached after consultation with the social worker from the service regarding 
the appropriateness to contact this relative. All bereaved relatives living within a circle of 100 kilometres of 
the hospice received the information letter about the study. After a week they were contacted by phone 
by a researcher (NR) to further inform them and enquire about their willingness to participate. In total, 
23 bereaved relatives participated in an interview. Ten relatives refused to participate, due to emotional 
concerns (n=6), lack of time (n=3), unknown reasons (n=1), and eleven relatives were not reached. The 
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interviews took place in February and March 2012.
Questionnaire
A semi-structured questionnaire, developed in collaboration with health care professionals (oncologists, 
palliative care physicians and nurses) was used for the interviews, to ensure consistency of topics addressed 
in all interviews. The questionnaire started with an open question ‘Can you tell me about the last month 
of life of your loved one?’, to encourage respondents to tell their story and experiences. Subsequently, 
different topics were addressed to investigate their experiences and perceptions of these topics (Box 1).
Process
All interviews were conducted at the location of the participants’ choice, i.e. respondents’ homes (n=20) 
or the hospice (n=3). All respondents gave written consent prior to the interview, and in the introduction 
it was made clear to all respondents that they could stop the interview at any time. During the interview, 
only the respondent and the researcher were present for all but four interviews where the respondent had 
invited a support person. All respondents consented to the interview being audio-taped. The interviews 
were transcribed verbatim by a confidential transcribing service, and all transcripts were checked by the 
interviewer (NR). 
Ethical approval
The Central Regional Ethics Committee, Ministry of Health, Wellington, New Zealand approved the study 
protocol (CEN/11/EXP/076).
Analysis
Data analysis was informed by qualitative methodology 15. The focus of analyses was the words, meanings 
and phrases used by interviewees 16.  Each interview was considered in relation to its predecessors. During 
data collection general themes arising from the interviews were discussed (NR, JC). After completing all 
interviews, all transcripts were re-read and annotated for initial coding, using the general themes of the 
questionnaire (NR). A set of transcripts was independently read and analysed to identify specific categories 
Box 1. Topics of questionnaire
Experiences in the last month of life
Awareness of dying (patient and relative)
Satisfaction with care
Experiences with food and fluids intake
Perception of food and fluid intake
Communication at the end of life
QODD (Quality of Death and Dying Questionnaire) 14
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within the general themes (NR, JC). The themes and categories were discussed until consensus was 
reached. Subsequently, the remaining interviews were coded (NR). The findings were later discussed with 
other members of the project group (AvdH, LZ), to support consistency and rigor in the data analysis 15. 
Data were coded using ATLAS.ti (version 6.1.1, ATLAS.ti GmbH, Berlin). Verbatim data is included in the 
research findings to ensure transparency, to make the data explicitly available and understandable to the 
reader 15.
RESULTS
Characteristics of respondents
The characteristics of bereaved relatives and deceased patients are presented in Table 8.1 and 8.2.
Table 8.1  Characteristics of deceased patients
Deceased patients     n=23     
% (n)
Age
Mean ± SD 76±12
Gender
Male 57 (13)
Female 43 (10)
Ethnicity
NZ European/Pakeha 96 (22)
Maori 4 (1)
Primary diagnosis
Cancer 74 (17)
End Stage Heart Failure 13 (3)
End Stage Renal Failure 9 (2)
End Stage Respiratory Disease 4 (1)
Place of death
Home 13 (3)
Hospital 9 (2)
Hospice 44 (10)
Residential care facility 34 (8)
Months in specialist palliative care 
Mean ± SD 2 ± 2
SD: standard deviation
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Meaning of oral intake at the end of life for relatives
Almost all bereaved relatives recognized decreased oral intake at the end of life as an important issue. 
When a patient was still able to eat and drink at the end of life, this was perceived as meaningful by 
relatives in different ways. One important aspect was the nutritional value of food and fluids. Relatives 
perceived oral intake at the end of life as being beneficial for the body, e.g. as giving physical strength, 
energy, and as contributing to the preservation of life. As long as the patients could just eat something, 
even just a spoonful, relatives interpreted this as the body and therefore the person still going on, which 
appeased them. 
I think if she didn’t eat she wouldn’t have been… she wouldn’t have talked to us the way she did. 
Talking was a little bit hard but she always managed to keep herself going and I’m sure the food 
helped in that area.  [F, daughter, rest home]
While she was doing that [eating and drinking] I gathered she might keep some strength. I don’t 
know, I mean, it’s just. It was important for me.  [F, daughter, hospice]
Table 8.2  Characteristics of bereaved relatives
Relatives     n=23     
% (n)
Age
Mean ± SD 65 ± 13
Gender
Male 22 (5)
Female 78 (18)
Education*
Low 78 (18)
High 22 (5)
Ethnicity 
European/Pakeha 91 (21)
Maori 9 (2)
Relationship to deceased patient
Partner 65 (15)
Son/daughter 35 (8)
* Low = level 1-4 according to ISCED guidance (primary school, lower secondary general education, lower vocational education, intermediate 
vocational or higher secondary general education), high= level 5-7 according to ISCED guidance (higher vocational education or university)
SD:	standard	deviation;	ISCED:	International	Classification	of	Education
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The meaning of oral intake at the end of life appeared to hold more importance to relatives than the 
nutritional value of food. The patient’s enjoyment of eating, drinking, or tasting meant a great deal to 
relatives, especially at the end of life where many enjoyments of life have disappeared. Happy memories 
of special occasions or when special food had been shared were recalled.
She seemed to enjoy the ice cream and a bit of jelly; I mean, as I say I took her whitebait fritters  
one night and she did have a smile on her face. She had those so it was good. So she did still 
appreciate food.  [F, daughter, rest home]
My most precious memory is probably the whitebait fritter, yeah that would have been the happiest 
I’ve ever seen him, having that whitebait fritter.  [F, daughter, rest home]
Partaking of food and drinks was often done together, creating a social activity that legitimized spending 
time together. Having a meal or having a cup of coffee was perceived as a social event, which facilitated 
conversations. Moments of eating or drinking together were often deeply appreciated by relatives. They 
made many efforts to create such moments, e.g. relatives had their meal on a tray, sitting next to the bed 
of the patient, and dressing the patient for the family Christmas dinner.
I spent a lot of time with her and we did a lot of talking, especially at that half past six morning cup 
of coffee. Normally I’d sort of get up, shower, gobble down our breakfast. I’d never have coffee; I’d go 
straight to work. So it made me sort of sit down and actually take time with people, actually having 
the coffee with her and I think probably that was probably the best you know, was just that little time 
and there was nobody calling in and just the two of us.  [F, daughter, hospice]
At the end of life, mealtimes also gave rhythm to the days and could serve as a reason for the patient 
to get dressed, which was appreciated by the family. Several rituals involving eating and drinking were 
described, such as having a whiskey every night together. These daily routines and habits were important 
for relatives, also as an attempt to hold on to normal life. 
I spent as much time as I could with her. I’d go up and have my lunchtime with her. I’d come home, my 
son was at home at that point so I’d feed him, get him sorted even though he was 20 odd. And then I’d 
go up to the hospital or hospice for the evening.  [M, partner, hospice]
Finally, accommodating patients’ wishes, regarding food, was also experienced as a way of caring and 
expressing love. Being able to do something, such as providing special food meant a great deal too relatives 
and made them feel less helpless. Relatives described many different ways they tried to accommodate 
patients’ choices and desires, conveying the significance of oral intake at the end of life for relatives.
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I’d always ring the night before and talk to her and ask her what she wanted brought over. The first 
thing was a coffee and the second thing was I think... but you know she just basically wanted to pick 
at things.  [M, son, rest home]
I’d go up at 8 o’clock in the morning, up at the hospice she like poached egg and toast, but yeah 
here [at the rest home]  it was just cereals and I said, ‘Right.’. So 8 o’clock in the morning I’d make her 
poached egg and take it to the rest home.  [M, partner, rest home]
Well I used to cook for him, and I’d go out and get whatever. You know he might say, “I’d like some 
mushrooms tonight.” So I’d go and specially get mushrooms for him and cook them up and so forth.  
[F, partner, home]
It was not easy to accommodate the patients’ wishes. Relatives described occasions in which the patient 
requested something special, such as whitebait fritters or Indian curry, and the moment relatives offered 
this, the patient was not able to eat it. This was distressing for relatives, making them feel helpless and 
thwarted in caring for their loved-one. Consequentially they worked to understand what was happening 
and to find ways to console themselves. 
I couldn’t say to him, “Do you want to die?” […] I just said to him at that time and I could have bitten my 
tongue after but I said, “I don’t know what you want to eat.” I said, “I’ve tried everything, I’ve moulied,” I 
said, “That was a roast meal and I’ve moulied the meat and the vegetables altogether for you.” I said, “A 
little baby can eat that.” “I don’t want it.” I said, “Well, I don’t know what the hell you’re going to live on.” 
That was about the only time I sort of said anything to him about things then.  
[F, partner, hospice]
I had all these things lined up, and my husband went out one night and mum said she wanted a curry 
and my darling husband went out and brought her curry from one of these places in town, it was 
really cold, wintery, yuk night and he went out and brought her a curry, and she said, “Oh you have it 
boy, I’m not hungry.  […] But that’s what she did, all the time. Just really finicky about stuff and you 
just couldn’t do anything. [F, daughter, rest home]
Responding to decreasing oral intake
It was difficult for relatives to witness the decrease in oral intake. In addition to their efforts to accommodate 
the patient’s wishes, they also worked to understand what was happening and to find ways to console 
themselves. 
Part of the process
Some relatives interpreted decreasing oral intake as being part of the normal (dying) process and saw it as 
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a sign of approaching death. They phrased it as “beyond coping with oral intake”. For them, this was directly 
linked to the stage of illness and to changing bodily needs, and they were aware that the end of life was near.
By that stage she didn’t really want it anyway and I think people were throwing food at her and she 
really didn’t want it anyway. By that stage I thought we were just forcing her to do something that… I 
guess in the last week for me, it was just let’s just let this be, let it be.  [F, daughter, rest home]
Yeah, because even though I don’t have a lot to do with dying people, I actually notice when they 
start to want to go because their eating gets less and less and less [… ] Yeah, so I sort of knew the 
telltale signs.  [F, partner, hospital]
Relatives may also realize that eating and drinking became a struggle for the patient, instead of something 
beneficial and enjoyable. Physical problems, such as lack of appetite, having no energy to eat, having no 
or an unpleasant taste, having trouble swallowing, or nausea and vomiting impaired their oral intake at 
the end of life.
He had no... well he didn’t have an appetite because he couldn’t... he said he couldn’t taste food, the 
food was horrible and he refused to eat it, and he is a person who loved his food, I mean he loved 
food. And he just had no appetite, no taste in his mouth, no nothing and he had thrush.  [F, daughter, 
rest home]
He was eating less and less, but he did always try and eat a little bit each time.  But you can imagine 
when you eat and then bring it back you get to the stage you don’t want to eat because you don’t 
want to be sick. [F, partner, hospice]
Changes in oral intake were often referenced against the person’s earlier preferences and appetite, when 
he or she was still healthy. What patients used to eat or drink or enjoyed were described as an intrinsic part 
of the patient’s identity. Decreasing oral intake therefore also symbolized losing the patient.
I bought little ice blocks, so that she could suck on, just on that. But she didn’t even want to do that, 
so, which was really quite unusual. For somebody who always loved her food. Such a difference, it 
was a big difference, yeah, getting used to it, the fact that she didn’t have an appetite at all.   
[F, daughter, hospice]
It was really difficult for her, so she… anyway I digress. But I’d go into the home and stuff and she just 
wasn’t wanting to go out; she didn’t feel like coffee, and her taste buds changed. She couldn’t drink 
her coffee; her coffee was her thing you know… I used to buy a coffee for her on the way into the 
home and yeah, she just didn’t want it, it tasted awful to her.  [F, daughter, rest home]
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Patient’s choice
Some relatives thought that a decreased oral intake was the patient’s choice. They perceived it as giving 
up by the patient. The patient had decided that it was enough and therefore deliberately stopped eating 
and drinking. This could be upsetting for relatives who may feel helpless, because they couldn’t do 
anything anymore for their loved one.
I had the feeling that he’s starved himself in the end because he didn’t like illness; he couldn’t cope 
with illness and yeah [crying] […] Nothing we could do to make him eat because, as I said, I kept 
saying to him, “I’ll go and get you something nice or some fish and chips or Chinese takeaway.” “No, 
no, don’t bother.” He’d given up.  [F, daughter, rest home]
Perceiving decreased oral intake as the person’s own choice, could allow some relatives to stop trying 
to persuade the patient to eat something. Efforts by relatives to make the patient eat could upset the 
patient, who knew best what was happening, what he or she needed, and what he or she wanted or not 
wanted. Perceiving eating and drinking as the patient’s own responsibility relieved relatives’ distress.
I came to the conclusion that it didn’t matter how I fretted, all I was doing was making him upset 
and me getting more stressed. I was as stressed as I could be. So I just decided, I’ll give him an offer 
of such and such, and let him choose and then I’ll make it for him and see what happens. […] and 
then I almost sort of gave up and thought well, he knows whether he’s hungry or not. He knows the 
repercussions; he knows what’s happening in the end; this is his choice of how he wants it; at this 
stage in his life, let it be.  [F, partner, rest home]
However, other relatives perceived maintaining oral intake as part of the battle against the disease and 
therefore against dying. Central to this perception were efforts to tempt the person with special foods and 
supplements. Giving up eating was not an option for these relatives.
I spent a fortune on special little things […] One day he said, “Does [the Oncologist] know you’re 
doing this?” I said, “I don’t give a bugger what he thinks,” I said, “I’m trying to get you some good 
blimmin` bacteria inside you again.” I said, “We’ve gotta fight this damn thing,” you know, so he’d do 
anything to please me.  [F, partner, hospice]
The vicious circle
Some relatives realized, in hindsight, that the patient was trying really hard to eat something because of 
them. They were caught in a vicious circle, in which the patient and the family didn’t want each other to 
worry and both tried hard to maintain the oral intake and avoid talking about its decrease. 
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I think she thought it [eating and drinking] was important for me. I think she wanted me to have this 
false hope that she would get better just to help me cope I think, at the time. And it went pretty well 
cause she was you know; I tried to be strong for her and she tried to be strong for me [crying].   
[F, daughter, hospice]
It [trying to make him eat and drink] upset me, but I was only trying to do it for his good.  And then he 
would feel bad, because he didn’t want to upset me.  It was a vicious circle. He never complained, he 
was amazing, he just accepted that it was his lot, and took it all in his stride.  [F, partner, hospice]
Communication and information: talking about it
Relatives recalled few in depth discussions about decreased oral intake with both health professionals 
and patients. Conversations with the patient predominantly concerned if and what the patient preferred 
to eat or drink. Some relatives avoided talking about the decreasing oral intake, because they didn’t 
want to upset the patient or considered talking about eating and drinking as futile. Furthermore, 
some relatives recalled having arguments with the patient when trying to persuade him or her to eat 
something. These arguments were perceived as upsetting and a struggle by the relatives, and remained 
vividly in their memory. 
Not into any depth because he just… like he was a very placid man and you could never argue with 
him. […] Over this and the food, he did actually get a bit stroppy and he’d just say, “Oh leave me 
alone for goodness sake I can’t eat, I can’t eat.” And then that would upset me because he’d been cross 
with me and he was never cross with me, so I thought, no, this is a fruitless exercise too, so I’m not 
even going to talk to you about it, if that’s the way you’re going to talk back to me. No, we didn’t do it 
in depth because he got too… I think he knew that he should have been; or couldn’t be bothered; or 
didn’t have the heart to; or didn’t want to; or whatever.  [F, partner, rest home]
I was always pumping drinks into him. I used to sit on the bed with a straw in his mouth and say 
“Suck!” He would say I was a bossy woman.  It was a struggle.  [F, partner, hospice]
Conversations with healthcare professionals predominantly concerned information for the relatives about 
oral intake at the end of life and what to expect. 
“Just let him eat whatever he wants”, and they [nurses] weren’t too worried about it. They said “Just 
get whatever you can and when you can into him.”  [F, partner, home]
Relatives were sometimes given a written pamphlet on food and fluids at the end of life. This information 
was often perceived as reassuring by the relatives, because it lifted some of the weight of responsibility 
off their shoulders.
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DISCUSSION
Decreasing oral intake in patients at the end of life is a meaningful change for relatives. When oral 
intake was still present at the end of life, relatives attributed multiple positive meanings to it, including 
nutritional, psychological and social meaning. Furthermore, it gave routine and structure to their daily 
life in a time of disorder. Relatives responded differently to a decreasing oral intake and also perceived 
different reasons for this decrease. Some viewed the decrease in oral intake as part of the dying process, 
related to the stage of illness, lack of appetite and physical inabilities. Others perceived decreasing oral 
intake as the patient’s choice. Some relatives were able to accept the decrease in oral intake, while others 
viewed maintaining oral intake as an important part of the battle against the disease and for life. Other 
relatives realized that the patient and they were keeping each other in the dark through their mutual 
efforts to maintain oral intake. Relatives recalled limited communication with health care professionals 
concerning oral intake at the end of life.
Several findings deserve particular attention. First, the broader meaning of eating is significant and 
important at the end of life. Some data on the meaning of food in other patient populations resonate with 
our results, although most did not address the relatives’ perspective. For head and neck cancer patients, 
physical, social and emotional losses related to eating problems have been described 17. Also in cachexic 
cardiac patients the broader meaning of food has been identified. These patients described a feeling of 
deprivation due to fatigue and lack of appetite, because of missing both eating and the related social 
environment. This could even lead to a loss of personal identity 18. These studies illustrate the broader 
social and relational meaning of eating and drinking, which our study shows also to be present for 
relatives of patients who are at the end of life. When addressing the issue of oral intake with patients and 
relatives, health care professionals should not only emphasize the nutritional element, but also be aware 
of these other elements.
Second, awareness of dying and relatives’ perceptions of decreased oral intake at the end of life seems 
to be related. McClement et al 13 have identified fighting back versus letting nature take its course as 
two opposite positions, between which relatives may also vacillate. Those fighting back believed that the 
decreased intake was largely responsible for the patient’s declining status instead of disease progression, 
while those who were letting nature take its course believed that the decreased intake was an expected 
occurrence as death became imminent.  Our results showed similar patterns, and these ways of responding 
by relatives were not static or exclusive.
Third, our study showed that, despite the significance of decreasing oral intake for relatives, only a few 
relatives recalled conversations with health care professionals about what to expect regarding oral intake 
at the end of life. This lack of attention regarding oral intake at the end of life has been noted before. It 
has been shown that family call the out-of-hours general practitioner practice often because of problems 
related to oral intake such as vomiting and dehydration, which resulted in potentially preventable hospital 
admissions at the end of life 19. Early communication regarding these problems may contribute to more 
efficient healthcare usage. 
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Since the primary goal of palliative care is not only to improve the quality of life of patients when facing the 
problems associated with a life-threatening illness, but also of their relatives 20, health care professionals 
should adequately address issues regarding patients decreasing oral intake, with family. Overall, more 
attention for issues regarding oral intake and related problems at the end of life may improve the quality 
of life of relatives and contribute to better healthcare usage.
There is a body of literature describing ANH at the end of life, discussing whether it is appropriate or not 
to administer ANH during the last weeks of life. To date, this controversy remains, although the positive 
effects seem limited 5,7-8. It has therefore been suggested to make decisions on ANH preference-based 21. 
When doing so, healthcare professionals should keep in mind that by administering artificial hydration 
probably not all issues relating to eating and drinking will be addressed. Health professionals should 
recognize the need for multiple conversations over the illness trajectory regarding declining oral intake 
and the broader meaning of eating and drinking at the end of life. 
Strengths and limitations
One strength of this study is that perceptions regarding oral intake at the end of life in terminal illness were 
derived from bereaved relatives of patients dying in different settings. Some caution must be exercised 
when using our findings in practice, because all patients were under the care of one single palliative care 
service, which might hamper the generalizability of the findings to other bereaved relatives. Furthermore, 
this study included relatives who had different relationships with the deceased patient, and the patients’ 
diagnoses were not restricted to cancer. Finally, the willingness of the bereaved relatives to participate 
in this research was noteworthy. Limitations include the following. First, the data collected for the study 
were generated from families receiving specialist palliative care. This might have led to a selection bias, 
which restricts the generalization of the results to other care settings. Second, ethnic minorities are 
underrepresented in this study, relatives were mainly of European descent, while in the New Zealand 
Maori constitute 17% of the population. The meaning of oral intake at the end of life for Maori and other 
ethnic groups should be further investigated, as it is known that cultural differences exist 22. 
CONCLUSION
Oral intake at the end of life has multiple meanings, going beyond the nutritional value of food and fluids. 
Psychological and social aspects of oral intake at the end of life also are significant for relatives and should 
be addressed when supporting relatives who are caring for a terminally ill patient. Views on decreasing 
oral intake are interconnected with awareness of dying. Communication with health care professionals 
concerning oral intake at the end of life seems limited. 
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The studies described in this thesis concern public opinions regarding end-of-life care and end-of-life 
decision making and (artificial) nutrition and hydration at the end of life. First, this chapter will address 
the research questions, as presented in the introduction chapter. This is followed by methodological 
considerations, a general discussion focusing on two important issues in these studies, i.e. management 
of suffering at the end of life and communication, and recommendations for policy, practice and future 
research.
MAIN FINDINGS
Public opinion of end-of-life decisions
After eight years of legislation of euthanasia and physician assisted suicide in the Netherlands, it is 
important to know to which extent the Dutch Euthanasia Act receives societal support. We examined the 
opinions of the general public and healthcare professionals on the legal requirements for euthanasia and 
physician-assisted suicide in written surveys (chapter 2). These surveys showed that the Dutch Euthanasia 
Act and its legal requirements are widely supported, both by the Dutch general public and by healthcare 
professionals. Major arguments for this support are the possibility of relief of unbearable suffering at 
the end of life and respect for the patient’s autonomy. Overall, both members of the general public and 
healthcare professionals seem to interpret the boundaries for euthanasia or physician-assisted suicide in 
a rather restrictive way. Both groups tend to support assistance in dying particularly in the presence of 
physical symptoms, such as pain, whereas they are more reticent about euthanasia or physician-assisted 
suicide in case of psychological or existential suffering, and in patients with early dementia. The Dutch 
Euthanasia Act does not state the presence of physical symptoms to be mandatory and also allows 
euthanasia or physician-assisted suicide in the latter cases, provided that all criteria of due care are fulfilled. 
One of the current topics of sparking debate in the Netherlands is euthanasia or physician-assisted suicide 
in older people who have a wish to die due to being tired of living. In our study, being tired of living 
was defined as the wish to die of older persons who do not have a serious medical condition. In such 
cases, euthanasia and physician-assisted suicide are not allowed in the Netherlands, because unbearable 
suffering needs to have a medical ground, as stated by the Supreme Court, the Royal Dutch Medical 
Association and the regional review committees. Our study (chapter 3) showed that a minority of the Dutch 
general public supports assistance in dying for older persons who are tired of living. This level of support 
is significantly less compared to the support for assistance in dying for patients who are terminally ill. In 
our study age and health of the respondents were not associated with acceptance of assistance in dying 
for older people who are tired of living. Our study further showed that those who support assistance in 
dying for older people who are tired of living were more likely to be highly educated, to be non-religious, 
to value control over their health decisions, and to have little trust in physicians to comply with their care 
wishes. A shared principle among these supporters seems to be respect for autonomy, which is one of the 
pillars of the Dutch Euthanasia Act.
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A way to safeguard respect for patient’s autonomy is advance care planning. Advance care planning is a 
process of communication among patients, healthcare professionals, and relatives regarding end-of-life 
care. It aims to ensure that patients’ values remain central in decision-making and that the care provided is 
consistent with patients’ preferences 1. Because of the potential benefits, it has been suggested to promote 
advance care planning, not only among patients but also among the general public 2. We investigated to 
what extent the Dutch general public is currently involved or inclined to be involved in advance care 
planning (chapter 4). Overall, the majority of the Dutch general public has thought about end-of-life 
care and decision-making, and a substantial part of the Dutch general public has actively discussed their 
preferences at least once with a relative. However, discussions with the physicians and written advance 
directives are rare among the Dutch general public. Older people and people having a poor health are 
more often (inclined to be) involved in advance care planning. Involvement in advance care planning is 
also associated with a preference to be involved in medical decision making and having little trust that 
physicians will comply with one’s preferences.
Role of (artificial) nutrition and hydration in end-of-life care
End-of-life care often involves decisions about withholding or withdrawing potentially life-prolonging 
treatment.  An international survey among palliative care experts that aimed at getting insight into 
issues that may complicate end-of-life decision-making showed that they often encounter issues that are 
complex in end-of-life decision-making about (artificial) nutrition and hydration 3. We conducted a Delphi 
study to explore the type of difficulties. This study (chapter 5) showed that important issues were the lack 
of knowledge about the effects of artificial nutrition and hydration and about how to communicate about 
it, both with the patient and the relatives. The palliative care professionals reported that decision-making 
about artificial nutrition and hydration at the end of life could substantially improve if there would be 
more general knowledge and evidence-based guidance about the effects of providing or withholding 
artificial nutrition and hydration on quality of life and on optimal strategies for communication with 
patient and relatives. 
To assess what knowledge about the effects of artificial nutrition and hydration on quality of life is 
currently available, we conducted a systematic literature review (chapter 6). This systematic literature 
review showed that providing artificial nutrition and hydration is a substantial practice in the last week 
of life of cancer patients, especially in hospitals, with frequencies up to 50-88%. However, the effects on 
patients’ comfort, symptoms and length of life seem limited.  We conducted a second systematic literature 
review on opinions on the use of artificial hydration at the end of life. This study showed a large variation 
in the opinions of physicians, nurses, patients, family members and the general public (chapter 7). The 
majority of patients and relatives and one-third of the general public believe that artificial hydration has a 
positive effect on terminally ill patients’ quality of life, symptoms and overall clinical condition, while many 
healthcare professionals feel that artificial hydration at the end of life might have significant negative 
effects for the patient, such as worsening fluid retention symptoms (e.g. oedema, ascites, pleural effusions) 
and maintaining a venous route that is burdensome for the patient. These different expectations of (the 
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benefits and burden of ) artificial hydration at the end of life potentially complicates end-of-life care, 
communication and decision-making.
We finally studied how bereaved relatives perceive nutrition and hydration at the end of life of the patient 
(chapter 8). This qualitative interview study showed that relatives assign significant meaning to oral 
intake, in relation to its nutritional value, its psychological and social impact, and the fact that it gives 
routine and structure to daily life. Therefore, decreasing oral intake of the patient at the end of life is a 
meaningful change for relatives, who may respond differently. Some relatives accept the decrease in oral 
intake, others view maintaining oral intake as an important part of the battle against the disease and for 
life. Relatives may realize that the patient and themselves are ‘keeping each other in the dark’ through 
their mutual efforts to maintain oral intake until the end of life.
METHODOLOGICAL CONSIDERATIONS
This thesis is based on three  studies, namely the KOPPEL study, the OPCARE9 collaboration and 
the	 COMMEND	 study,	 that	 all	 used	 different	methods;	 a	 survey	 among	 the	 Dutch	 general	 public,	 an	
international Delphi study among palliative care professionals, two systematic literature reviews and a 
qualitative interview-study of bereaved relatives in New Zealand.
Public survey
In general, the aim of public surveys is to collect timely evidence on public opinions, attitudes and values. 
Surveys provide descriptive information at one specific point in time, as being a snapshot. Our survey 
among the Dutch general public aimed to evaluate opinions of Dutch general public regarding end-of-
life decision-making. To enable more in-depth understanding of the quantitative results of the survey, 
we also conducted 16 qualitative interviews with selected respondents, using purposive sampling. In 
general,	there	are	two	major	criticisms	about	internet	panels;	1)	internet	panels	are	often	self-selected,	
and 2) internet panels exclude people who do not have access to the internet or a computer. To address 
these criticisms, we have used the CentERpanel of the University Tilburg. This internet panel consists of 
a random sample of people based on postal codes (thus, it is not self-selected) and CentERdata enables 
all selected members to participate in the panel by providing them additional tools, such as a NexBox, 
television or internet connection (thus, no restriction to internet users only).
Despite a good response rate, the respondents were not fully representative of the Dutch population: the 
respondents were slightly older, more often male, more often highly educated and more often sharing 
a household. The overrepresentation of highly educated people has possibly led to an overestimation of 
the support for assistance in dying for older people who are tired of living and the overrepresentation of 
older people has possibly led to an overestimation of the actual involvement in advance care planning of 
the Dutch general public. Further, migrants were underrepresented. As known, cultural factors influence 
healthcare use 4, health communication 5, end-of-life care and decision-making 6, and they may influence 
opinions on these issues.  
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Delphi study
The Delphi technique is in essence a series of sequential questionnaires, or rounds, interspersed by 
controlled feedback, that seek to gain the most reliable consensus of opinion of a group of experts 7. 
Within healthcare research, the Delphi technique has been used for several goals, such as identifying key 
issues, emerging trends, future developments, and research priorities.  Our two-round Delphi study aimed 
at identifying the most important issues and considerations in end-of-life decision-making as experienced 
by palliative care experts.  Some limitations should be taken into account when interpreting the results. 
The quality of the results of a Delphi study depends on two major aspects, the quality of the expert 
panel and the quality of the questionnaires. We used a large international panel consisting of palliative 
care experts (physicians, nurses, and other healthcare professionals). These palliative care experts were 
selected by members of the OPCARE9 consortium. In this consortium, every country (n=9) had a national 
reference group, consisting of palliative care experts. The contact person of each country selected ten 
experts for the Delphi study using this reference group. It is not possible to determine to which extent 
the expert panel was representative of the population of palliative care experts in these nine countries. 
Nevertheless, the presence of different professions as planned and the average palliative care experience 
of twelve years suggest that the expert panel represents a broad and experienced group of palliative care 
experts.  One limitation is that all experts worked in an institutional setting, and the results can thus not 
be generalized to home care settings. In addition, the experts were predominantly physicians and nurses, 
because they were more inclined to respond. This might have led to an emphasis on medical issues. The 
response among experts who were asked to participate in the Delphi study was satisfactory, namely 76% 
in the first round and 60% in the second.
Systematic literature reviews
The process of systematic literature reviews consists of locating, appraising and synthesizing the evidence 
available from previous studies relevant to the research question. We have conducted two systematic 
literature	 reviews;	 the	 first	 aimed	 to	 get	 insight	 into	 the	practices	 and	 effects	 of	 artificial	 nutrition	 and	
hydration at the end of life and the second aimed to get insight into the opinions on artificial hydration at 
the end of life. One of the methodological considerations of our systematic literature reviews is that we did 
not conduct a Cochrane review or meta-analysis, the golden standard among systematic literature review 
protocols. Because we only could include one randomized controlled trial, we decided to also include 
papers on studies involving other levels of evidence, such as observational studies.  This limits the quality 
of the data found in the systematic literature review. Furthermore, we were not able to assess the quality of 
the papers systematically, because many papers did not give detailed information about the methods used. 
We aimed to have an overview of the current state of knowledge and therefore limited our search to 
papers that were published between 1998 and 2009. A consequence might be that not all studies on the 
practices and effects of artificial nutrition and hydration were included. 
To improve the comprehensiveness of the search strategy, a hand search of ten high-impact medical 
journals publishing about palliative care was conducted. Further, all references of the included papers 
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were checked. The latter resulted in one additional study. In the second review we combined the search 
strategy of the first systematic literature review with a newly developed search strategy focused primarily 
on opinions on the provision of artificial hydration at the end of life. This additional search resulted in five 
additional papers.  
Qualitative interviews
Qualitative interviews are most useful when aiming for an in-depth insight into a topic which is little 
researched. A qualitative interview seeks to cover both a factual and a meaning level, with an emphasis 
on the latter. Our interview study among bereaved relatives aimed at contributing to a more thorough 
understanding of relatives’ concerns regarding a decreased oral intake of the patient at the end of life.
To ensure the rigor of this study, all interviews with the bereaved relatives were audio-taped and 
transcribed by a professional transcribing service. Furthermore, all transcripts of the interviews were 
reviewed and two researchers independently developed a code tree, which was subsequently discussed. 
A set of transcripts was independently read to further identify specific codes within the general themes 
until saturation was reached. The final code tree was discussed until consensus was reached.
One methodological limitation of this study is the fact that all patients were under the care of one single 
palliative care service in New Zealand, which might hamper the generalizability of the findings to other 
bereaved relatives. Furthermore, we have only included bereaved relatives of European and Maori 
descent. The meaning of oral intake is culturally sensitive, so might be different for e.g. Asian people. 
We contacted the bereaved relatives at least two months post bereavement and the interviews were 
planned at least three months post bereavement. This relatively short period was chosen because of 
earlier positive experiences with similar time periods, which suggested that at this point in time there 
might be an acceptable balance between the burden of an (early) interview or questionnaire and recall 
bias 8-9. Furthermore, all deaths were more or less expected since all patients were under the care of a 
specialist palliative care service and expectedness of the death is known to be associated with a less 
severe bereavement reaction six weeks post bereavement 10.
INTERPRETATION OF FINDINGS
Suffering at the end of life
One of the due care criteria of the Dutch Euthanasia Act is that the physician has to be convinced that 
the patient’s suffering is unbearable without prospect of improvement. Alleviating suffering at the end 
of life is a widely used argument in the debate on euthanasia. This thesis shows that the Dutch general 
public, nurses and physicians are inclined to accept euthanasia in case of unbearable physical suffering. If 
a patient’s suffering is exclusively rooted in psychosocial problems or spiritual issues, there is substantially 
less support for granting a euthanasia request 11. Moreover, euthanasia in case of suffering due to being 
tired of living (non-physical suffering) is clearly less supported in Dutch society: 25% of the general public 
and 18-19% of the healthcare professionals would accept euthanasia in such cases. These opinions are 
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reflected in current euthanasia practices in the Netherlands: euthanasia and physician-assisted suicide 
mainly concern cancer patients 12. Previous research concerning opinions of the Dutch general public and 
physicians showed similar findings, namely that the Dutch general public is somewhat more permissible 
towards euthanasia in case of physical suffering compared to non-physical suffering and compared 
to physicians 13. Moreover, physicians are more inclined to grant a euthanasia request that is based on 
suffering due to physical symptoms 14-15.
End-of-life care is aimed at addressing all dimensions of suffering at the end of life, because suffering obviously 
entails more than physical symptoms. Suffering is a complex concept and has physical, psychological, social 
and spiritual components. Cassel defined suffering as “the distress brought about by an actual or perceived 
impending threat to the integrity or continued existence of the whole person, and it requires a sense of the 
future and of the past” 16. Kahn defines suffering as “an individual’s experience of threat to self and a meaning 
given to events such as pain or loss” 17. Dame Cicely Saunders has introduced the concept of total pain, 
which includes physical symptoms, mental distress, social problems and emotional problems 18, inspired 
by a patient who said about her pain “All of me is wrong”. For many, Cicely Saunders is the founder of the 
international hospice movement that has spearheaded new approaches to the care of dying people and 
their relatives. Moreover, her concept of total pain has inspired the WHO definition of palliative care that 
includes suffering due to “pain and other problems, physical, psychosocial and spiritual” 19.  
A study among terminally ill cancer patients showed that one in every four cancer patients suffered 
unbearably at the end of life, and that half of the unbearable aspects occurred in the psychological, 
social and spiritual domain 20. Our New Zealand study among bereaved relatives illustrates the social 
component of suffering: the relatives’ experiences showed that the loss of the ability to eat of the patient 
was experienced as a social issue that affected the quality of life of both relatives and the patient. In 
addition, relatives and patients may mutually reinforce their distress concerning nutrition and hydration 
at the end of life 21. The burden for relatives of being involved in the dying trajectory of a loved one at the 
social level is substantial, and this burden increases when the patient’s functional status declines 22, and 
affects the patients as well 23.
Despite empirical and theoretical evidence of the multidimensionality of pain and suffering, palliative 
care practice and research largely focus on the physical dimension of suffering and quality of life. A recent 
systematic literature review showed that only seven of the 29 instruments to assess quality of life of terminally 
ill patients have incorporated a social dimension 24. Obviously, this focus on the physical dimension of 
suffering does not reflect the complex burden of patients and their relatives when death approaches. To 
adequately address suffering and provide optimal end-of-life care, adequate assessment of the needs of 
the patients and relatives in all relevant dimensions is of utmost importance. High-quality communication 
between patients, relatives and healthcare professionals is of essence to achieve that goal.
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Communication in end-of-life care
Open discussions of end-of-life contribute to a better quality of care 25. Communication is one of the key 
elements of quality of end-of-life care for seriously ill patient and their family members 26, and it has been 
identified as the most important factor to explain variance in relatives’ satisfaction with end-of-life care 27. 
However, we demonstrated that international palliative care professionals perceive communication with 
both the patient and the relatives about end-of-life care and decisions on interventions such as artificial 
nutrition and hydration as difficult 28. Furthermore, concrete end-of-life discussions between healthcare 
professionals and patients or their relatives seem to be rare. Our study among bereaved relatives 
suggests that there are limited in depth discussions between healthcare professionals and relatives about 
significant issues such as nutrition at the end of life 21. People also tend not actively engage in end-of-
life discussions with their physician, despite the fact that the majority of the Dutch general public has 
thought about end-of-life care and decision-making. Moreover, only 24% of the people who have drafted 
an advance directive have discussed it with their physician 29. 
Shared decision-making is often seen as the ideal. Shared decision-making is an interactive, collaborative, 
and on-going process in which healthcare professionals and patients mutually engage by sharing 
information, wishes and decisions 30-32. In our survey, two thirds of the general public reported to support 
shared decision-making at the end of life 29, which is in line with the findings of a systematic literature 
review showing that the majority of patients receiving palliative care want to be involved in decision-
making 33. 
Reality does not always correspond with the ideal of shared decision-making. A recent systematic 
literature review showed that although the majority of patients want to participate in treatment decisions 
to some extent, most do not achieve their preferred level of involvement because decisions are delayed 
and alternative treatment options are seldom discussed 33.  Known barriers for end-of-life discussions 
are physicians’ and patients’ ambivalent attitudes towards bad prognosis 34. The initiation of end-of-life 
discussions seems to be the major bottle neck 29, 34-35. It has been suggested that physicians are reluctant 
to discuss end-of-life issues and tend to wait until the patient raises the topic 36. However, there is also 
a general reluctance among patients to (spontaneously) talk about their problems and needs. The use 
of difficult medical terms might also hamper effective communication 34. An additional barrier for end-
of-life communication is the fact that active participation in end-of-life discussions might be impossible 
for terminally ill patients because of their impaired capacity due to either the underlying illness or drug 
administration such as sedatives. It is therefore important to anticipate various scenarios, to timely 
communicate, and to think ahead. 
To support both patient and the physician in initiating end-of-life discussions and achieve the preferred 
level of involvement in end-of-life decision-making, advance care planning has been widely promoted 37-
38. Advance care planning includes communication to clarify a patient’s understanding of their illness and 
treatment	options;	to	understand	their	values,	beliefs,	and	goals	of	care;	and	to	identify	their	wishes	for	
end-of-life care. Advance care planning not only safeguards that patients’ values remain central in end-of-
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life	decision-making;	it	also	prepares	patients	and	their	relatives	for	complex	end-of-life	decisions.	
In the nineties of the previous century, research on advance care planning predominantly was focused 
on the use of advance directives, rather than on advance care planning as a communication process. 
Important	limitations	of	advance	directives	have	been	identified;	no	positive	effects	of	advance	directives	
on the quality of care, quality of life, and satisfaction of patients and relatives 39-41;	 and	 limited	use	of	
advance directives 42-46, despite many efforts to promote it 45, 47-49. This incapacity of advance directives 
to affect future care has been described as the false promise of advance directives 50. But when advance 
care planning is approached as a continuous process of communication that aims at understanding 
the patient’s values and at preparing the patient and their relatives for complex end-of-life decisions it 
does improve end-of-life care. A recent randomized controlled trial showed that advance care planning 
improves end-of-life care and patient and family satisfaction and that it improves the quality of life of 
bereaved relatives (less stress, anxiety, and depression post bereavement) 51. To effectively promote 
advance care planning, a dual approach is needed: both physicians and patients need to be indicated 
about how to initiate end-of-life discussions 36.   
Communication at the end of life not only entails process-related aspects, it needs content as well. The 
currently limited evidence-base for end-of-life care might hamper communication at the end of life. 
Nutrition and hydration at the end of life is a clear example. As indicated by palliative care experts, end-of-
life decision making regarding artificial nutrition and hydration would substantially improve if there would 
be more knowledge on the effects 28. This lack of evidence regarding artificial nutrition and hydration is 
confirmed by our systematic literature review. Providing artificial nutrition and hydration seems to have 
limited effects on comfort, symptoms and length of survival, but we could only include one randomized 
controlled trial 52. Further research is needed, as earlier suggested by two recent Cochrane reviews that 
also found too few studies to draw firm conclusions on the effect of artificial nutrition and hydration at 
the end of life 53-54. 
The lack of evidence is also illustrated by the wide variety of opinions on the use of artificial nutrition 
and hydration 11,55, which underlines the importance of end-of-life communication about expectations 
and preferences. First, an important goal of end-of-life care is to honour patients’ preferences based on 
their concept of a good death. Continuous communication is necessary to get insight into the patients’ 
values, beliefs, and preferences for goals of care. Secondly, variety in opinions potentially hampers end-
of-life communication, because patients and professionals approach end-of-life discussions with different 
expectations and preferences 56. 
IMPLICATIONS FOR POLICY, PRACTICE AND FUTURE RESEARCH
Policy and practice implications
This thesis shows that there is ample societal support for the Dutch Euthanasia Act, both among the 
general public and healthcare professionals, especially in the presence of physical symptoms. Both the 
general public and professionals consider euthanasia more problematic if a patient’s unbearable suffering 
is rooted in psychosocial or spiritual issues. Moreover, most professionals and members of the general 
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public seem to interpret the boundaries of euthanasia or physician-assisted suicide in a rather restrictive 
way, and either expanding or limiting the scope of the Act does not seem to be indicated based on public 
opinions. 
Although euthanasia seems not to be considered to be an appropriate way to alleviate all types of suffering 
at the end of life, obviously, suffering is not restricted to physical symptoms. Suffering is a complex, holistic 
concept and more attention for this multidimensional approach of suffering at the end of life is needed. 
Moreover, the importance of social suffering should be recognized. Outcome measures to assess quality 
of life should also incorporate the social dimension of quality of life of the patient. Further, addressing 
relatives’ distress not only improves the quality of life of the relatives also contributes to the well-being of 
the terminally ill patient. Some validated tools to assess (and address) the distress and needs of relatives, 
e.g. FAMCARE 57-58, are available for clinical practice. 
In order to provide high-quality end-of-life care, it is important to communicate adequately. Therefore, 
effective strategies to support (the initiation of ) end-of-life discussions by patients and healthcare 
professionals are needed. Important societal initiatives, such as Dying Matters (UK) 59 and STEM 60 (the 
Netherlands), have been launched.  These initiatives aim at further increasing people’s consciousness 
of human mortality, and at stimulating people to consider their preferences for and attitudes towards 
end-of-life care and to discuss these with relatives and healthcare professionals. Furthermore, the Royal 
Dutch Medical Association has recently published a pamphlet “Timely end-of-life discussions with your 
physician”, both for physicians and patients, to support communication at the end of life 61. Moreover, clear 
evidence about the effects of end-of-life interventions might also contribute to adequate communication 
and decision-making.
Recommendations for future research
The findings reported in this thesis evoke several new questions. First of all, although this thesis shows 
that the Euthanasia Act has ample societal support, continued monitoring of euthanasia practices and 
opinions on euthanasia is valuable. At this moment, little is known about the true prevalence of older 
people who have a wish to die because they suffer of being tired of living 62. How practices in this area 
develop in our aging society has to be awaited.
Secondly, the complex nature of suffering and in particular the importance of the social dimension of 
suffering needs more attention. We have studied social suffering from the relatives’ perspective, within a 
specialist palliative care setting in New Zealand, but it is also important to further investigate the impact 
of social suffering on patients. Further research is also needed to verify our findings in other (cultural) 
settings.
Thirdly, end-of-life communication and decision-making should be fostered with evidence of effective 
strategies. Many initiatives and interventions to promote end-of-life discussions are present, which should 
be underpinned with research on their effectiveness. Advance care planning is such an intervention, but 
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the effects of advance care planning on the quality of life and quality of care are not indisputable. More 
research on the effect of advance care planning and how to improve it is needed.
Lastly, in general, more evidence based end-of-life care is needed. To ensure high-quality end-of-life 
care, more insight is needed in the effects of (withholding or withdrawing) potentially life-prolonging 
treatments, such as artificial nutrition and hydration. Large international comparative studies are of the 
essence in this field. 
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SUMMARY
In the introduction (chapter 1), the background and aim of this thesis are described. End-of-life care aims 
to improve quality of life of patients and their relatives facing problems associated with life-threatening 
illness in the last days of life. End-of-life decision-making is an important aspect of end-of-life care that 
can have a significant impact on the process of dying and dying patients’ comfort in the last days of life. 
Moreover, end-of-life decisions are known to occur in 23-51% of all deaths in Europe. 
End-of-life decisions are subject to societal debate. Better understanding of current public opinion on 
end-of-life decisions can strengthen the societal debate in the Netherlands. End-of-life decision-making 
regarding artificial nutrition and hydration at the end of life is internationally shared to be important and 
better understanding can contribute to better end-of-life care.
The aim of this thesis was to contribute to better understanding of end-of-life decision-making practices. 
Two topics were addressed:
•	 public	opinion	on	end-of-life	decision-making	in	the	Netherlands,	and
•	 (artificial)	nutrition	and	hydration	at	the	end	of	life.
In Part 1, public opinion in the Netherlands on euthanasia, physician-assisted suicide and advance 
care planning is described. In the Netherlands, euthanasia has been debated extensively, which has 
led to the Euthanasia Act in 2002. After a decade, public debate remains vivid, especially regarding the 
boundaries and interpretation of the Euthanasia Act. Nowadays, one of the subjects of much debate 
concerns euthanasia or physician-assisted suicide in older people who are suffering due to being tired of 
living. Better understanding of current public opinions regarding the Act might strengthen the societal 
debate. The chapters in part 1 are based on the results of the KOPPEL study. This study involved a mixed-
method design: in the cross-sectional survey among the general public, 1960 respondents completed a 
questionnaire	(response	rate	78%);	16	of	those	were	personally	interviewed.
Chapter 2 reports on the results of surveys among the general public and healthcare professionals which 
examined their opinions on the legal requirements for euthanasia and physician-assisted suicide. These 
surveys demonstrated that the Dutch Euthanasia Act and its legal requirements are widely supported, 
both by the Dutch general public and by healthcare professionals. Major arguments for this support are 
the possibility of relief of unbearable suffering at the end of life and respect for patient’s autonomy. Overall, 
both members of the general public and healthcare professionals seem to interpret the boundaries for 
euthanasia or physician-assisted suicide in a rather restrictive way. Both groups tend to support assistance 
in dying particularly in the presence of physical symptoms, such as pain, whereas they are more reticent 
about euthanasia or physician assisted suicide in case of psychological or existential suffering, and in 
patients with early dementia. The Dutch Euthanasia Act does not state the presence of physical symptoms 
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to be mandatory and also allows euthanasia or physician assisted suicide in the latter cases, provided that 
all criteria of due care are fulfilled. 
Chapter 3 describes the results of the cross-sectional survey among members of the Dutch general public 
related to the opinions of the general public on assistance in dying in older people who are tired of living. 
Being tired of living was defined as the wish to die of older persons who do not have a serious medical 
condition. This is one of the current topics of sparking debate in the Netherlands. To date, euthanasia 
and physician-assisted suicide for older people who are tired of living is not allowed in the Netherlands, 
because unbearable suffering needs to have a medical ground, as stated by the Supreme Court, the 
Royal Dutch Medical Association and the regional review committees. Our study showed that a minority 
of the Dutch general public supports assistance in dying for older people who are tired of living. This 
level of support is significantly less compared to the support for assistance in dying for patients who are 
terminally ill.  To better understand which subgroup supports assistance in dying for older people, we 
have analysed the characteristics of the supporters. In our study age and health of the respondents were 
not associated with acceptance of assistance in dying for older people who are tired of living. Our study 
further showed that those who support assistance in dying for older people who are tired of living were 
more likely to be highly educated, to be non-religious, to value control over their health decisions, and to 
have little trust in physicians to comply with their care wishes. A shared principle among these supporters 
seems to be respect for autonomy, which is one of the pillars of the Dutch Euthanasia Act. 
Chapter 4 describes to what extent the Dutch general public is currently involved or inclined to be 
involved in advance care planning. Advance care planning is a process of communication among patients, 
healthcare professionals, and relatives regarding end-of-life care. It aims to ensure that patients’ values 
remain central in decision-making and that the care provided is consistent with patients’ preferences. 
Our study showed that the majority of the Dutch general public (70%) has thought about end-of-life 
care and decision-making, and a substantial part of the Dutch general public has actively discussed their 
preferences at least once with a relative (64%). However, discussions with the physicians (13%) and written 
advance directives (7%) are rare among the Dutch general public. Older people and people having a poor 
health more often (incline to) engage in advance care planning. Involvement in advance care planning is 
also associated with a preference to be involved in medical decision-making and having little trust that 
physicians will comply with one’s preferences.
End-of-life decision-making encompasses more than euthanasia and physician-assisted suicide. An 
internationally shared important end-of-life decision concerns withholding or withdrawing potentially 
life-prolonging treatment, in particular artificial nutrition and hydration at the end of life. Part 2 of this 
thesis	concerns	several	studies	about	nutrition	and	hydration	at	the	end	of	 life;	a	Delphi	study	among	
90 international palliative care experts (response rate 60-76%), two systematic literature reviews, and 
a qualitative interview study among 23 bereaved relatives in New Zealand. These studies derive from 
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OPCARE9, a European collaborative project to optimize research for the care of cancer patients in the last 
days of life.
 
Chapter 5 describes the results of a two-round Delphi study that aimed to investigate which key issues 
healthcare professionals encounter when making decisions about artificial nutrition and hydration at the 
end of life. This study among international palliative care experts showed that important issues were the 
lack of knowledge about the effects of artificial nutrition and hydration and about how to communicate 
about it, both with patients and relatives. The palliative care experts reported that decision-making 
about artificial nutrition and hydration at the end of life could substantially improve if there would be 
more general knowledge and evidence-based guidance about the effects of providing or withholding 
artificial nutrition and hydration on quality of life and on optimal strategies for communication with 
patient and relatives. 
In Chapter 6, a systematic literature review about the effects of artificial nutrition and hydration is 
described. This systematic literature review aimed at synthesizing current knowledge of the effects of 
artificial nutrition and hydration in the last week of life on the quality of life and length of life of advanced 
cancer patients. The review included 15 papers, including one randomized controlled trial. It showed 
that providing artificial nutrition and hydration is a substantial practice in the last week of life of cancer 
patients, especially in hospital, with frequencies up to 50-88%. Several studies reported on the benefits 
and burdens of artificial hydration, but no studies that assessed the effect of artificial nutrition were found. 
Artificial hydration was found to have limited impact on patients’ symptoms: one study found less chronic 
nausea after receiving hydration and another study found some association between hydration and signs 
of dehydration. No significant relationships between hydration and general comfort or quality of life 
measures were found. One study assessed the effect of artificial nutrition and hydration on survival and 
found no association. 
Chapter 7 reports on a second systematic literature review, on opinions on the use of artificial hydration 
at the end of life. This review included 11 papers. It showed a large variation in the opinions of physicians, 
nurses, patients, family members and the general public. The majority of patients and relatives and one-
third of the general public believe that artificial hydration has a positive effect on quality of life, symptoms 
and overall clinical condition, while many healthcare professionals feel that artificial hydration at the end 
of life might have significant negative effects for the patient, such as worsening fluid retention symptoms 
(e.g. oedema, ascites, pleural effusions) and maintaining a venous route that is burdensome for the 
patient. These different expectations of (the benefits and burden of ) artificial hydration at the end of life 
potentially complicates end-of-life care, communication and decision-making.
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Chapter 8 describes a qualitative interview study on bereaved relatives’ perceptions of nutrition and 
hydration at the end of life of the patient. This study was performed in New Zealand. In total, 23 bereaved 
relatives were interviewed. It showed that relatives assign significant meaning to oral intake, in relation to 
its nutritional value, its psychological and social meaning, and the fact that it gives routine and structure 
to daily life. Therefore, decreasing oral intake of the patient at the end of life is a meaningful change for 
relatives, who may respond differently. Some relatives accept the decrease in oral intake, while others 
view maintaining oral intake as an important part of the battle against the disease and for life. Relatives 
may realize that the patient and themselves are ‘keeping each other in the dark’ through their mutual 
efforts to maintain oral intake until the end of life.
In the final chapter (Chapter 9), the main findings are integrated and recommendations for policy, practice 
and future research are given. It is concluded that there is ample support for the Dutch Euthanasia Act, 
both among the general public and healthcare professionals, especially in the presence of physical 
symptoms. Both the general public and professionals consider euthanasia more problematic if a patient’s 
unbearable suffering is rooted in psychosocial problems or spiritual issues. 
End-of-life decision-making regarding nutrition and hydration can substantially improve by more 
evidence-based guidance and international palliative care professionals perceive communication with 
both the patient and the relatives about it as difficult. More attention is needed for the significance of 
(artificial) nutrition and hydration at the end of life and for communication about it.  
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SAMENVATTING
In hoofdstuk 1 worden de achtergronden en de doelstelling van dit proefschrift beschreven. Zorg in 
de laatste levensfase heeft als doel het verbeteren van de kwaliteit van leven van patiënten met een 
levensbedreigende ziekte en hun naasten. 
Medische beslissingen rond het levenseinde zijn een belangrijk onderdeel van zorg in de laatste levensfase 
en kunnen een belangrijke invloed hebben op het proces van overlijden en het comfort van patiënten 
in de laatste levensfase. In Europa wordt 23-51% van alle sterfgevallen voorafgegaan door medische 
beslissingen met een mogelijk levensbekortend effect.
Besluitvorming rond het levenseinde is regelmatig onderwerp van maatschappelijke debat. Kennis 
van publieke opinie op dit terrein kan dit debat informeren en verbeteren. Het al dan niet kunstmatig 
toedienen van vocht en voeding in de laatste levensfase wordt internationaal gezien als een belangrijk en 
complex onderwerp waarover beslissingen genomen moeten worden. Meer inzicht in de voors en tegens 
ervan zal bijdragen aan betere zorg in de laatste levensfase. 
Het doel van dit proefschrift is om het inzicht in de opvattingen over en praktijk van zorg en besluitvorming 
rond het levenseinde te vergroten. Twee onderwerpen zijn uitgelicht:
•	 publieke	opinie	over	besluitvorming	rond	het	levenseinde	in	Nederland,	en
•	 (kunstmatige	toediening	van)	vocht	en	voeding	in	de	laatste	levensfase.
Deel 1 van dit proefschrift beschrijft de publieke opinie over euthanasie, hulp bij zelfdoding en proactieve 
zorgplanning in Nederland. In Nederland zijn de voorwaarden waaronder euthanasie toelaatbaar is 
gedurende de laatste vier decennia uitgebreid bediscussieerd, hetgeen in 2002 heeft geresulteerd 
in de inwerkingtreding van de Wet toetsing levensbeëindiging op verzoek en hulp bij zelfdoding 
(euthanasiewet). Daarna is het maatschappelijke debat steeds levendig geweest, vooral betreffende de 
reikwijdte van de euthanasiewet. Een van de veelvuldig bediscussieerde onderwerpen is euthanasie of 
hulp bij zelfdoding voor ouderen die ´klaar met leven´ zijn. Wij deden onderzoek naar de publieke opinie 
over dit onderwerp in de KOPPEL studie. Deze studie omvat zowel kwantitatief als kwalitatief onderzoek: 
wij voerden een vragenlijststudie uit onder het Nederlandse publiek, waarbij 1960 respondenten een 
vragenlijst hebben ingevuld (respons percentage 78%), en hielden persoonlijke interviews met 16 van 
deze respondenten. Het vragenlijstonderzoek werd ook onder zorgprofessionals uitgevoerd, zowel onder 
artsen (respons percentage 41%, n=793) als verpleegkundigen (n=1243).
Hoofdstuk 2 beschrijft de resultaten van de vragenlijststudies naar de opvattingen van het Nederlandse 
publiek en zorgprofessionals over de wettelijke voorwaarden voor euthanasie en hulp bij zelfdoding. Deze 
vragenlijststudies laten zien dat de euthanasiewet breed wordt gedragen, zowel door het Nederlandse 
publiek als door zorgprofessionals. Belangrijke argumenten voor de steun voor de euthanasiewet zijn 
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de mogelijkheid om ondraaglijk lijden in de laatste levensfase te kunnen verlichten en het belang van 
respect voor de autonomie van de patiënt. Zowel het Nederlandse publiek als zorgprofessionals lijken 
de grenzen aan euthanasie en hulp bij zelfdoding vrij restrictief te interpreteren. Beide groepen vinden 
euthanasie en hulp bij zelfdoding vooral acceptabel in het geval van lichamelijke symptomen, zoals pijn, 
terwijl ze in het geval van psychisch of existentieel lijden terughoudender zijn. De euthanasiewet schrijft 
niet voor dat er sprake moet zijn van lichamelijke symptomen en geeft ruimte voor euthanasie en hulp 
bij zelfdoding in het geval van psychisch of existentieel lijden, mits aan alle zorgvuldigheidscriteria is 
voldaan.
Hoofdstuk 3 beschrijft de resultaten van de vragenlijststudie naar de opvattingen van het Nederlandse 
publiek over euthanasie en hulp bij zelfdoding voor ouderen die ‘klaar met leven’ zijn. ‘Klaar met leven’ is 
hier gedefinieerd als het hebben van een stervenswens zonder dat er sprake is van een ernstige medisch 
classificeerbare ziekte. Euthanasie of hulp bij zelfdoding bij ouderen die ‘klaar met leven’ zijn is niet 
toegestaan in Nederland. Ondraaglijk lijden moet volgens de Hoge Raad, de regionale toetsingscommissies 
en de Koninklijke Nederlandsche Maatschappij tot bevordering der Geneeskunst (KNMG) voortkomen uit 
een medisch classificeerbare aandoening. Deze studie laat zien dat een minderheid van het Nederlandse 
publiek euthanasie en hulp bij zelfdoding bij ouderen die ‘klaar met leven’ zijn ondersteunt. Dit is duidelijk 
minder dan de steun voor euthanasie en hulp bij zelfdoding bij ongeneeslijk zieke patiënten. Er werd geen 
verband tussen de leeftijd en gezondheid van de respondenten en hun opvattingen over euthanasie en 
hulp bij zelfdoding voor ouderen die ‘klaar met leven’ zijn gevonden. Voorstanders hiervoor lijken meer 
waarde te hechten aan de autonomie van de patiënt bij verzoeken om euthanasie of hulp bij zelfdoding.
In hoofdstuk 4 wordt beschreven in welke mate het Nederlandse publiek betrokken is, of betrokken zou 
willen zijn, bij proactieve zorgplanning (advance care planning). Proactieve zorgplanning is een proces van 
communicatie tussen patiënt, naasten, en zorgprofessionals over zorg rond het levenseinde. Proactieve 
zorgplanning heeft als doel te waarborgen dat de waarden van de patiënt centraal staan in beslissingen 
rond het levenseinde en dat zorg rond het levenseinde conform de wensen en voorkeuren van de patiënt 
is. De vragenlijststudie liet zien dat de meerderheid van het Nederlandse publiek (70%) wel eens heeft 
nagedacht over zorg rond het levenseinde en dat een substantieel deel van het Nederlandse publiek dit 
ook wel eens heeft besproken met naasten (64%). Een minderheid heeft de eigen wensen wel eens met 
een arts besproken (13%) of deze vastgelegd in een schriftelijke wilsverklaring (7%). Ouderen en mensen 
met een slechte gezondheid zijn relatief vaker betrokken bij een vorm van proactieve zorgplanning dan 
jongeren en gezonde mensen. Betrokkenheid bij proactieve zorgplanning hangt daarnaast ook samen 
met een algemene voorkeur voor betrokkenheid bij medische beslissingen en met minder vertrouwen 
hebben in het feit dat artsen de wensen over zorg en beslissingen rond het levenseinde zullen respecteren.
Besluitvorming rond het levenseinde omvat meer dan alleen beslissingen over euthanasie en hulp 
bij zelfdoding. Besluitvorming over het staken of onthouden van potentieel levensverlengende 
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behandelingen in de laatste levensfase wordt internationaal als een belangrijke beslissing gezien, in het 
bijzonder besluitvorming over kunstmatige toediening van vocht en voeding. Deel 2 van dit proefschrift 
bevat meerdere studies over vocht en voeding in de laatste levensfase, namelijk een Delphi studie onder 
90 internationale palliatieve zorgprofessionals (response percentage 60-76%), twee systematische 
literatuurstudies en een interviewstudie met nabestaanden in Nieuw Zeeland. Deze studies komen 
voort uit OPCARE9, een Europees project waarin professionals uit negen landen met elkaar hebben 
samengewerkt om onderzoek naar de zorg voor kankerpatiënten in de laatste levensfase en voor hun 
naasten te optimaliseren.
Hoofdstuk 5 beschrijft de resultaten van de Delphi studie die als doel had om na te gaan welke 
belangrijke problemen palliatieve zorgprofessionals ervaren tijdens besluitvorming over kunstmatige 
toediening van vocht en voeding in de laatste levensfase. Deze studie liet zien dat gebrek aan kennis 
over de effecten van (het nalaten van) kunstmatige toediening van vocht en voeding en over adequate 
manieren van communicatie met zowel patiënt als naasten als belangrijke problemen werden ervaren. 
Daarnaast gaven de experts aan dat besluitvorming over kunstmatige toediening van vocht en voeding 
in de laatste levensfase verbeterd zou kunnen worden als over deze onderwerpen meer kennis en meer 
op wetenschappelijk onderzoek gestoelde richtlijnen zouden bestaan.
In hoofdstuk 6 worden de resultaten van een systematische literatuurstudie naar de praktijk en de 
effecten van kunstmatige toediening van vocht en voeding in de laatste levensdagen van kankerpatiënten 
beschreven. In totaal zijn 15 artikelen geïncludeerd. Het toedienen van vocht en voeding in de laatste 
levensdagen bleek in veel landen veelvuldig plaats te vinden, vooral in het ziekenhuis. De effecten van 
kunstmatige toediening van vocht in de laatste levensdagen op het comfort van de patiënt lijken beperkt. 
Eén studie rapporteerde minder misselijkheid bij toediening van vocht en een andere studie vond een 
associatie tussen het toedienen van vocht en minder fysieke tekenen van dehydratie (droge mond en 
oksels en diepliggende ogen). Daarnaast beschreven twee studies negatieve effecten van kunstmatige 
toediening van vocht, namelijk meer ascites en meer drainage. Er waren geen studies die de effecten 
van kunstmatige toediening van voeding separaat bestudeerden. In één studie werd gekeken naar de 
effecten van kunstmatige toediening van vocht en voeding in de laatste levensdagen op overleving, maar 
er werd geen relatie gevonden.
Hoofdstuk 7 beschrijft een tweede systematische literatuurstudie naar de opvattingen over kunstmatige 
toediening van vocht in de laatste levensdagen van kankerpatiënten. In deze literatuurstudie konden 
11 artikelen worden geïncludeerd die een grote variatie aan opvattingen van artsen, verpleegkundigen, 
patiënten, naasten en het algemene publiek lieten zien. De meerderheid van patiënten en naasten en 
een derde van het algemene publiek meenden dat kunstmatige toediening van vocht in de laatste 
levensdagen een positief effect heeft op kwaliteit van leven, symptomen en de algehele conditie van de 
patiënt. De meeste zorgprofessionals echter dachten dat toediening van vocht juist negatieve effecten 
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voor de patiënt heeft, zoals het verergeren van symptomen van vochtretentie en de noodzaak van het 
handhaven van een voor de patiënt belastend infuus. Deze verschillende opvattingen over (de effecten 
van) kunstmatige toediening van vocht in de laatste levensdagen kunnen adequate zorg, communicatie 
en besluitvorming in de laatste levensdagen in de weg staan.
Hoofdstuk 8 beschrijft een kwalitatieve interviewstudie over de opvattingen van nabestaanden over eten 
en drinken in de laatste levensfase van de patiënt. Deze studie is in Nieuw Zeeland uitgevoerd en in totaal 
zijn er 23 nabestaanden geïnterviewd. Deze studie liet zien dat nabestaanden veel betekenis toekennen 
aan voeding in de laatste levensfase, zowel in relatie tot de voedingswaarde zelf als aan psychologische 
en sociale aspecten en het feit dat voeding routine en structuur aan het dagelijkse leven geeft. 
Verminderde orale inname van voeding door de patiënt in de laatste levensfase is dan ook een belangrijke 
verandering voor naasten, die hierop verschillend kunnen reageren. Sommige naasten accepteren de 
verminderde orale inname als onderdeel van het stervensproces, terwijl anderen het handhaven ervan 
als een belangrijk onderdeel zien van het gevecht tegen de ziekte. Naasten gaven soms aan dat zij en de 
patiënt elkaar in het ongewisse hadden gelaten over het naderende afscheid door hun inspanningen om 
te blijven eten en drinken tot het einde van het leven.
Tenslotte wordt in hoofdstuk 9 een samenvatting gegeven van de gevonden resultaten en worden deze 
resultaten beschouwd in relatie tot eerder onderzoek en methodologische overwegingen. Ook worden 
implicaties voor onderzoek, beleid en praktijk besproken.
Een van de belangrijkste conclusies van dit proefschrift is dat er ruime steun is voor de Nederlandse 
euthanasiewet, zowel onder het Nederlandse publiek als onder zorgprofessionals, voornamelijk als 
patiënten lijden aan fysieke symptomen. Zowel het Nederlandse publiek als zorgprofessionals vinden 
euthanasie meer problematisch voor patiënten bij wie het lijden voortkomt uit psychosociale of 
existentiële problematiek.
Daarnaast komt duidelijk naar voren dat experts verwachten dat besluitvorming in de laatste levensfase 
over (kunstmatige toediening van) vocht en voeding verbeterd kan worden door evidence-based 
richtlijnen. Daarin is ook aandacht nodig voor communicatie met patiënt en naasten over vocht en 
voeding in de laatste levensfase. 
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De afgelopen jaren heb ik met veel plezier aan dit proefschrift gewerkt en ben zeer dankbaar voor deze 
prachtige tijd. Maar een proefschrift schrijven doe je zeker niet alleen en ik wil dan ook graag dit deel van 
het ‘boekje’ gebruiken om iedereen die direct of indirect heeft bijgedragen aan dit proefschrift hartelijk 
te bedanken. Graag wil ik alle respondenten bedanken voor hun deelname aan de verschillende studies. 
Zonder hen geen onderzoek. Ik ben bevoorrecht met enorme hoeveelheden vragenlijsten en interviews 
van zowel burgers, professionals en nabestaanden. Nogmaals dank voor uw openheid en bereidheid om 
met mij te spreken, ook in tijden van verdriet en verlies. Daarnaast wil ik ook een aantal mensen speciaal 
noemen die mijn promotietijd extra glans hebben gegeven.
Geachte promotoren, beste Agnes, beste Hans, zonder jullie was dit proefschrift niet tot stand gekomen. 
Jullie wetenschappelijke huwelijk heeft geleid tot een naadloze aanvulling op elkaar als begeleiders en 
hiervan heb ik de vruchten mogen plukken. Hartelijk dank voor jullie steun en vertrouwen. 
Geachte professor van der Heide, beste Agnes, wat een enorme eer om jouw allereerste promovendus te 
mogen zijn. Altijd wist jij met scherpe analyses en een kritische blik mij weer verder te helpen en ben ik je 
enorm dankbaar voor alle mogelijkheden die je me gegeven hebt. Je bent een voorbeeld voor ons allen 
en ik kijk uit naar je oratie. 
Geachte professor van Delden, beste Hans, met plezier kijk ik terug op onze discussies over de KOPPEL 
resultaten, over de ‘so what’ vraag. En zelfs voor logistieke ondersteuning vanuit Genève draai jij je hand 
niet om, dank je wel. 
Geachte copromotoren, wat had ik zonder jullie gemoeten? Beste Lia, in het geweld van ons Europees 
project OPCARE9 voelde ik me altijd door je gesteund en waren we een sterk team. Ik voelde me meteen 
thuis bij je. Je bent een kei van een dokter en een bevlogen onderzoeker die fier op de barricades staat 
voor meer aandacht voor een goed sterfbed. Je hebt me aangestoken, bedankt. 
Beste Judith, ik vind het fantastisch dat je mijn copromoter bent. Samenwerken met jou is een feest. 
Jouw verfrissende blik en tomeloze enthousiasme en energie zullen me altijd bij blijven en ik hoop in de 
toekomst nog veel met je samen te mogen werken.
Zoals gezegd, promoveren doe je niet alleen, en dat geldt zeker voor mij. Tijdens mijn promotietijd heb 
ik de eer gehad om deel uit te maken van verschillende omvangrijke samenwerkingsverbanden, zoals 
OPCARE9 en KOPPEL. En naast mijn vaste werkplek bij de afdeling Maatschappelijk Gezondheidszorg van 
het Erasmus MC heb ik ook als onderzoeker mogen werken in Italië, Nieuw Zeeland en Zwitserland. Aan 
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van KOPPEL. Bedankt hiervoor!
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Beste MGZ-collega’s, jullie geven het Ae-gebouw kleur! Bedankt voor de heerlijke tijd, voor alle 
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congressen, met bijzonder op de door ons georganiseerde Hollandse avonden tijdens de EAPC. Ook het 
zelf kokkerellen ging ons goed af. Bedankt voor alles, ik zal jullie missen!
Beste	kamergenoten,	Erica	en	Evelien,	we	hebben	bijna	vier	jaar	samen	op	de	kamer	gezeten;	een	drie-
eenheid die werkte. In Ae-140 was altijd tijd voor gezelligheid en om je hart te luchten, hartstikke bedankt 
hiervoor.  En Erica, ik ben heel blij dat jij naast me wilt staan als paranimf, kan je vast voelen hoe het is om 
op deze plek te staan.
Beste oud-collega’s van het UMC Utrecht, beste professor Verbout, professor Saris en professor Dhert, ooit 
begon mijn werkende leven bij jullie op de afdeling Orthopaedie als onderzoekscoördinator. Niet alleen 
heb ik Joost bij jullie gevonden, ook enthousiastmeerden jullie mij voor onderzoek. Bedankt hiervoor!
Beste NIVEL collega’s, ik ben nog maar net bij het NIVEL begonnen, maar ik voel me nu al thuis. Dank je wel 
hiervoor en voor de interesse in mijn boekje.
 
Een mensenleven bestaat uit meer dan promoveren alleen en gelukkig ben ik gezegend met vele lieve 
mensen om mij heen die mijn leven verrijken.
Lieve ‘studiemeiden’, Janine, Lobke, Nienke, Noortje, Marieke, Josja en Leonie. De naam dekt al lang niet 
meer, maar what’s in a name? Al jaren samen, met vele hoogtepunten en ook groot verdriet. Bedankt voor 
alle muzikale en culinaire afleidingen in de vorm van vakanties, weekendjes weg, festivals, concerten, 
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ben trots om je vriendin te zijn en kan niet wachten op onze volgende avonturen. Dank je wel, lieve schat!
Lieve Lob, in de turbulente start van mijn studietijd ‘adopteerde’ jij me meteen tijdens de eerste 
werkgroep en vanaf toen is een hele dierbare vriendschap ontstaan. Vele fantastische herinneringen, 
van foute feestjes tot een gezinsvakantie in Frankrijk, ze zijn me allemaal even dierbaar. En nu sta je aan 
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Lieve Dimfy, Maaike en Monique, vriendinnetjes van het eerste uur. VWO2 in het Brabantse Uden, daar 
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